0001144204-15-065561.txt : 20151116 0001144204-15-065561.hdr.sgml : 20151116 20151116085256 ACCESSION NUMBER: 0001144204-15-065561 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20150930 FILED AS OF DATE: 20151116 DATE AS OF CHANGE: 20151116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BLONDER TONGUE LABORATORIES INC CENTRAL INDEX KEY: 0001000683 STANDARD INDUSTRIAL CLASSIFICATION: RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663] IRS NUMBER: 521611421 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-14120 FILM NUMBER: 151231830 BUSINESS ADDRESS: STREET 1: ONE JAKE BROWN RD STREET 2: PO BOX 1000 CITY: OLD BRIDGE STATE: NJ ZIP: 08857 BUSINESS PHONE: 9086794000 MAIL ADDRESS: STREET 1: ONE JAKE BROWN ROAD CITY: OLD BRIDGE STATE: NJ ZIP: 08857 10-Q 1 v424280_10q.htm 10-Q

 

SECURITIES AND EXCHANGE COMMISSION

 

WASHINGTON, D.C. 20549

 

 

 

FORM 10-Q

 

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2015.

 

OR

 

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM              TO               .

 

Commission file number 1-14120

 

BLONDER TONGUE LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   52-1611421
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)

 

One Jake Brown Road, Old Bridge, New Jersey   08857
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (732) 679-4000

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes  x  No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

 

Yes  x  No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “accelerated filer,” “large accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨ Accelerated filer ¨
   
Non-accelerated filer ¨ Smaller reporting company x

 

(Do not check if a smaller reporting company)

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨  No x

 

Number of shares of common stock, par value $.001, outstanding as of November 6, 2015: 6,554,736

 

The Exhibit Index appears on page 19.

 

   
 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)

 

   (unaudited)     
   September 30,   December 31, 
   2015   2014 
Assets          
Current assets:          
Cash  $304   $232 
Accounts receivable, net of allowance for doubtful accounts of  $191 and $176   2,171    2,425 
Inventories   7,623    9,257 
Prepaid and other current assets   284    651 
Total current assets   10,382    12,565 
Inventories, net of non-current   1,391    1,628 
Property, plant and equipment, net of accumulated depreciation and amortization   3,744    3,923 
License agreements, net   594    645 
Intangible assets, net   1,827    1,962 
Goodwill   493    493 
Other assets   130    28 
   $18,561   $21,244 
Liabilities and Stockholders’ Equity          
Current liabilities:          
Line of credit  $2,539   $1,269 
Current portion of long-term debt   3,673    286 
Accounts payable   1,944    1,351 
Accrued compensation   553    513 
Accrued benefit liability   260    260 
Income taxes payable   24    24 
Other accrued expenses   198    101 
Total current liabilities   9,191    3,804 
           
Long-term debt   14    3,607 
Deferred income taxes   95    95 
Commitments and contingencies   -    - 
Stockholders’ equity:          
Preferred stock, $.001 par value; authorized 5,000 shares; No shares outstanding   -    - 

Common stock, $.001 par value; authorized 25,000 shares, 8,464 shares
Issued and 6,555 and 6,263 shares outstanding at Sept. 30, 2015 and Dec. 31, 2014

   8    8 
Paid-in capital   26,390    26,435 
Accumulated deficit   (9,471)   (4,096)
Accumulated other comprehensive loss   (1,354)   (1,354)
Treasury stock, at cost, 1,909 and 2,202 shares   (6,312)   (7,255)
Total stockholders’ equity   9,261    13,738 
   $18,561   $21,244 

 

See accompanying notes to condensed consolidated financial statements

 

 - 2 

 

 

BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES 

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(unaudited)

 

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2015   2014   2015   2014 
Net sales  $5,704   $8,659   $15,729   $23,065 
Cost of goods sold   4,931    5,173    12,040    14,347 
Gross profit   773    3,486    3,689    8,718 
Operating expenses:                    
Selling   776    807    2,392    2,500 
General and administrative   1,003    1,161    3,085    3,631 
Research and development   869    865    2,598    2,634 
    2,648    2,833    8,075    8,765 
Earnings (loss) from operations   (1,875)   653    (4,386)   (47)
Other Expense:   Interest expense (net)   (83)   (69)   (249)   (183)
Earnings (loss) before income taxes   (1,958)   584    (4,635)   (230)
Provision (benefit) for income taxes   -    -    -    - 
Net earnings (loss)  $(1,958)  $584   $(4,635)  $(230)
Basic and diluted net earnings (loss) per share  $(0.30)  $0.09   $(0.72)  $(0.04)
Basic weighted averages shares outstanding   6,555    6,226    6,407    6,220 
Diluted weighted average shares outstanding   6,555    6,320    6,407    6,220 

 

See accompanying notes to condensed consolidated financial statements

 

 - 3 

 

 

BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(unaudited)

 

   Nine  Months Ended September 30, 
   2015   2014 
Cash Flows From Operating Activities:          
Net loss  $(4,635)  $(230)
Adjustments to reconcile net loss to cash provided by (used in) operating activities:          
Stock compensation expense   158    186 
Depreciation   367    339 
Amortization   634    735 
Provision for inventory reserves   1,026    107 
Provision for doubtful accounts.   15    - 
Changes in operating assets and liabilities:          
Accounts receivable   239    560 
Inventories   845    958 
Prepaid and other current assets   367    (244)
Other assets   (102)   24 
Accounts payable, accrued compensation and other accrued expenses   730    272 
Net cash provided by (used in) operating activities   (356)   2,707 
Cash Flows From Investing Activities:          
Capital expenditures   (188)   (508)
Additional licenses   (448)   (369)
Net cash used in investing activities   (636)   (877)
Cash Flows From Financing Activities:          
Net borrowings (repayments) on line of credit   1,270    (275)
Repayments of long-term debt   (206)   (204)
Proceeds from exercise of stock options   -    12 
Net cash provided by (used in) financing activities   1,064    (467)
Net increase in cash   72    1,363 
Cash, beginning of period  $232   $67 
Cash, end of period  $304   $1,430 
Supplemental Cash Flow Information:          
Cash paid for interest  $221   $190 
Cash paid for income taxes   -    - 

 

See accompanying notes to condensed consolidated financial statements.

 

 - 4 

 

 

BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands)

(unaudited)

 

Note 1 - Company and Basis of Presentation

 

Blonder Tongue Laboratories, Inc. (together with its consolidated subsidiaries, the “Company”) is a technology-development and manufacturing company that delivers television signal encoding, transcoding, digital transport, and broadband product solutions to the cable markets the Company serves, including the multi-dwelling unit market, the lodging/hospitality market and the institutional market including, hospitals, prisons and schools, primarily throughout the United States and Canada. The condensed consolidated financial statements include the accounts of Blonder Tongue Laboratories, Inc. and its wholly-owned subsidiaries. Significant intercompany accounts and transactions have been eliminated in consolidation.

 

The results for the third quarter of 2015 are not necessarily indicative of the results to be expected for the full fiscal year and have not been audited. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting primarily of normal recurring accruals, necessary for a fair statement of the results of operations and cash flows for the periods presented and the condensed consolidated balance sheet at September 30, 2015. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to SEC rules and regulations. These financial statements should be read in conjunction with the financial statements and notes thereto that were included in the Company’s latest annual report on Form 10-K for the year ended December 31, 2014, filed with the SEC on March 21, 2015.

 

Note 2 – Liquidity and Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business. During the nine months ended September 30, 2015, the Company experienced a decline in sales, a reduction in working capital, reported a loss from operations and net cash used in operating activities, in conjunction with liquidity constraints. Furthermore, the Company’s Revolver and Term Loan will expire by their terms on February 1, 2016, unless extended. The above factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

 

In response to lower than expected sales due to a slowdown in market activities experienced during the first half of the fiscal year, the Company implemented a two-phase cost-reduction program which is expected to reduce annualized expenses by approximately $2,100, including a temporary reduction in certain executive salaries, a decrease in workforce and a decrease in engineering consulting expenses. In September 2015, the Company then developed and implemented a third phase cost reduction plan, which is expected to further reduce annualized expenses by approximately $750.

 

The Company’s primary sources of liquidity are its existing cash balances, cash generated from operations and amounts available under the Santander Financing (as defined in Note 6 below). As of September 30, 2015, the Company had approximately $2,539 outstanding under the Revolver (as defined in Note 6 below) and $483 of additional availability for borrowing under the Revolver. The Company expects to either obtain an extension of the maturity date or refinance all or part of the Santander indebtedness prior to February 1, 2016. If anticipated operating results are not achieved, and or sufficient funds are not obtained, from the Company’s expected refinancing, further reductions in operating expenses may be needed and could have a material adverse effect on the Company’s ability to achieve its intended business objectives. 

 

The Company cannot provide any assurance that it will be able to refinance its current debt obligations. If the Company is unable to refinance, it may be required to take additional measures to reduce costs in order to conserve its cash in amounts sufficient to sustain operations and meet its obligations.

 

 - 5 

 

 

BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands)

(unaudited)

 

Note 3- Earnings (loss) Per Share

 

Earnings (loss) per share is calculated in accordance with ASC Topic 260 “Earnings Per Share,” which provides for the calculation of “basic” and “diluted” earnings (loss) per share. Basic earnings (loss) per share includes no dilution and is computed by dividing net earnings (loss) by the weighted average number of common shares outstanding for the period.  Diluted earnings per share reflect, in periods in which they have a dilutive effect, the effect of common shares issuable upon exercise of stock options. The diluted share base excludes incremental shares of 2,183 and 1,015 related to stock options for the three month periods ended September 30, 2015 and 2014, respectively and 1,799 and 1,443 for the nine month periods ended September 30, 2015 and 2014, respectively. These shares were excluded due to their antidilutive effect.

 

Note 4 – New Accounting Pronouncements

 

In July 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) ASU No. 2015-11, Simplifying the Measurement of Inventory: Topic 330 (“ASU 2015-11”). Topic 330 currently requires an entity to measure inventory at the lower of cost or market. Market could be replacement cost, net realizable value, or net realizable value less an approximately normal profit margin. ASU 2015-11 requires that inventory measured using either the first-in, first-out (FIFO) or average cost method be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Adoption of ASU 2015-11 is required for fiscal reporting periods beginning after December 15, 2016, including interim reporting periods within those fiscal years. The Company does not expect adoption of ASU 2015-11 to have a material impact on its consolidated financial statements.

 

In July 2015, the FASB issued ASU No. 2015-12 “Plan Accounting: Defined Benefit Pension Plans (Topic 960), Defined Contribution Pension Plans (Topic 962), Health and Welfare Benefit Plans (Topic 965): Part I. Fully Benefit-Responsive Investment Contract; Part II. Plan Investment Disclosures; Part III. Measurement Date Practical Expedient” (“ASU 2015-12”). ASU 2015-12 Part II simplifies the disclosure of plan assets by removing the requirement to disaggregate the fair value of assets disclosed by general type. The Company is currently assessing the impact that adopting this new accounting guidance will have on its Consolidated Financial Statements. ASU 2015-12 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2015, and early adoption is permitted. Accordingly, the standard is effective for the Company on January 1, 2016.

 

In April 2015, the FASB issued ASU No. 2015-4, “Practical Expedient for the Measurement Date of an Employer’s Defined Benefit Obligation and Plan Assets” to provide a practical expedient related to the measurement date of the defined benefit plan assets and obligations. The practical expedient allows employers with fiscal year-end dates that do not coincide with a calendar month-end to measure pension and post-retirement benefit plan assets and obligations as of the calendar month-end date closest to the fiscal year-end. The standard requires entities that elect the practical expedient to adjust the measurement of benefit plan assets and obligations for contributions or significant events between the month end measurement date and the entity’s fiscal year end. The ASU is effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Earlier adoption is permitted. The Company does not expect adoption of ASU 2015-4 to have a material impact on its consolidated financial statements.

 

The FASB, the Emerging Issues Task Force and the SEC have issued certain accounting standards updates and regulations as of September 30, 2015 that will become effective in subsequent periods; however, management of the Company does not believe that any of those updates would have significantly affected the Company’s financial accounting measures or disclosures had they been in effect during 2015 or 2014, and does not believe that any of those pronouncements will have a significant impact on the Company’s consolidated financial statements at the time they become effective.

 

 - 6 

 

 

BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands)

(unaudited)

 

Note 5 – Inventories

 

Inventories net of reserves are summarized as follows:

 

   September 30,
2015
   December 31,
2014
 
Raw Materials  $4,791   $5,151 
Work in process   2,233    3,045 
Finished Goods   5,391    5,487 
    12,415    13,683 
Less current inventory   (7,623)   (9,257)
    4,792    4,426 
Less reserve for slow moving and obsolete inventory   (3,401)   (2,798)
   $1,391   $1,628 

 

Inventories are stated at the lower of cost, determined by the first-in, first-out (“FIFO”) method, or market.

 

The Company periodically analyzes anticipated product sales based on historical results, current backlog and marketing plans. Based on these analyses, the Company anticipates that certain products will not be sold during the next twelve months. Inventories that are not anticipated to be sold in the next twelve months, have been classified as non-current.

 

Approximately 100% and 66% of the non-current inventories were comprised of finished goods at both September 30, 2015 and December 31, 2014, respectively. The Company has established a program to use interchangeable parts in its various product offerings and to modify certain of its finished goods to better match customer demands. In addition, the Company has instituted additional marketing programs to dispose of the slower moving inventories. During the three and nine months ended September 30, 2015, the Company increased the inventory reserve by $1,008 and $1,026, respectively.

 

The Company continually analyzes its slow-moving inventories. Based on historical and projected sales volumes and anticipated selling prices, the Company establishes reserves.

 

Note 6 – Debt

 

On August 6, 2008, the Company entered into a Revolving Credit, Term Loan and Security Agreement with Santander Bank, N.A. (formerly known as Sovereign Bank, N.A.) through its Sovereign Business Capital division (“Santander”), pursuant to which the Company obtained an $8,000 credit facility from Santander (the “Santander Financing”). The Company and Santander entered into a series of amendments to the foregoing Revolving Credit, Term Loan and Security Agreement (as so amended, the “Santander Agreement”), including the Seventh Amendment referenced below, which, among other things, adjusted the Santander Financing to $8,783 consisting of (i) a $5,000 asset-based revolving credit facility (“Revolver”) and (ii) a $3,783 term loan facility (“Term Loan”), each expiring on February 1, 2016. The amounts which may be borrowed under the Revolver are based on certain percentages of Eligible Receivables and Eligible Inventory, as such terms are defined in the Santander Agreement. The obligations of the Company under the Santander Agreement are secured by substantially all of the assets of the Company and certain of its subsidiaries.

 

Under the Santander Agreement, the Revolver currently bears interest at a rate per annum equal to the prime lending rate announced from time to time by Santander (“Prime”) plus 1.50% or the LIBOR rate plus 4.25%. The Term Loan currently bears interest at a rate per annum equal to Prime plus 1.75% or the LIBOR rate plus 4.50%. Prime was 3.25% at September 30, 2015. LIBOR rate loans under the Santander Agreement may be borrowed for interest periods of one, three or six months. The LIBOR rates for interest periods of one-month, three-months and six-months were 0.19%, 0.32% and 0.53%, respectively, at September 30, 2015. The per annum interest rates above became effective on January 21, 2015, pursuant to the terms of the Seventh Amendment described below.

 

 - 7 

 

 

BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands)

(unaudited)

 

On November 14, 2015, the Company entered into the Eleventh Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Eleventh Amendment”) to amend the Santander Financing. The Eleventh Amendment (i) waived the Company’s failure of compliance with the Minimum EBITDA and leverage ratio covenants for the measurement period ended September 30, 2015, effective as of September 30, 2015, and (ii) increased the advance rate applicable to Eligible Inventory (as defined in the Santander Agreement) from 25% to 35% through and until February 1, 2016, after which it will revert back to 25%. The Eleventh Amendment also contains other customary representations, covenants, terms and conditions. In connection with the Eleventh Amendment, the Company agreed to pay Santander an amendment fee of $50, which is payable in ten weekly installments of $5 each.

 

On October 14, 2015, the Company entered into the Tenth Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Tenth Amendment”) to amend the Santander Financing. The Tenth Amendment extended the increase in the advance rate applicable to Eligible Inventory (as defined in the Santander Agreement) from 25% to 35% through and until November 30, 2015, after which it will revert back to 25%. The Tenth Amendment also contains other customary representations, covenants, terms and conditions. In connection with the Tenth Amendment, the Company paid Santander an amendment fee of $5.

 

On August 12, 2015, the Company entered into the Ninth Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Ninth Amendment”) to amend the Santander Financing. The Ninth Amendment waived the Company’s failure of compliance with the Minimum EBITDA covenant for the measurement period ended June 30, 2015, effective as of June 30, 2015, and also contains other customary representations, covenants, terms and conditions. In connection with the Ninth Amendment, the Company paid Santander an amendment fee of $20.

 

On May 14, 2015, the Company entered into the Eighth Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Eighth Amendment”) to amend the Santander Financing. The Eighth Amendment (i) waived the Company’s failure of compliance with the Minimum EBITDA covenant for the three-month period ended March 31, 2015, effective as of March 31, 2015, and (ii) increased the advance rate applicable to Eligible Inventory (as defined in the Santander Agreement) from 25% to 35% through and until September 30, 2015, after which it will revert back to 25%. The Eighth Amendment also contains other customary representations, covenants, terms and conditions. In connection with the Eighth Amendment, the Company paid Santander an amendment fee of $15. The Eighth Amendment is in lieu of the Temporary Overadvance Facility, as more fully discussed in the next following paragraph.

 

On March 30, 2015, Santander agreed to provide the Company with $500 of additional availability beyond its borrowing base under the Revolver (the “Temporary Overadvance Facility”) during the period April 1, 2015 through April 24, 2015, for which the Company paid Santander an accommodation fee of $2.5. Under the agreement, the Company was required to eliminate the outstanding balance under the Temporary Overadvance Facility on or before September 30, 2015, which was accomplished prior to entering into the Eight Amendment.

 

On January 21, 2015, the Company entered into the Seventh Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Seventh Amendment”) to amend the Santander Financing. The Seventh Amendment (i) extended by one year the Termination Date of the Santander Agreement from February 1, 2015 to February 1, 2016; (ii) continued the installment payments of principal under the Term Loan at the same monthly payment of $18 per month for the additional year until the final payment of unpaid principal and interest is due on February 1, 2016; (iii) increased the interest rates applicable to the Revolver and the Term Loan by one quarter of one percent (0.25%); and (iv) reset and modified the Minimum EBITDA covenant to address the term being extended by one year. The Seventh Amendment also contains other customary representations, covenants, terms and conditions. The Company paid a $15 amendment fee to Santander in connection with the Amendment.

 

On March 28, 2014, the Company entered into a Sixth Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Sixth Amendment”) to amend the Santander Financing. The Sixth Amendment (i) reduced the maximum amount available for borrowing under the Revolver from $6,000 to $5,000, (ii) increased the interest rates applicable to the Revolver and the Term Loan by three quarters of one percent, (iii) modified the Company’s fixed charge coverage ratio covenant to eliminate the testing thereof with respect to the trailing 12-month period ended as of December 31, 2013, (iv) eliminated the fixed charge coverage ratio covenant with respect to all periods after December 31, 2013, (v) modified the minimum EBITDA covenant to (a) eliminate the testing thereof with respect to the fiscal year ended December 31, 2013, (b) change the manner of calculation thereof, and (c) impose a quarterly building minimum EBITDA covenant test, commencing with the fiscal quarter ended on March 31, 2014, and thereafter for the two fiscal quarters ended June 30, 2014, the three fiscal quarters ended September 30, 2014, the four fiscal quarters ended December 31, 2014 and thereafter quarterly on a trailing four fiscal quarter basis, (vi) reduced the advance rate applicable to Eligible Inventory (as defined in the Santander Agreement) from 50% to 35%, with a further reduction in such advance rate to 25% effective on or about June 27, 2014 and (vii) reduced the sublimit on advances against such Eligible Inventory from $3,000 to $2,000. In connection with the Sixth Amendment, the Company paid Santander an amendment fee of $45.

 

 - 8 

 

 

BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands)

(unaudited)

 

Upon termination of the Revolver, all outstanding borrowings under the Revolver are due. The outstanding principal balance of the Revolver was $2,539 at September 30, 2015. The Term Loan requires equal monthly principal payments of approximately $18 each, plus interest, with the remaining balance due at maturity. The outstanding principal balance of the Term Loan was $3,622 at September 30, 2015.

 

The Santander Agreement contains customary representations and warranties as well as affirmative and negative covenants, including certain financial covenants. The Santander Agreement contains customary events of default, including, among others, non-payment of principal, interest or other amounts when due.

 

Note 7 – Legal Proceedings

 

The Company may be a party to certain proceedings incidental to the ordinary course of its business, none of which, in the current opinion of management, may be likely to have a material adverse effect on the Company’s business, financial condition, results of operations, or cash flows.

 

Note 8 – Subsequent Events

 

The Company has evaluated subsequent events through the filing of its condensed consolidated financial statements with the SEC.

 

 - 9 

 

 

ITEM 2.   MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward-Looking Statements

 

In addition to historical information, this Quarterly Report contains forward-looking statements regarding future events relating to such matters as anticipated financial performance, business prospects, technological developments, new products, research and development activities and similar matters. The Private Securities Litigation Reform Act of 1995, the Securities Act of 1933 and the Securities Exchange Act of 1934 provide safe harbors for forward-looking statements. In order to comply with the terms of these safe harbors, the Company notes that a variety of factors could cause the Company’s actual results and experience to differ materially and adversely from the anticipated results or other expectations expressed in the Company’s forward-looking statements. The risks and uncertainties that may affect the operation, performance, development and results of the Company’s business include, but are not limited to, those matters discussed herein in the section entitled Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations. The words “believe,” “expect,” “anticipate,” “project,” “target,” “intend,” “plan,” “seek,” “estimate,” “endeavor,” “should,” “could,” “may” and similar expressions are intended to identify forward-looking statements. In addition, any statements that refer to projections for our future financial performance, the anticipated sales in our business returning to historical norms, our ability to extend or refinance our debt obligations, any anticipated expense reductions, uncertainty regarding the adequacy of capital resources and liquidity, alternative sources of additional capital or extensions of the advance rate under the Santander financing, and other characterizations of future events or circumstance are forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. In addition to the risk factors in Part II, Item 1A below, readers should also carefully review the risk factors described in other documents the Company files from time to time with the Securities and Exchange Commission, including without limitation, the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 (See Item 1 – Business; Item 1A – Risk Factors; Item 3 – Legal Proceedings and Item 7 – Management’s Discussion and Analysis of Financial Condition and Results of Operations).

 

General

 

The Company is a technology-development and manufacturing company that delivers a wide range of products and services to the cable entertainment and media industry. For 65 years, Blonder Tongue/Drake products have been deployed in a long list of locations, including lodging/hospitality, multi-dwelling units/apartments, broadcast studios/networks, education universities/schools, healthcare hospitals/fitness centers, government facilities/offices, prisons, airports, sports stadiums/arenas, entertainment venues/casinos, retail stores, and small-medium businesses. These applications are variously described as commercial, institutional and/or enterprise environments and will be referred to herein collectively as “CIE”. The customers we serve include business entities installing private video and data networks in these environments, whether they are the largest cable television operators, telco or satellite providers, integrators, architects, engineers or the next generation of Internet Protocol Television (“IPTV”) streaming video providers. The technology requirements of these markets change rapidly and the Company’s research and development team is continually delivering high performance-lower cost solutions to meet customers’ needs.

 

The Company’s strategy is focused on providing a wide range of products to meet the needs of the CIE environments described above (e.g., hotels, hospitals, prisons, schools, etc.), and to provide offerings that are optimized for an operator’s existing infrastructure, as well as the operator’s future strategy. A key component of this growth strategy is to provide products that deliver the latest technologies (such as IPTV and digital SD and HD video content) and have a high performance-to-cost ratio.

 

The Company has seen a continuing long-term shift in product mix from analog products to digital products and expects this shift to continue. Any substantial decrease in sales of analog products without a related increase in digital products could have a material adverse effect on the Company’s results of operations, financial condition and cash flows. Despite this long-term trend, sales of digital video headend products were $2,610,000 and $4,508,000 in the third three months of 2015 and 2014, respectively and $7,115,000 and $12,034,000 in the first nine months of 2015 and 2014, respectively. Likewise, sales of analog video headend products were $930,000 and $2,318,000 in the third three months of 2015 and 2014, respectively and $2,843,000 and $5,979,000 in the first nine months of 2015 and 2014 respectively.

 

The Company’s manufacturing is allocated primarily between its facility in Old Bridge, New Jersey the (“Old Bridge Facility”) and a key contract manufacturer located in the People’s Republic of China (“PRC”). The Company currently manufactures most of its digital products, including the latest encoder and EdgeQAM collections at the Old Bridge Facility. Since 2007 the Company has transitioned and continues to manufacture certain high volume, labor intensive products, including many of the Company’s analog products, in the PRC, pursuant to a manufacturing agreement that governs the production of products that may from time to time be the subject of purchase orders submitted by (and in the discretion of) the Company. The Company may transition additional products to the PRC if determined by the Company to be advantageous based upon changing business and market conditions. Manufacturing products both at the Company’s Old Bridge Facility as well as in the PRC, enables the Company to realize cost reductions while maintaining a competitive position and time-to-market advantage.

 

 - 10 

 

 

Results of Operations

 

Third three months of 2015 Compared with third three months of 2014

 

Net Sales. Net sales decreased $2,955,000 or 34.1%, to $5,704,000 in the third three months of 2015 from $8,659,000 in the third three months of 2014. The decrease is primarily attributed to a decrease in sales of digital video headend products and analog video headend products offset by an increase in contracted manufactured products and data products. Sales of digital video headend products were $2,610,000 and $4,508,000, analog video headend products were $930,000 and $2,318,000, contract manufactured products were $447,000 and $82,000 and data products were $314,000 and $2,000 in the third three months of 2015 and 2014, respectively.

 

Cost of Goods Sold. Cost of goods sold decreased to $4,931,000 for the third three months of 2015 from $5,173,000 for the third three months of 2014, but increased as a percentage of sales to 86.5% from 59.7%. The decrease was primarily due to a decrease in overall sales. The increase as a percentage of sales was primarily attributed to an overall increase in manufacturing overhead, an increase in inventory reserve of $900,000, as well as a less favorable product mix.

 

Selling Expenses. Selling expenses decreased to $776,000 for the third three months of 2015 from $807,000 in the third three months of 2014, but increased as percentage of sales to 13.6% for the third three months of 2015 from 9.3% for the third three months of 2014. The $31,000 decrease was primarily the result of a reduction in salary expense (including fringe benefits) of $94,000 due to a decrease in headcount and by a reduction of $54,000 due to the closing of our Canadian facility offset by an increase in royalty expense of $131,000. The percentage increase was primarily the result of lower sales.

 

General and Administrative Expenses. General and administrative expenses decreased to $1,003,000 for the third three months of 2015 from $1,161,000 for the third three months of 2014, but increased as a percentage of sales to 17.6% for the third three months of 2015 from 13.4% for the third three months of 2014. The $158,000 decrease was primarily the result of a reduction in salary expense (including fringe benefits) of $240,000 due to a decrease in head count offset by an increase in professional fees of $69,000. The percentage increase was primarily the result of lower sales.

 

Research and Development Expenses. Research and development expenses increased to $869,000 in the third three months of 2015 from $865,000 in the third three months of 2014, and increased as a percentage of sales to 15.2% for the third three months of 2015 from 10.0% for the third three months of 2014. This $4,000 increase is primarily the result of an increase in salary expense (including fringe benefits) of $19,000 due to an increase in head count, offset by a decrease in consulting expenses of $46,000. The percentage increase was primarily the result of lower sales.

 

Operating Income (Loss). Operating loss of $(1,875,000) for the third three months of 2015 represents a $2,528,000 decrease from the operating income of $653,000 for the third three months of 2014. Operating income (loss) as a percentage of sales was (32.9%) in the third three months of 2015 compared to 7.5% in the third three months of 2014.

 

Other Expense. Interest expense increased to $79,000 in the third three months of 2015 from $69,000 in the third three months of 2014. The increase is the result of higher average borrowings and higher interest rates.

 

First nine months of 2015 Compared with first nine months of 2014

 

Net Sales. Net sales decreased $7,336,000 or 31.8%, to $15,729,000 in the first nine months of 2015 from $23,065,000 in the first nine months of 2014. The decrease is primarily attributed to a decrease in sales of digital video headend products, analog video headend products and HFC distribution products, offset by an increase in contract manufactured products and data products. Sales of digital video headend products were $7,115,000 and $12,034,000, analog video headend products were $2,843,000 and $5,979,000, HFC distribution products were $2,802,000 and $3,260,000, contract manufactured products were $1,144,000 and $296,000 and data products were $499,000 and $15,000 in the first nine months of 2015 and 2014, respectively.

 

 - 11 

 

 

Cost of Goods Sold. Cost of goods sold decreased to $12,040,000 for the first nine months of 2015 from $14,347,000 for the first nine months of 2014, but increased as a percentage of sales to 76.6% from 62.2%. The decrease was primarily due to a decrease in overall sales. The increase as a percentage of sales was primarily attributed to an overall increase in manufacturing overhead, an increase in inventory reserve of $900,000 as well as a less favorable product mix.

 

Selling Expenses. Selling expenses decreased to $2,392,000 for the first nine months of 2015 from $2,500,000 in the first nine months of 2014, but increased as percentage of sales to 15.2% for the first nine months of 2015 from 10.8% for the first nine months of 2014. The $108,000 decrease was primarily due to a reduction of $162,000 as a result of the closing of our Canadian facility and a reduction in salary expense (including fringe benefits) of $44,000 due to a decrease in headcount offset by an increase in royalty expense of $124,000. The percentage increase was primarily the result of lower sales.

 

General and Administrative Expenses. General and administrative expenses decreased to $3,085,000 for the first nine months of 2015 from $3,631,000 for the first nine months of 2014, but increased as a percentage of sales to 19.6% for the first nine months of 2015 from 15.7% for the first nine months of 2014. The $546,000 decrease was primarily the result of a decrease in salary expense (including fringe benefits) of $467,000 due to decreased headcount and a decrease in travel and entertainment of $100,000. The percentage increase was primarily the result of lower sales.

 

Research and Development Expenses. Research and development expenses decreased to $2,598,000 in the first nine months of 2015 from $2,634,000 in the first nine months of 2014, but increased as a percentage of sales to 16.5% for the first nine months of 2015 from 11.4% for the first nine months of 2014. This $36,000 decrease is primarily the result of a decrease in amortization expense of $46,000 relating to license fees. The percentage increase was primarily the result of lower sales.

 

Operating Income (Loss). Operating loss of $(4,386,000) for the first nine months of 2015 represents a $4,339,000 increase from the operating loss of $(47,000) for the first nine months of 2014. Operating loss as a percentage of sales was (27.9%) in the first nine months of 2015 compared to (0.2%) in the first nine months of 2014.

 

Other Expense. Interest expense increased to $228,000 in the first nine months of 2015 from $183,000 in the first nine months of 2014. The increase is the result of higher average borrowings and higher interest rates.

 

Liquidity and Capital Resources

 

As of September 30, 2015 and December 31, 2014, the Company’s working capital was $1,191,000 and $8,761,000, respectively. The decrease in working capital is primarily due to the reclassification of the Santander Term Loan of $3,387,000 from long term to short term, an increase of borrowings on the Revolver of $1,270,000 and decrease of inventories of $1,634,000.

 

The Company’s net cash used in operating activities for the nine month period ended September 30, 2015 was $356,000, primarily due to a net loss of $4,635,000 offset by non-cash adjustments of $2,200,000, a decrease in inventory of $845,000 and an increase in accounts payable and accrued expenses of $730,000.

 

Cash used in investing activities for the nine month period ended September 30, 2015 was $636,000, of which $448,000 was attributable to additional license fees and $188,000 was attributable to capital expenditures.

 

Cash provided by financing activities was $1,064,000 for the first nine months of 2015, which was comprised of net borrowings on the Revolver of $1,270,000 offset by repayment of debt of $206,000.

 

Under the Santander Agreement, the Revolver currently bears per annum interest at a rate per annum equal to the prime lending rate announced from time to time by Santander (“Prime”) plus 1.50% or the LIBOR rate plus 4.25%. The Term Loan currently bears interest at a rate per annum equal to Prime plus 1.75% or the LIBOR rate plus 4.50%. Prime was 3.25% at September 30, 2015. LIBOR rate loans under the Santander Agreement may be borrowed for interest periods of one, three or six months. The LIBOR rates for interest periods of one-month, three-months and six-months were 0.19%, 0.32% and 0.53%, respectively, at September 30, 2015. The per annum interest rates above became effective on January 21, 2015, pursuant to the terms of the Seventh Amendment described below.

 

On November 14, 2015, the Company entered into the Eleventh Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Eleventh Amendment”) to amend the Santander Financing. The Eleventh Amendment (i) waived the Company’s failure of compliance with the Minimum EBITDA and leverage ratio covenants for the measurement period ended September 30, 2015, effective as of September 30, 2015, and (ii) increased the advance rate applicable to Eligible Inventory (as defined in the Santander Agreement) from 25% to 35% through and until February 1, 2016, after which it will revert back to 25%. The Eleventh Amendment also contains other customary representations, covenants, terms and conditions. In connection with the Eleventh Amendment, the Company agreed to pay Santander an amendment fee of $50,000, which is payable in ten weekly installments of $5,000 each.

 

 - 12 

 

 

On October 14, 2015, the Company entered into the Tenth Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Tenth Amendment”) to amend the Santander Financing. The Tenth Amendment extended the increase in the advance rate applicable to Eligible Inventory (as defined in the Santander Agreement) from 25% to 35% through and until November 30, 2015, after which it will revert back to 25%. The Tenth Amendment also contains other customary representations, covenants, terms and conditions. In connection with the Tenth Amendment, the Company paid Santander an amendment fee of $5,000.

 

On August 12, 2015, the Company entered into the Ninth Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Ninth Amendment”) to amend the Santander Financing. The Ninth Amendment waived the Company’s failure of compliance with the Minimum EBITDA covenant for the measurement period ended June 30, 2015, effective as of June 30, 2015, and also contains other customary representations, covenants, terms and conditions. In connection with the Ninth Amendment, the Company paid Santander an amendment fee of $20,000.

 

On May 14, 2015, the Company entered into the Eighth Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Eighth Amendment”) to amend the Santander Financing. The Eighth Amendment (i) waived the Company’s failure of compliance with the Minimum EBITDA covenant for the three-month period ended March 31, 2015, effective as of March 31, 2015, and (ii) increased the advance rate applicable to Eligible Inventory (as defined in the Santander Agreement) from 25% to 35% through and until September 30, 2015, after which it will revert back to 25%. The Eighth Amendment also contains other customary representations, covenants, terms and conditions. In connection with the Eighth Amendment, the Company paid Santander an amendment fee of $15,000. The Eighth Amendment is in lieu of the Temporary Overadvance Facility, as more fully discussed in the next paragraph.

 

On March 30, 2015, Santander agreed to provide the Company with $500,000 of additional availability beyond its borrowing base under the Revolver (the “Temporary Overadvance Facility”) during the period April 1, 2015 through April 24, 2015, for which the Company paid Santander an accommodation fee of $2,500. Under the agreement, the Company was required to eliminate the outstanding balance under the Temporary Overadvance Facility on or before September 30, 2015, which was accomplished prior to entering into the Eight Amendment.

 

On January 21, 2015, the Company entered into the Seventh Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Seventh Amendment”) to amend the Santander Financing. The Seventh Amendment (i) extended by one year the Termination Date of the Santander Agreement from February 1, 2015 to February 1, 2016; (ii) continued the installment payments of principal under the Term Loan at the same monthly payment of $18,000 per month for the additional year until the final payment of unpaid principal and interest is due on February 1, 2016; (iii) increased the interest rates applicable to the Revolver and the Term Loan by one quarter of one percent (0.25%); and (iv) reset and modified the Minimum EBITDA covenant to address the term being extended by one year. The Seventh Amendment also contains other customary representations, covenants, terms and conditions. The Company paid a $15,000 amendment fee to Santander in connection with the Seventh Amendment.

 

On March 28, 2014, the Company entered into a Sixth Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Sixth Amendment”) to amend the Santander Financing. The Sixth Amendment (i) reduced the maximum amount available for borrowing under the Revolver from $6,000,000 to $5,000,000, (ii) increased the interest rates applicable to the Revolver and the Term Loan by three quarters of one percent, (iii) modified the Company’s fixed charge coverage ratio covenant to eliminate the testing thereof with respect to the trailing 12-month period ended as of December 31, 2013, (iv) eliminated the fixed charge coverage ratio covenant with respect to all periods after December 31, 2013, (v) modified the minimum EBITDA covenant to (a) eliminate the testing thereof with respect to the fiscal year ended December 31, 2013, (b) change the manner of calculation thereof, and (c) imposed a quarterly building minimum EBITDA covenant test, commencing with the fiscal quarter ended on March 31, 2014, and thereafter for the two fiscal quarters ended June 30, 2014, the three fiscal quarters ended September 30, 2014, the four fiscal quarters ended December 31, 2014 and thereafter quarterly on a trailing four fiscal quarter basis, (vi) reduced the advance rate applicable to Eligible Inventory (as defined in the Santander Agreement) from 50% to 35%, with a further reduction in such advance rate to 25% effective on or about June 27, 2014 and (vii) reduced the sublimit on advances against such Eligible Inventory from $3,000,000 to $2,000,000. In connection with the Sixth Amendment, the Company paid Santander an amendment fee of $45,000.

 

Upon termination of the Revolver, all outstanding borrowings under the Revolver are due. The outstanding principal balance of the Revolver was $2,539,000 at September 30, 2015. The Term Loan requires equal monthly principal payments of approximately $18,000 each, plus interest, with the remaining balance due at maturity. The outstanding principal balance of the Term Loan was $3,622,000 at September 30, 2015.

  

The Santander Agreement contains customary representations and warranties as well as affirmative and negative covenants, including certain financial covenants. The Santander Agreement contains customary events of default, including, among others, non-payment of principal, interest or other amounts when due.

 

 - 13 

 

 

The Company’s primary sources of liquidity at this time are its existing cash balances, cash generated from operations and amounts available under the Santander Financing, which is scheduled to mature and be due and payable in full on February 1, 2016. As of September 30, 2015, the Company had approximately $2,539,000 outstanding under the Revolver and $483,000 of additional availability for borrowing under the Revolver. As of October 31, 2015, the Company had approximately $2,268,000 outstanding under the Revolver and $560,000 of additional availability for borrowing under the Revolver. While the Company anticipates either obtaining an extension to the maturity date of its existing indebtedness or refinancing all or part of its existing indebtedness prior to February 1, 2016, there can be no assurances that an extension or refinancing will be available on acceptable terms or at all. Debt financing, if available, could impose additional cash payment obligations and additional covenants and operating restrictions.

 

As a result of lower than expected net sales in the first three quarters of 2015, the reduction, pursuant to the Sixth Amendment, in the advance rate applicable to Eligible Inventory from 50% to 25% and the temporary increase in that advance rate to 35% until February 1, 2016 pursuant to the Eighth, Tenth and Eleventh Amendments, the Company experienced a material decrease in its liquidity in the first three quarters of 2015. In addition, the Company’s sales have been slower than anticipated to recover to historical norms, and the Company no longer believes sales will recover to historical norms during the fourth quarter of 2015. In light of these developments and as detailed below, the Company is taking a more defensive posture and developing plans for managing operations through a more extended period of diminished sales levels than originally expected.

 

As disclosed above, during the nine months ended September 30, 2015, the Company experienced a decline in sales, a reduction in working capital, reported a loss from operations and net cash used in operating activities in conjunction with liquidity constraints. Furthermore, the Company’s Revolver and Term Loan will expire by their terms on February 1, 2016, unless extended. Based upon these events and trends occurring in the Company’s business, along with current expectations for the next 12 months, the Company may not have sufficient liquidity to sustain operations for the next 12 months. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.

 

As described below, the Company is focused on implementing a turnaround strategy, and in March of 2015 it started to implement operational and financial processes to improve liquidity and profitability. In addition to seeking to extend or refinance its outstanding indebtedness with Santander that is due on February 1, 2016, the Company is also evaluating and in discussions regarding other options to resolve its liquidity issues, including exploring alternative sources of additional capital (debt and equity). In this regard, on November 13, 2015, the Company received the Pallé Commitment (as defined below) to lend up to $600,000 to the Company pursuant to a Subordinated Loan (as defined below). In addition, the Company received the ZyCast Proposal (as defined below) to purchase $1,000,000 of the Company’s common stock. As more fully discussed below, these initiatives are subject to a number of conditions, including satisfactory due diligence and satisfactory amendment to the Company’s Revolver and Term Loan. Given these conditions, there can be no assurance that the Pallé Commitment or the ZyCast Proposal will be consummated and the funding received. The Company is also in discussions with Santander to extend the maturity date of the Company’s Revolver and Term Loan. As of the date of this Report, however, uncertainty exists as to the ultimate outcome of a refinancing or extension of the Company’s Revolver and Term Loan and any commitment or proposal. Accordingly, there are no assurances that these commitments, proposals or discussions will result in any transaction, or that any such transaction, if implemented, will be successful.

 

On November 13, 2015, the Company received a commitment from Robert J. Pallé and Carol Pallé (“Pallé Commitment”) to provide the Company with senior, subordinated, convertible debt financing of up to $600,000 (“Subordinated Loan”). The Subordinated Loan will consist of a revolving credit facility and a term loan. The revolving credit facility will accrue interest at 12% per annum, which at the Company’s option will be paid-in-kind or in cash. The revolving credit facility will expire three years from the date of closing. The term loan will accrue interest at 12% per annum (subject to increase by 5% if certain conditions are not met with regard to the convertibility of the debt into shares of the Company’s common stock), paid-in-kind, and will expire three years from the date of closing. The lender has the option to convert the principal balance of the Subordinated Loan into shares of the Company’s common stock at $0.54 per share, subject to certain conditions surrounding the timing of conversion and any necessary shareholder approval required by the rules of the NYSE MKT. This commitment is subject to a number of conditions, including, among others, (i) satisfactory due diligence, (ii) the parties entering into a note, subordination agreement and other related documentation to effectuate the Subordinated Loan, (iii) satisfactory amendment of the Company’s Revolver and Term Loan, and (iv) compliance with applicable securities laws and stock exchange requirements. Given these conditions, there can be no assurance that the Pallé Commitment will be completed and the funding received. The foregoing summary of the Pallé Commitment is not complete and is qualified in its entirety by reference to the full text of the Pallé Commitment attached hereto as Exhibit 10.4, which is incorporated herein by reference.

 

 - 14 

 

 

In November, 2015, the Company received a proposal from ZyCast Technology, Inc. to invest $1,000,000 to purchase shares of the Company’s common stock at a price equal to the greater of: (a) 110% of the average closing price of the Common Stock on the NYSE MKT during the ten trading days ending on the earlier of (i) the business day immediately preceding the date this proposal is publicly announced and (ii) the business day immediately preceding the closing date for the sale, and (b) fifty cents ($0.50) per share (“ZyCast Proposal”). ZyCast Technology is a Taiwanese electronics manufacturer who is seeking to enter into certain strategic initiatives with the Company to sell certain products in the Asian market. This proposal is subject to a number of conditions, including, among others, (i) satisfactory due diligence, (ii) the parties entering into a stock purchase agreement to effectuate the sale, (iii) a written commitment for an additional $500,000 debt investment in the Company by another party, (iv) satisfactory amendment of the Company’s Revolver and Term Loan, (v) the ability of ZyCast to appoint a director to the Company’s Board of Directors, and (vi) the parties entering into an agreement that grants ZyCast rights to use the Blonder Tongue name and logo on certain products sold by ZyCast in the Asian market. Given these conditions, there can be no assurance that the ZyCast Proposal will be completed and the funding received. The foregoing summary of the ZyCast Proposal is not complete and is qualified in its entirety by reference to the full text of the ZyCast Proposal attached hereto as Exhibit 10.5, which is incorporated herein by reference.

 

In other efforts to alleviate the liquidity pressures and reposition the Company to become profitable at a lower level of net sales, earlier in 2015 the Company implemented a two-phase cost-reduction program, which is expected to reduce annualized expenses by approximately $2,100,000, including a temporary reduction in certain executive salaries, a decrease in workforce and a decrease in engineering consulting expenses. The Company also developed and implemented a third phase cost reduction plan in September 2015, which is expected to reduce annualized expenses by approximately $750,000, including a temporary reduction in certain salaries and a decrease in workforce. In November 2015, the Company developed and implemented a fourth phase cost reduction plan, which is expected to reduce annualized expenses by approximately $1,000,000, including a temporary reduction in certain salaries and a decrease in workforce. The Company is also implementing certain sales initiatives to increase the Company’s operating cash flow. Although the Company believes it has made progress under these programs (e.g., the Company’s liquidity position has modestly improved since March 30, 2015), the Company operates in a rapidly evolving and often unpredictable business environment that may change the timing or amount of expected future cash receipts and expenditures. Accordingly, there can be no assurance that the Company’s planned operational improvements will be successful. If anticipated operating results are not achieved, and or sufficient funds are not obtained from the Company’s efforts to refinance and raise capital, further reductions in operating expenses may be needed and could have a material adverse effect on the Company’s ability to achieve its intended business objectives and continue as a going concern.

  

The Company also expects to make financed and unfinanced long-term capital expenditures from time to time in the ordinary course of business, which capital expenditures were $188,000 and $673,000 in the nine months ended September 30, 2015 and the year ended December 31, 2014, respectively. Subject to the liquidity concerns noted above, the Company expects to use cash generated from operations, amounts available under its credit facility (including the anticipated refinancing) and purchase-money financing to meet any anticipated long-term capital expenditures.

  

New Accounting Pronouncements

 

See Note 4 of the Notes to Condensed Consolidated Financial Statements for a full description of recent accounting pronouncements, including the anticipated dates of adoption and the effects on the Company’s consolidated financial position and results of operations.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable to smaller reporting companies.

 

 - 15 

 

 

ITEM 4. CONTROLS AND PROCEDURES

 

The Company maintains a system of disclosure controls and procedures designed to provide reasonable assurance that information required to be disclosed in the Company’s reports filed or submitted pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that such information is accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.  The Company carried out an evaluation, under the supervision and with the participation of management, including the principal executive officer and principal financial officer, of the design and operation of the Company’s disclosure controls and procedures as of the end of the period covered by this report. Based on this evaluation, the Company’s principal executive officer and principal financial officer concluded that the Company’s disclosure controls and procedures were effective at September 30, 2015.

 

During the quarter ended September 30, 2015, there have been no changes in the Company’s internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

The Company may be a party to certain proceedings incidental to the ordinary course of its business, none of which, in the current opinion of management, is likely to have a material adverse effect on the Company’s business, financial condition, results of operations, or cash flows.

 

ITEM 1A. RISK FACTORS

 

Our business involves various risks and uncertainties in addition to the normal risks of business, some of which are discussed elsewhere in this Report, including under "Forward-Looking Statements" under Part I, Item 2 of this Report, and in our other filings with the SEC.  It should be noted that our business may be adversely affected by a downturn in general economic conditions and other forces beyond our control. In addition, other risks and uncertainties not presently known or that we currently believe to be immaterial may also adversely affect our business. Any such risks or uncertainties, or any of the following risks or uncertainties, that develop into actual events could result in a material and adverse effect on our business, financial condition, results of operations, or liquidity.

 

During the nine months ended September 30, 2015, there have been no material changes in our risk factors from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2014 except for the changes and additions described below.  The risks described below, together with all of the other information included in this Report, should be carefully considered in evaluating our business and prospects.  Please refer to our Annual Report on Form 10-K for the year-ended December 31, 2014 for a list of our other risk factors.  Solely for purposes of the risk factors in this Item 1A, the terms “we,” “our” and “us” refer to Blonder Tongue Laboratories, Inc. and its subsidiaries.

 

There is substantial doubt about our ability to continue as a going concern.

 

Our condensed consolidated financial statements for the quarter ended September 30, 2015 included herein contain a "going concern" explanatory paragraph.

 

During the nine months ended September 30, 2015, we experienced a decline in sales, a reduction in working capital, reported loss from operations and net cash used in operating activities in conjunction with liquidity constraints. Furthermore, our Revolver and Term Loan will expire February 1, 2016.  Based upon these facts and trends, together with our current expectations for the next four fiscal quarters, we believe that we may not have sufficient liquidity necessary to sustain operations for the next twelve months. These factors, among others, raise substantial doubt regarding our ability to continue as a going concern.

 

If suppliers, customers, employees or other stakeholders lose confidence in the business, it may be more difficult for us to operate and could materially adversely affect our business, results of operations, and financial condition.

 

Doubts regarding our ability to continue as a going concern could result in loss of confidence by our customers, suppliers, employees and other stakeholders, which, in turn, could materially adversely affect our ability to operate. Concerns about our financial condition may cause our suppliers and other counterparties to tighten credit terms or cease doing business with us altogether, which would have a material adverse effect on our business and results of operations.

 

 - 16 

 

 

Our stock price has been volatile and any investment in our common stock could suffer a significant decline or total loss in value.

 

Because we face significant uncertainties relating to our liquidity and ability to generate sufficient cash flows from operations and to continue to operate our business as a going concern, our stock price is volatile and any investment in our common stock could suffer a significant decline or total loss in value. Furthermore, we may not be able to maintain compliance with the continued listing standards of the NYSE MKT LLC or any other national securities exchange or over-the-counter market on which our common stock is then traded, which may also adversely affect the trading price of our common stock.

 

ITEM 5. OTHER INFORMATION

 

On November 14, 2015, the Company entered into the Eleventh Amendment to Revolving Credit, Term Loan and Security Agreement, among Santander Bank, N.A., Blonder Tongue Laboratories, Inc., and R. L. Drake Holdings, LLC. Further details surrounding this agreement are described above in “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources,” which description is incorporated into this Item 5 by reference. The summary in this paragraph of the Eleventh Amendment is not complete and is qualified in its entirety by reference to the full text of the Eleventh Amendment, which is filed as Exhibit 10.3 hereto and is incorporated herein by reference.

 

On November 13, 2015, the Pallé Commitment was made by Robert J. Pallé and Carol Pallé to the Company. Further details surrounding this commitment are described above in “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources,” which description is incorporated into this Item 5 by reference. The summary in this paragraph of the Pallé Commitment is not complete and is qualified in its entirety by reference to the full text of the Pallé Commitment, which is filed as Exhibit 10.4 hereto and is incorporated herein by reference.

 

ITEM 6. EXHIBITS

 

The exhibits are listed in the Exhibit Index appearing at page 19 herein.

 

 - 17 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  BLONDER TONGUE LABORATORIES, INC.
     
Date:  November 16, 2015 By: /s/  Robert J. Pallé, Jr.
    Robert J. Pallé, Jr.
    Chief Executive Officer and President
    (Principal Executive Officer)
     
  By: /s/  Eric Skolnik
    Eric Skolnik
    Senior Vice President and Chief Financial Officer
    (Principal Financial Officer)

 

 - 18 

 

 

EXHIBIT INDEX

 

Exhibit #   Description   Location
3.1   Restated Certificate of Incorporation of Blonder Tongue Laboratories, Inc.   Incorporated by reference from Exhibit 3.1 to Registrant’s S-1 Registration Statement No. 33-98070 originally filed October 12, 1995, as amended.
         
3.2   Restated Bylaws of Blonder Tongue Laboratories, Inc., as amended.   Incorporated by reference from Exhibit 3.2 to Registrant’s Annual Report on Form 10-K/A originally filed May 9, 2008.
         
10.1   Ninth Amendment to Revolving Credit, Term Loan and Security Agreement, dated August 12, 2015, by and among Santander Bank, N.A., Blonder Tongue Laboratories, Inc. and R. L. Drake Holdings, LLC.   Incorporated by reference from Exhibit 10.2 to Registrant’s Quarterly Report on Form 10-Q, filed August 14, 2015
         
10.2   Tenth Amendment to Revolving Credit, Term Loan and Security Agreement, dated October 14, 2015, by and among Santander Bank, N.A., Blonder Tongue Laboratories, Inc. and R. L. Drake Holdings, LLC.   Incorporated by reference from Exhibit 99.1 to Registrant’s Current Report on Form 8-k, filed October 20, 2015
         
10.3  

Eleventh Amendment to Revolving Credit, Term Loan and Security Agreement, dated November 14, 2015, by and among Santander Bank, N.A., Blonder Tongue Laboratories, Inc. and R. L. Drake Holdings, LLC.

  Filed herewith
         

10.4

 

Commitment Letter from Robert J. Pallé and Carol Pallé to Blonder Tongue Laboratories, Inc., dated as of November 13, 2015.

 

Filed herewith.

         

10.5

 

Letter of Intent Proposal from ZyCast Technology, Inc., dated as of November 13, 2015.

 

Filed herewith.

         
31.1   Certification of  Robert J. Pallé, Jr. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   Filed herewith.
         
31.2   Certification of Eric Skolnik pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   Filed herewith.
         
32.1   Certification pursuant to Section 906 of Sarbanes-Oxley Act of 2002.   Filed herewith.
         
101.1   Interactive data files.   Filed herewith.

 

 - 19 

 

EX-10.3 2 v424280_ex10-3.htm EXHIBIT 10.3

Exhibit 10.3

 

ELEVENTH AMENDMENT TO REVOLVING CREDIT,

TERM LOAN AND SECURITY AGREEMENT

 

THIS ELEVENTH AMENDMENT TO REVOLVING CREDIT, TERM LOAN AND SECURITY AGREEMENT (the “Agreement”) is entered into on November 14, 2015, by and among BLONDER TONGUE LABORATORIES, INC., a corporation organized under the laws of the State of Delaware (“BTL”), R. L. DRAKE HOLDINGS, LLC, a limited liability company organized under the laws of the State of Delaware (“RL Drake” and collectively with BTL, the “Borrower”), the financial institutions which are now or which hereafter become a party hereto (collectively, the “Lenders” and individually a “Lender”) and SANTANDER BANK, N.A. (formerly known as Sovereign Bank, N.A.) (“Santander”), as agent for Lenders (Santander, in such capacity, the “Agent”).

 

RECITALS

 

Whereas, the Borrower and the Lenders entered into a Revolving Credit, Term Loan and Security Agreement dated August 6, 2008, as amended by that certain First Amendment to Revolving Credit Term Loan and Security Agreement dated January 14, 2011, that certain Second Amendment to Revolving Credit Term Loan and Security Agreement dated February 1, 2012, that certain letter agreement dated August 10, 2012 (constituting the third amendment to the Revolving Credit, Term Loan and Security Agreement), that certain Fourth Amendment to Revolving Credit, Term Loan and Security Agreement dated March 27, 2013, that certain Fifth Amendment to Revolving Credit, Term Loan and Security Agreement dated November 13, 2013, that certain Sixth Amendment to Revolving Credit, Term Loan and Security Agreement dated March 28, 2014, that certain Seventh Amendment to Revolving Credit, Term Loan and Security Agreement dated January 21, 2015, that certain Eighth Amendment to Revolving Credit, Term Loan and Security Agreement dated May 14, 2015, that certain Ninth Amendment to Revolving Credit, Term Loan and Security Agreement dated August 12, 2015 and that certain Tenth Amendment to Revolving Credit, Term Loan and Security Agreement dated October 14, 2015, as the same shall be further amended by this Agreement (as may be further amended, restated, replaced and/or modified from time to time, the “Loan Agreement”); and

 

Whereas, the Borrower and the Lenders have agreed to modify the terms of the Loan Agreement as set forth in this Agreement to, among other things, temporarily modifying the Inventory Advance Rate.

 

Now, therefore, in consideration of the Lender’s continued extension of credit and the agreements contained herein, the parties agree as follows:

 

AGREEMENT

 

1)ACKNOWLEDGMENT OF BALANCE. The Borrower acknowledges that the most recent statement of account sent to the Borrower with respect to the Obligations is correct.

 

2)WAIVERS. The Borrower hereby acknowledges and agrees that it has failed to comply, as of September 30, 2015, with Subsections 6.5(b) and 6.5(c) of the Loan Agreement. The Lenders hereby waive the Events of Default (as defined in the Loan Agreement) which would otherwise exist by reason of the failure of the Borrower to comply, as of September 30, 2015, with Subsection 6.5(b) of the Loan Agreement (relating to Balance Sheet Leverage Ratio) and Subsection 6.5(c) of the Loan Agreement (relating to Minimum EBITDA); provided, however, that (i) the waivers contained in this paragraph will not be deemed to apply to any provision of the Loan Agreement or any of the Other Documents other than said Subsections 6.5(b) and 6.5(c) of the Loan Agreement and (ii) the waivers contained in this paragraph will not be deemed to apply as of any date other than as of September 30, 2015. Nothing contained herein will be deemed to constitute a waiver (other than the express waivers set forth herein) or a release of any provision of any of the Other Documents. No Default or Event of Default (each as defined in the Loan Agreement) is deemed waived (other than pursuant to the express waivers set forth herein) or released by this Agreement, whether or not known to the Lenders. Nothing contained herein will in any event be deemed to constitute an agreement to give a waiver or release or to agree to any amendment or modification or any provision of any of the Other Documents on any other or future occasion.

 

 

 

 

3)MODIFICATIONS. The Loan Agreement be and hereby is modified as follows:

 

(A)The following definition in Section 1.2 of the Loan Agreement is hereby deleted, and is replaced to read as follows:

 

Additional Availability Period” shall mean the period beginning on the date of the Eleventh Amendment and ending on the close of business on February 1, 2016.

(B)The following definitions are hereby added to Section 1.2 of the Loan Agreement to read as follows:

 

Eleventh Amendment” shall mean that certain Eleventh Amendment to Revolving Credit, Term Loan and Security Agreement dated the Eleventh Amendment Closing Date by and among the Borrower, the Lenders and the Agent.

 

Eleventh Amendment Closing Date” shall mean as of November 14, 2015.

 

4)TEMPORARY ADVANCE RATE INCREASE. During the Additional Availability Period, the Inventory Advance Rate set forth in Subsection 2.1(a)(ii) of the Loan Agreement will be increased to 35%, reverting back to 25% immediately upon the expiration of such Additional Availability Period.  In further clarification of the foregoing, upon the expiration of the Additional Availability Period, the Inventory Advance Rate will be 25%.

 

5)FINANCIAL REPORTS. By not later than December 14, 2015, Borrower shall provide Agent with the following financial reports either prepared by the Borrower’s consultant, or by the Borrower and validated by the consultant: (a) forecast for the fourth quarter of fiscal year 2015, (b) forecast for fiscal year 2016 and (c) thirteen-week rolling cash flow analysis.

 

6)SECRETARY’S CERTIFICATES AND RESOLUTIONS. By not later than November 20, 2015, Borrower shall provide the Agent with secretary’s certificates and resolutions, in form and substance acceptable to the Agent, which approve the modification contemplated hereby.

 

7)ACKNOWLEDGMENTS. The Borrower acknowledges and represents that:

 

(A)    the Loan Agreement and Other Documents, as amended hereby, are in full force and effect without any defense, claim, counterclaim, right or claim of set-off;

 

(B)    to the best of its knowledge, no default by the Agent or the Lenders in the performance of their duties under the Loan Agreement or the Other Documents has occurred;

 

(C)    all representations and warranties of the Borrower contained herein and in the Other Documents are true and correct in all material respects as of this date, except for any representation or warranty that specifically refers to an earlier date;

 

(D)    the Borrower has taken all necessary action to authorize the execution and delivery of this Agreement; and

 

(E)    this Agreement is a modification of an existing obligation and is not a novation.

 

8)PRECONDITIONS. As a precondition to the effectiveness of any of the modifications, consents, or waivers contained herein, the Borrower agrees to:

 

(A)    provide the Agent with this Agreement, properly executed;

 

(B)    pay to the Agent an amendment fee in the amount of $50,000, which shall be payable weekly in ten (10) equal installments of $5,000 each, beginning on November 20, 2015 and thereafter on the Friday of each week; and

 

(C)    pay, promptly upon presentation of an invoice therefor, all other fees and costs incurred by the Lenders in entering into this Agreement, including, but not limited to, all reasonable legal fees incurred by the Agent.

 

9)MISCELLANEOUS. This Agreement shall be construed in accordance with and governed by the laws of the State of New Jersey, without reference to that state’s conflicts of law principles. This Agreement and the Other Documents constitute the sole agreement of the parties with respect to the subject matter thereof and supersede all oral negotiations and prior writings with respect to the subject matter thereof. No amendment of this Agreement, and no waiver of any one or more of the provisions hereof shall be effective unless set forth in writing and signed by the parties hereto. The illegality, unenforceability or inconsistency of any provision of this Agreement shall not in any way affect or impair the legality, enforceability or consistency of the remaining provisions of this Agreement or the Other Documents. This Agreement and the Other Documents are intended to be consistent. However, in the event of any inconsistencies among this Agreement and any of the Other Documents, the terms of this Agreement, then the Loan Agreement shall control. This Agreement may be executed in any number of counterparts and by the different parties on separate counterparts. Each such counterpart shall be deemed an original, but all such counterparts shall together constitute one and the same agreement.

 

 

 

 

10)DEFINITIONS. The terms used herein and not otherwise defined or modified herein shall have the meanings ascribed to them in the Loan Agreement. The terms used herein and not otherwise defined or modified herein or defined in the Loan Agreement shall have the meanings ascribed to them by the Uniform Commercial Code as enacted in New Jersey.

 

IN WITNESS WHEREOF, the undersigned have signed and sealed this Agreement the day and year first above written.

 

ATTEST:   BLONDER TONGUE LABORATORIES, INC.
     
     
By:      By:   
Name: ERIC SKOLNIK   Name: ROBERT J. PALLÉ
Title: Assistant Secretary   Title: Chief Executive Officer
     
     
WITNESS:   R. L. DRAKE HOLDINGS, LLC
     
     
By:     By:  
Name: ERIC SKOLNIK   Name: ROBERT J. PALLÉ
Title: Secretary   Title: President
     
     
    SANTANDER BANK, N.A.,
    (formerly known as Sovereign Bank, N.A.),
    as Lender and as Agent
     
     
    By:  
    Name: DWIGHT F. FAIRCHILD
    Title: Senior Vice President

 

 

EX-10.4 3 v424280_ex10-4.htm EXHIBIT 10.4

Exhibit 10.4

 

Robert J. and Carol M Pallé

21 Desai Court

Freehold, NJ 07728

November 13, 2015

Blonder Tongue Laboratories, Inc.

One Jake Brown Road

Old Bridge, NJ 08857

 

Re:Commitment to Invest in Subordinated Debt

 

Ladies and Gentlemen:

 

Subject to the terms and conditions hereof, Robert J. and Carol M Pallé, jointly and severally (collectively, “Junior Lender”) hereby confirm their commitment to provide Blonder Tongue Laboratories, Inc. (the “Company”) and R.L. Drake Holdings, LLC, a wholly-owned subsidiary of the Company (“Drake” and, collectively with the Company, “Borrower”) with senior secured, subordinated, convertible debt financing in an aggregate principal amount of at least six hundred thousand dollars ($600,000.00) (the “Debt”). The Debt will include the following components, subject to the parties mutually agreeing to vary such terms:

 

Revolver

Term/Amortization: Three (3) years from Closing.

 

Interest: 12% per annum, PIK or pay, as determined each month by the Company.

 

Term Loan

Term/Amortization: Three (3) years from Closing.

 

Non-amortizing bullet payable at maturity.

 

Interest: 12% per annum, PIK, subject to increase by 500 bps if the Company is not successful in obtaining stockholder approval of convertibility of all principal of the Term Loan following Junior Lender’s request to do so, with such additional interest being current pay and not PIK.

 

Subject to the approval of the Company’s Senior Lender, Junior Lender will receive a (i) first lien on specified Company assets agreed to by the Senior Lender, (ii) second lien on all other assets of Borrower and all subsidiaries upon which a lien may be perfected by filing a Form UCC-1 and (iii) second mortgage on the Old Bridge, New Jersey property of the Company.

 

At the option of Junior Lender, the principal balance of the Term Loan (including all accreted principal on account of PIK interest from the Term Loan) will be convertible into shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”) up to an amount that is below the “change in control” threshold amount under Section 713(b) of the NYSE MKT Rules, at any time prior to maturity at an exercise price per share equal to the greater of (a) 110% of the average closing price of the Common Stock on the NYSE MKT during the ten trading days ending on the earlier of (i) the business day immediately preceding the date the Junior Lender’s commitment to provide the Debt financing pursuant to this commitment letter (this “Letter”) is publicly announced and (ii) the business day immediately preceding the date of Closing (as defined below), and (b) fifty cents ($0.50). At the request of Junior Lender, the Company will seek stockholder approval with respect to convertibility of the remaining Term Loan principal in excess of the NYSE MKT Rule 713(b) threshold. Revolver principal will also be convertible into Common Stock on the same basis as the Term Loan if Borrower has not repaid the Revolver in full within the three (3) year term. At any time that the Common Stock has achieved and maintained an average trading price equal to 200% of the conversion price for a period of 60 days, the Company can provide Junior Lender with a notice of conversion, following receipt of which the Junior Lender must exercise its conversion rights within 20 business days or they will expire.

 

 - 1 - 

 

 

The closing of the transactions contemplated hereunder shall take place remotely via the exchange of documents, signatures and funding of any portion of the Debt by Junior Lender requested by the Company, on such date and at such time following satisfaction of the conditions to closing set forth below as is determined by the Company in its sole discretion (the “Closing”). At the Closing, the Company shall deliver to Junior Lender an executed senior secured, subordinated, convertible note (the “Note”) representing the Company’s obligations to Junior Lender as described herein.

 

The obligations of the parties to consummate the transactions contemplated by this letter are subject to the conditions stated in this Letter, including, without limitation:

 

(a)satisfactory completion of due diligence performed by each party as to the other before the Closing;
(b)the negotiation, execution, approval and acceptance by the parties of a Note, Subordination agreement between Junior Lender and Senior Lender, and any other documentation or agreements, in mutually acceptable form, which may be required or appropriate to effectuate the transactions contemplated hereby.
(c)the transactions contemplated hereby complying with all applicable securities laws and the rules of NYSE MKT; and
(d)satisfactory amendment of the Company’s existing credit facility with its Senior Lender including, without limitation, modifying the financial covenants, extending the maturity date and reaching such other accommodations with the Senior Lender as are deemed reasonably necessary by the parties.

 

The parties will use commercially reasonable efforts to finalize and sign the Note and related transaction documents, satisfy the other conditions precedent set forth herein and conduct the Closing of the transaction as soon as reasonably practicable.

 

(Signature Page Follows)

 - 2 - 

 

 

If the foregoing Letter is acceptable, please return an executed copy to our attention.

 

  Sincerely,
   
   
  /s/ Robert J. Pallé
  Robert J. Pallé
   
   
  /s/ Carol M. Pallé
  Carol M. Pallé

 

 

AGREED AND ACKNOWLEDGED:

BLONDER TONGUE LABORATORIES, INC.

 

 

 

By:/s/ Eric Skolnik

Eric Skolnik

Senior Vice President

 

 

 - 3 - 

EX-10.5 4 v424280_ex10-5.htm EXHIBIT 10.5

Exhibit 10.5

 

ZyCast Technology Inc.
No.33, Lane 181, Chung Hwa Road Section 4,
Hsin Chu City, Taiwan , 30060

 

November 11, 2015

 

 

Blonder Tongue Laboratories, Inc.

One Jake Brown Road

Old Bridge, NJ 08857

Attention: Robert J. Pallé, Chief Executive Officer

 

Re: Letter of Intent to Purchase Common Stock

 

Dear Mr. Pallé:

 

Subject to the terms and conditions hereof, ZyCast Technology Inc, ( “Purchaser”) hereby confirms its proposal to invest one million U.S. Dollars (USD 1,000,000.00) (the “Purchase Price”) in order to purchase unregistered shares of the common stock, $0.001 par value per share (the “Common Stock”) of Blonder Tongue Laboratories, Inc. (the “Company”) at a price per share equal to the greater of (a) 110% of the average closing price of the Common Stock on the NYSE MKT during the ten trading days ending on the earlier of (i) the business day immediately preceding the date Purchaser’s proposal to purchase Common Stock pursuant to this Letter of Intent (this “Letter”) is publicly announced and (ii) the business day immediately preceding the date of Closing (as defined below) and (b) fifty cents ($0.50). The shares of Common Stock Purchaser would purchase pursuant to this Letter shall be referred to in this Letter as the “Shares.”

 

The purchase and sale of the Shares shall take place remotely via the exchange of documents, signatures and Purchase Price, on such date and at such time following satisfaction of the conditions to closing set forth below as is determined by the Company in its sole discretion (which purchase and sale is designated as the “Closing”). At the Closing, the Company shall deliver to the Purchaser a certificate representing the Shares being purchased by Purchaser or enter the issuance of uncertificated Shares on the Company’s books, against payment by Purchaser of the Purchase Price therefor by wire transfer to a bank account designated by the Company, or by such other method acceptable to the Company.

 

The obligations of the parties to consummate the issuance and sale of the Shares to Purchaser and the other transactions contemplated by this letter are subject to the conditions stated in this Letter, including, without limitation:

 

(a)satisfactory completion of due diligence performed by each party as to the other before the Closing, including but not limited Purchaser review of the Company financial performance for the third quarter 2015 and the Company’s future financial projections, cash flow, COGS, gross margin, and other expenses;

 

(b)the negotiation, execution, approval and acceptance by the parties of a Stock Purchase Agreement and any other documentation or agreements, in mutually acceptable form, which may be required or appropriate to effectuate the issuance and sale of the Shares to Purchaser;

 

(c)the transactions contemplated hereby complying with all applicable securities laws and the rules of NYSE MKT;

 

 - 1 - 

 

 

(d)satisfactory amendment of the Company’s existing credit facility with its lender including, without limitation, modifying the financial covenants, extending the maturity date and reaching such other accommodations with the lender as are deemed reasonably necessary by the parties;

 

(e)an investor providing the Company with a written commitment to invest at least $500,000 in senior secured, subordinated debt of the Company, which may be convertible into Common Stock of the Company at a conversion price no more favorable to such investor than the Purchase Price to be paid by the Purchaser hereunder, subject to satisfaction of conditions similar to those set forth herein and to the negotiation and execution, as between the investor and the Company’s lender, of a mutually satisfactory intercreditor and subordination agreement; and

 

(f)a representative designated by Purchaser shall have been elected as a director of the Company filling the vacancy created by James Luksch’s resignation therefrom, with such Purchaser representative to serve for the remaining term of Mr. Luksch on the Board, and with the Company agreeing to recommend election of the Purchaser representative so long as (i) Purchaser continues to own at least an agreed upon minimum percentage of the Shares and (ii) the Purchaser representative meets the current criteria for Board members as established by the Company’s Nominating Committee and Board of Directors.

 

(g)the negotiation, execution, approval and acceptance of an Agreement that grants the Purchaser rights to use the Blonder Tongue name and logo on products sold by the Purchaser in the Asian market.

 

The parties will use commercially reasonable efforts to finalize and sign the Stock Purchase Agreement, satisfy the other conditions precedent set forth herein and conduct the Closing of the transaction as soon as reasonably practicable.

 

If the foregoing Letter is acceptable, please return an executed copy to my attention.

 

  Sincerely,
     
  Zycast Technology Inc.
     
     
  By: /s/ LC Chang            2015.11.11  
  Name: LC Chang
  Title: General Manager
     

 

AGREED AND ACKNOWLEDGED:

 

BLONDER TONGUE LABORATORIES, INC.

 

By: /s/ Robert Palle 11-13-2015

Name: Robert Palle

Title: President

 

 

 

 

 - 2 - 

EX-31.1 5 v424280_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

CERTIFICATION

 

I, Robert J. Pallé, Jr., certify that:

 

1.            I have reviewed this quarterly report on Form 10-Q of Blonder Tongue Laboratories, Inc.;

 

2.            Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.            Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.            The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

 

a)            Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

 

b)            Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)            Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)            Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.            The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)            All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)            Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 16, 2015

 

  /s/  Robert J. Pallé, Jr.
  Robert J. Pallé, Jr.
  Chief Executive Officer and President
  (Principal Executive Officer)

 

   

 

EX-31.2 6 v424280_ex31-2.htm EXHIBIT 31.2

 

Exhibit 31.2

CERTIFICATION

 

I, Eric Skolnik, certify that:

 

1.            I have reviewed this quarterly report on Form 10-Q of Blonder Tongue Laboratories, Inc.;

 

2.            Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.            Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.            The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

 

a)            Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

 

b)            Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)            Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)            Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.            The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)            All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)            Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 16, 2015

 

  /s/  Eric Skolnik
  Eric Skolnik
  Senior Vice President and Chief Financial Officer
  (Principal Financial Officer)

 

   

 

EX-32.1 7 v424280_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

To the knowledge of each of the undersigned, this Report on Form 10-Q for the quarter ended September 30, 2015 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of Blonder Tongue Laboratories, Inc. for the applicable reporting period.

 

Date:  November 16, 2015 By: /s/  Robert J. Pallé, Jr.
    Robert J. Pallé, Jr., Chief Executive Officer and President
     
  By: /s/  Eric Skolnik
    Eric Skolnik, Chief Financial Officer

 

   

 

EX-101.INS 8 bdr-20150930.xml XBRL INSTANCE DOCUMENT 0001000683 2014-01-01 2014-09-30 0001000683 2014-01-01 2014-12-31 0001000683 2015-01-01 2015-09-30 0001000683 2014-07-01 2014-09-30 0001000683 2015-07-01 2015-09-30 0001000683 2015-09-30 0001000683 2015-11-06 0001000683 2014-12-31 0001000683 2013-12-31 0001000683 2014-09-30 0001000683 us-gaap:RevolvingCreditFacilityMember bdr:SantanderBankMember 2008-08-06 0001000683 bdr:TermLoanCreditFacilityMember bdr:SantanderBankMember 2008-08-06 0001000683 us-gaap:RevolvingCreditFacilityMember bdr:SantanderBankMember 2015-09-30 0001000683 bdr:SantanderBankMember us-gaap:RevolvingCreditFacilityMember 2015-01-01 2015-09-30 0001000683 us-gaap:RevolvingCreditFacilityMember bdr:SantanderBankMember bdr:SeventhAmendmentMember 2008-08-06 0001000683 bdr:SantanderBankMember us-gaap:RevolvingCreditFacilityMember 2008-08-01 2008-08-06 0001000683 us-gaap:RevolvingCreditFacilityMember us-gaap:MinimumMember bdr:EighthAmendmentMember 2015-03-31 0001000683 us-gaap:RevolvingCreditFacilityMember us-gaap:MaximumMember bdr:EighthAmendmentMember 2015-03-31 0001000683 bdr:SantanderBankMember us-gaap:RevolvingCreditFacilityMember 2015-03-01 2015-03-30 0001000683 bdr:SantanderBankMember us-gaap:RevolvingCreditFacilityMember 2015-04-24 0001000683 us-gaap:RevolvingCreditFacilityMember bdr:EighthAmendmentMember 2015-09-30 0001000683 bdr:EighthAmendmentMember 2015-09-30 0001000683 bdr:NinthAmendmentMember bdr:SantanderBankMember 2015-08-01 2015-08-12 0001000683 bdr:TermLoanCreditFacilityMember bdr:SeventhAmendmentMember 2015-01-01 2015-01-21 0001000683 bdr:TermLoanCreditFacilityMember 2015-01-01 2015-01-21 0001000683 us-gaap:MaximumMember bdr:SixthAmendmentMember 2014-03-28 0001000683 us-gaap:MinimumMember bdr:SixthAmendmentMember 2014-03-28 0001000683 us-gaap:RevolvingCreditFacilityMember 2015-01-01 2015-09-30 0001000683 us-gaap:RevolvingCreditFacilityMember 2015-09-30 0001000683 bdr:TermLoanCreditFacilityMember 2015-09-30 0001000683 bdr:SixthAmendmentMember 2014-01-01 2014-12-31 0001000683 us-gaap:MaximumMember bdr:SixthAmendmentMember 2014-12-31 0001000683 us-gaap:MinimumMember bdr:SixthAmendmentMember 2014-12-31 0001000683 us-gaap:MaximumMember bdr:SixthAmendmentMember 2014-06-27 0001000683 us-gaap:MinimumMember bdr:SixthAmendmentMember 2014-06-27 0001000683 bdr:TermLoanCreditFacilityMember bdr:SeventhAmendmentMember 2015-01-01 2015-09-30 0001000683 bdr:TenthAmendmentMember 2015-10-01 2015-10-14 0001000683 us-gaap:RevolvingCreditFacilityMember bdr:TenthAmendmentMember us-gaap:MinimumMember 2015-10-14 0001000683 us-gaap:RevolvingCreditFacilityMember bdr:TenthAmendmentMember us-gaap:MaximumMember 2015-10-14 0001000683 bdr:SixthAmendmentMember 2015-01-01 2015-09-30 0001000683 bdr:TermLoanCreditFacilityMember 2015-01-01 2015-09-30 0001000683 bdr:TenthAmendmentMember 2015-10-14 0001000683 bdr:TwophaseCostreductionProgramMember 2015-01-01 2015-09-30 0001000683 bdr:ThirdPhaseCostReductionProgramMember 2015-01-01 2015-09-30 0001000683 us-gaap:RevolvingCreditFacilityMember bdr:EleventhAmendmentMember us-gaap:MinimumMember 2015-11-14 0001000683 us-gaap:RevolvingCreditFacilityMember bdr:EleventhAmendmentMember us-gaap:MaximumMember 2015-11-14 0001000683 bdr:EleventhAmendmentMember 2015-11-14 0001000683 bdr:EleventhAmendmentMember 2015-11-01 2015-11-14 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 304000 232000 2171000 2425000 7623000 9257000 284000 651000 10382000 12565000 1391000 1628000 3744000 3923000 594000 645000 1827000 1962000 493000 493000 130000 28000 2539000 1269000 3673000 286000 1944000 1351000 553000 513000 260000 260000 24000 24000 198000 101000 9191000 3804000 14000 3607000 95000 95000 0 0 0 0 8000 8000 26390000 26435000 -9471000 -4096000 -1354000 -1354000 6312000 7255000 9261000 13738000 8659000 5704000 5173000 4931000 3486000 773000 807000 776000 1161000 1003000 865000 869000 653000 -1875000 69000 83000 584000 -1958000 0 0 584000 -1958000 0.09 -0.30 23065000 15729000 14347000 12040000 8718000 3689000 2500000 2392000 3631000 3085000 2634000 2598000 -47000 -4386000 183000 249000 -230000 -4635000 0 0 -230000 -4635000 -0.04 -0.72 6555000 6226000 6407000 6220000 6555000 6320000 6407000 6220000 339000 367000 735000 634000 186000 158000 107000 1026000 -560000 -239000 -958000 -845000 244000 -367000 -24000 102000 272000 730000 2707000 -356000 508000 188000 -877000 -636000 204000 206000 -275000 1270000 -467000 1064000 1363000 72000 67000 1430000 190000 221000 0 0 15000 0 448000 369000 4791000 5151000 2233000 3045000 5391000 5487000 3401000 2798000 5000000 3783000 0.0019 0.0032 0.0053 0.0325 8783000 8000000 0.25 0.35 500000 2500 15000 0.25 20000 18000 15000 0.0025 6000000 5000000 18000 2539000 3622000 45000 3000000 2000000 0.5 0.35 2016-02-01 10-Q false 2015-09-30 2015 Q3 BLONDER TONGUE LABORATORIES INC 0001000683 --12-31 Smaller Reporting Company BDR 6554736 18561000 21244000 18561000 21244000 2648000 2833000 8075000 8765000 0 12000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">Note 1 - Company and Basis of Presentation</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Blonder Tongue Laboratories, Inc. (together with its consolidated subsidiaries, the &#8220;<b>Company</b>&#8221;) is a technology-development and manufacturing company that delivers television signal encoding, transcoding, digital transport, and broadband product solutions to the cable markets the Company serves, including the multi-dwelling unit market, the lodging/hospitality market and the institutional market including, hospitals, prisons and schools, primarily throughout the United States and Canada. The condensed consolidated financial statements include the accounts of Blonder Tongue Laboratories, Inc. and its wholly-owned subsidiaries. Significant intercompany accounts and transactions have been eliminated in consolidation.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The results for the third quarter of 2015 are not necessarily indicative of the results to be expected for the full fiscal year and have not been audited. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting primarily of normal recurring accruals, necessary for a fair statement of the results of operations and cash flows for the periods presented and the condensed consolidated balance sheet at September 30, 2015. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to SEC rules and regulations. These financial statements should be read in conjunction with the financial statements and notes thereto that were included in the Company&#8217;s latest annual report on Form 10-K for the year ended December 31, 2014, filed with the SEC on March 21, 2015.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">Note 2 &#150; Liquidity and Going Concern</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">&#160;</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business. During the nine months ended September 30, 2015, the Company experienced a decline in sales, a reduction in working capital, reported a&#160;loss from operations and net cash used in operating activities in conjunction with liquidity constraints. Furthermore, the Company&#8217;s Revolver and Term Loan will by their terms on February 1, 2016, unless extended.&#160;The above factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In response to lower than expected sales due to a slowdown in market activities experienced during the first half of the fiscal year, the Company implemented a two-phase cost-reduction program which is expected to reduce annualized expenses by approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,100</font>, including a temporary reduction in certain executive salaries, a decrease in workforce and a decrease in engineering consulting expenses. In September 2015, the Company then developed and implemented a third phase cost reduction plan, which is expected to further reduce annualized expenses by approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">750</font>.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company&#8217;s primary sources of liquidity are its existing cash balances, cash generated from operations and amounts available under the Santander Financing (as defined in Note 6 below). As of September 30, 2015, the Company had approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,539</font> outstanding under the Revolver (as defined in Note 6 below) and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">483</font> of additional availability for borrowing under the Revolver.&#160;The Company expects to either obtain an extension of the maturity date or refinance all or part of the Santander indebtedness prior to February 1, 2016. If anticipated operating results are not achieved, and or sufficient funds are not obtained, from the Company&#8217;s expected refinancing, further reductions in operating expenses may be needed and could have a material adverse effect on the Company&#8217;s ability to achieve its intended business objectives.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font>&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company cannot provide any assurance that it will be able to refinance its current debt obligations. If the Company is unable to refinance, it may be required to take additional measures to reduce costs in order to conserve its cash in amounts sufficient to sustain operations and meet its obligations.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 483000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">Note 3- Earnings (loss) Per Share</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Earnings (loss) per share is calculated in accordance with ASC Topic 260 &#8220;Earnings Per Share,&#8221; which provides for the calculation of &#8220;basic&#8221; and &#8220;diluted&#8221; earnings (loss) per share. Basic earnings (loss) per share includes no dilution and is computed by dividing net earnings (loss) by the weighted average number of common shares outstanding for the period.&#160; Diluted earnings per share reflect, in periods in which they have a dilutive effect, the effect of common shares issuable upon exercise of stock options. The diluted share base excludes incremental shares of 2,183 and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,015</font> related to stock options for the three month periods ended September 30, 2015 and 2014, respectively and 1,799&#160;and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,443</font> for the nine month periods ended September 30, 2015 and 2014, respectively. These shares were excluded due to their antidilutive effect.</font></div> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">Note 4 &#150; New Accounting Pronouncements</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In July 2015, the Financial Accounting Standards Board (&#8220;<b>FASB&#8221;)</b> issued Accounting Standards Update <b>(&#8220;ASU&#8221;)</b> ASU No. 2015-11, Simplifying the Measurement of Inventory: Topic 330 (&#8220;<b>ASU 2015-11&#8221;</b>). Topic 330 currently requires an entity to measure inventory at the lower of cost or market. Market could be replacement cost, net realizable value, or net realizable value less an approximately normal profit margin. ASU 2015-11 requires that inventory measured using either the first-in, first-out (FIFO) or average cost method be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Adoption of ASU 2015-11 is required for fiscal reporting periods beginning after December 15, 2016, including interim reporting periods within those fiscal years. The Company does not expect adoption of ASU 2015-11 to have a material impact on its consolidated financial statements.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 22.5pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In July 2015, the FASB issued ASU No. 2015-12 &#8220;Plan Accounting: Defined Benefit Pension Plans (Topic 960), Defined Contribution Pension Plans (Topic 962), Health and Welfare Benefit Plans (Topic 965): Part I. Fully Benefit-Responsive Investment Contract; Part II. Plan Investment Disclosures; Part III. Measurement Date Practical Expedient&#8221; (&#8220;ASU 2015-12&#8221;). ASU 2015-12 Part II simplifies the disclosure of plan assets by removing the requirement to disaggregate the fair value of assets disclosed by general type. The Company is currently assessing the impact that adopting this new accounting guidance will have on its Consolidated Financial Statements. ASU 2015-12 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2015, and early adoption is permitted. Accordingly, the standard is effective for the Company on January 1, 2016.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 22.5pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In April 2015, the FASB issued ASU No. 2015-4, &#8220;Practical Expedient for the Measurement Date of an Employer&#8217;s Defined Benefit Obligation and Plan Assets&#8221; to provide a practical expedient related to the measurement date of the defined benefit plan assets and obligations. The practical expedient allows employers with fiscal year-end dates that do not coincide with a calendar month-end to measure pension and post-retirement benefit plan assets and obligations as of the calendar month-end date closest to the fiscal year-end. The standard requires entities that elect the practical expedient to adjust the measurement of benefit plan assets and obligations for contributions or significant events between the month end measurement date and the entity&#8217;s fiscal year end. The ASU is effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Earlier adoption is permitted. The Company does not expect adoption of ASU 2015-4 to have a material impact on its consolidated financial statements.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The FASB, the Emerging Issues Task Force and the SEC have issued certain accounting standards updates and regulations as of September 30, 2015 that will become effective in subsequent periods; however, management of the Company does not believe that any of those updates would have significantly affected the Company&#8217;s financial accounting measures or disclosures had they been in effect during 2015 or 2014, and does not believe that any of those pronouncements will have a significant impact on the Company&#8217;s consolidated financial statements at the time they become effective.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Note 5 &#150; Inventories</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Inventories net of reserves are summarized as follows:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 95%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%" colspan="2"> <div style="CLEAR:both;CLEAR: both">September&#160;30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%" colspan="2"> <div style="CLEAR:both;CLEAR: both">December&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">Raw Materials</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">4,791</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">5,151</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">Work in process</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">2,233</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">3,045</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">Finished Goods</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">5,391</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">5,487</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">12,415</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">13,683</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">Less current inventory</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">(7,623)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">(9,257)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">4,792</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">4,426</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">Less reserve for slow moving and obsolete inventory</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">(3,401)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">(2,798)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">1,391</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">1,628</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Inventories are stated at the lower of cost, determined by the first-in, first-out (&#8220;FIFO&#8221;) method, or market.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company periodically analyzes anticipated product sales based on historical results, current backlog and marketing plans. Based on these analyses, the Company anticipates that certain products will not be sold during the next twelve months. Inventories that are not anticipated to be sold in the next twelve months, have been classified as non-current.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Approximately 100% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 66</font></font>% of the non-current inventories were comprised of finished goods at both September 30, 2015 and December 31, 2014, respectively. The Company has established a program to use interchangeable parts in its various product offerings and to modify certain of its finished goods to better match customer demands. In addition, the Company has instituted additional marketing programs to dispose of the slower moving inventories. During the three and nine months ended September 30, 2015, the Company increased the inventory reserve by $1,008 and $1,026, respectively.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font><font style="FONT-SIZE: 10pt">&#160;</font></div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company continually analyzes its slow-moving inventories. Based on historical and projected sales volumes and anticipated selling prices, the Company establishes reserves.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Inventories net of reserves are summarized as follows:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 95%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%" colspan="2"> <div style="CLEAR:both;CLEAR: both">September&#160;30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%" colspan="2"> <div style="CLEAR:both;CLEAR: both">December&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">Raw Materials</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">4,791</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">5,151</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">Work in process</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">2,233</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">3,045</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">Finished Goods</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">5,391</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">5,487</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">12,415</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">13,683</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">Less current inventory</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">(7,623)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">(9,257)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">4,792</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">4,426</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">Less reserve for slow moving and obsolete inventory</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">(3,401)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">(2,798)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">1,391</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">1,628</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 12415000 13683000 4792000 4426000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">Note 8 &#150; Subsequent Events</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company has evaluated subsequent events through the filing of its condensed consolidated financial statements with the SEC.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">Note 7 &#150; Legal Proceedings</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company may be a party to certain proceedings incidental to the ordinary course of its business, none of which, in the current opinion of management, may be likely to have a material adverse effect on the Company&#8217;s business, financial condition, results of operations, or cash flows.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 5000 0.25 0.35 25% effective on or about June 27, 2014 Santander (Prime) plus 1.50% or the LIBOR rate plus 4.25% Prime plus 1.75% or the LIBOR rate plus 4.50% 191000 171000 0.001 0.001 5000000 5000000 0 0 0.001 0.001 25000000 25000000 8464000 8464000 6555000 6263000 1909000 2202000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">Note 6 &#150; Debt</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On August 6, 2008, the Company entered into a Revolving Credit, Term Loan and Security Agreement with Santander Bank, N.A. (formerly known as Sovereign Bank, N.A.) through its Sovereign Business Capital division (&#8220;<b>Santander</b>&#8221;), pursuant to which the Company obtained an $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8,000</font> credit facility from Santander (the &#8220;<b>Santander Financing</b>&#8221;). The Company and Santander entered into a series of amendments to the foregoing Revolving Credit, Term Loan and Security Agreement (as so amended, the &#8220;<b>Santander Agreement</b>&#8221;), including the Seventh Amendment referenced below, which, among other things, adjusted the Santander Financing to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8,783</font> consisting of (i) a $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5,000</font> asset-based revolving credit facility (&#8220;<b>Revolver</b>&#8221;) and (ii) a $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,783</font> term loan facility (&#8220;<b>Term Loan</b>&#8221;), each expiring on February 1, 2016. The amounts which may be borrowed under the Revolver are based on certain percentages of Eligible Receivables and Eligible Inventory, as such terms are defined in the Santander Agreement. The obligations of the Company under the Santander Agreement are secured by substantially all of the assets of the Company and certain of its subsidiaries.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Under the Santander Agreement, the Revolver currently bears interest at a rate per annum equal to the prime lending rate announced from time to time by <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Santander (&#8220;Prime&#8221;) plus 1.50% or the LIBOR rate plus 4.25%</font>. The Term Loan currently bears interest at a rate per annum equal to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Prime plus 1.75% or the LIBOR rate plus 4.50%</font>. Prime was <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3.25</font>% at September 30, 2015. LIBOR rate loans under the Santander Agreement may be borrowed for interest periods of one, three or six months. The LIBOR rates for interest periods of one-month, three-months and six-months were <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.19</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.32</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.53</font>%, respectively, at September 30, 2015. The per annum interest rates above became effective on January 21, 2015, pursuant to the terms of the Seventh Amendment described below.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On November 14, 2015, the Company entered into the Eleventh Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the &#8220;<b>Eleventh Amendment</b>&#8221;) to amend the Santander Financing. The Eleventh Amendment (i) waived the Company&#8217;s failure of compliance with the Minimum EBITDA and leverage ratio covenants for the measurement period ended September 30, 2015, effective as of September 30, 2015, and (ii) increased the advance rate applicable to Eligible Inventory (as defined in the Santander Agreement) from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25</font>% to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 35</font>% through and until February 1, 2016, after which it will revert back to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25</font>%. The Eleventh Amendment also contains other customary representations, covenants, terms and conditions.&#160;In connection with the Eleventh Amendment, the Company agreed to pay Santander an amendment fee of $50, which is payable in ten weekly installments of $5 each.</div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On October 14, 2015, the Company entered into the Tenth Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the &#8220;<b>Tenth Amendment</b>&#8221;) to amend the Santander Financing. The Tenth Amendment extended the increase in the advance rate applicable to Eligible Inventory (as defined in the Santander Agreement) from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25</font>% to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 35</font>% through and until November 30, 2015, after which it will revert back to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25</font>%. The Tenth Amendment also contains other customary representations, covenants, terms and conditions. In connection with the Tenth Amendment, the Company paid Santander an amendment fee of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font>.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On August 12, 2015, the Company entered into the Ninth Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the &#8220;<b>Ninth Amendment</b>&#8221;) to amend the Santander Financing. The Ninth Amendment waived the Company&#8217;s failure of compliance with the Minimum EBITDA covenant for the measurement period ended June 30, 2015, effective as of June 30, 2015, and also contains other customary representations, covenants, terms and conditions. In connection with the Ninth Amendment, the Company paid Santander an amendment fee of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">20</font>.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On May 14, 2015, the Company entered into the Eighth Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the &#8220;<b>Eighth Amendment</b>&#8221;) to amend the Santander Financing. The Eighth Amendment (i)&#160;waived the Company&#8217;s failure of compliance with the Minimum EBITDA covenant for the three-month period ended March 31, 2015, effective as of March 31, 2015, and (ii) increased the advance rate applicable to Eligible Inventory (as defined in the Santander Agreement) from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25</font>% to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 35</font>% through and until September 30, 2015, after which it will revert back to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25</font>%. The Eighth Amendment also contains other customary representations, covenants, terms and conditions. In connection with the Eighth Amendment, the Company paid Santander an amendment fee of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">15</font>. The Eighth Amendment is in lieu of the Temporary Overadvance Facility, as more fully discussed in the next following paragraph.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On March 30, 2015, Santander agreed to provide the Company with $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">500</font> of additional availability beyond its borrowing base under the Revolver (the &#8220;<b>Temporary Overadvance Facility</b>&#8221;) during the period April 1, 2015 through April 24, 2015, for which the Company paid Santander an accommodation fee of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.5</font>. Under the agreement, the Company was required to eliminate the outstanding balance under the Temporary Overadvance Facility on or before September 30, 2015, which was accomplished prior to entering into the Eight Amendment.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On January 21, 2015, the Company entered into the Seventh Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the &#8220;<b>Seventh Amendment</b>&#8221;) to amend the Santander Financing. The Seventh Amendment (i) extended by one year the Termination Date of the Santander Agreement from February 1, 2015 to February 1, 2016; (ii) continued the installment payments of principal under the Term Loan at the same monthly payment of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">18</font> per month for the additional year until the final payment of unpaid principal and interest is due on <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">February 1, 2016</font>; (iii)&#160;increased the interest rates applicable to the Revolver and the Term Loan by one quarter of one percent (<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.25</font>%); and (iv) reset and modified the Minimum EBITDA covenant to address the term being extended by one year. The Seventh Amendment also contains other customary representations, covenants, terms and conditions. The Company paid a $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">15</font> amendment fee to Santander in connection with the Amendment.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On March 28, 2014, the Company entered into a Sixth Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the &#8220;<b>Sixth Amendment</b>&#8221;) to amend the Santander Financing. The Sixth Amendment (i)&#160;reduced the maximum amount available for borrowing under the Revolver from $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6,000</font> to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5,000</font>, (ii) increased the interest rates applicable to the Revolver and the Term Loan by three quarters of one percent, (iii) modified the Company&#8217;s fixed charge coverage ratio covenant to eliminate the testing thereof with respect to the trailing 12-month period ended as of December 31, 2013, (iv) eliminated the fixed charge coverage ratio covenant with respect to all periods after December 31, 2013, (v) modified the minimum EBITDA covenant to (a) eliminate the testing thereof with respect to the fiscal year ended December 31, 2013, (b) change the manner of calculation thereof, and (c) impose a quarterly building minimum EBITDA covenant test, commencing with the fiscal quarter ended on March 31, 2014, and thereafter for the two fiscal quarters ended June 30, 2014, the three fiscal quarters ended September 30, 2014, the four fiscal quarters ended December 31, 2014 and thereafter quarterly on a trailing four fiscal quarter basis, (vi) reduced the advance rate applicable to Eligible Inventory (as defined in the Santander Agreement) from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 50</font>% to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 35</font>%, with a further reduction in such advance rate to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">25% effective on or about June 27, 2014</font></font> and (vii) reduced the sublimit on advances against such Eligible Inventory from $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,000</font> to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,000</font>. In connection with the Sixth Amendment, the Company paid Santander an amendment fee of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">45</font>.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Upon termination of the Revolver, all outstanding borrowings under the Revolver are due. The outstanding principal balance of the Revolver was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,539</font> at September 30, 2015. The Term Loan requires equal monthly principal payments of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">18</font> each, plus interest, with the remaining balance due at maturity. The outstanding principal balance of the Term Loan was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,622</font> at September 30, 2015.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Santander Agreement contains customary representations and warranties as well as affirmative and negative covenants, including certain financial covenants. The Santander Agreement contains customary events of default, including, among others, non-payment of principal, interest or other amounts when due.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0.66 0.25 2100000 750000 2183 1015 1799 1443 1008000 1 0.25 0.35 0.25 5 50 EX-101.SCH 9 bdr-20150930.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 106 - Disclosure - Company and Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 107 - Disclosure - Liquidity and Going Concern link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - Earnings (loss) Per Share link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - New Accounting Pronouncements link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - Inventories link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - Debt link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - Legal Proceedings link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - Inventories (Tables) link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - Liquidity and Going Concern (Details Textual) link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - Earnings (loss) Per Share (Details Textual) link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - Inventories (Details) link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - Inventories (Details Textual) link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - Debt (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 10 bdr-20150930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 11 bdr-20150930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 12 bdr-20150930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 13 bdr-20150930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EXCEL 14 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`+A&<$>4SP1@@0$``(0.```3````6T-O;G1E;G1?5'EP97-= M+GAM;,U7RV[",!#\%91K18QI2Q\"+J77%JG]`3?9$`N_9)L`?U\[0-5&*8*6 M2'N)X\SNSMAKCY3Q^]:`ZVVD4&Z2E-Z;1T)<5H)D+M4&5$`*;27S86H7Q+!L MR19`AH/!B&1:>5"^[V.-9#I^K0Z6\F0DOI`#550]XW-@1: MSUM.20B>!]214/I?W(>3DFD+)Q'&P`XO1AOZVWXWO`=WIB'VMWW]K M>@TZ4@\=FL19.H9(=%PCT7,[%````*P(```L```!?.0Q(OW[CMB`PD.MQ-*O>X^NO`ZIK`XTHO8<4M?'5$Q^#*G* M_=ITJK$"2+8CCVG!D4*>-BP>-9?20D0[8$NP+,L5R*V.V:SGVL7.U49V[M,4 M1Y26M#;3"&>6X9MY6&3I//B)]!=C;IK>TI;MR5/0!_ZS#0//>997'L=V+YRO M+0O]C^AY%.!)T:'B1?4C9@,2[2F]@OIZ`(4QOCLEFI2"(S>C@KN_V/P"4$L# M!!0````(`+A&<$<8Z>6=,@$``.8,```:````>&PO7W)E;',O=V]R:V)O;VLN M>&UL+G)E;'/%UTMN@S`0@.&K(!\@9DA"$A2RRB;;MA>P8'@H8"/;59O;UV51 MT8='72#-!@269K[5CSAKEQ9/."C?&^VZ?G+)^SAH5X3WI>B\GPHI7=7AJ-S& M3*C#:6/LJ'QXM*V<5'57+C+V[ M#M$[.=]@$Q:$X\>$_UEOFJ:O\&JJUQ&U_T,AOQ8(&0=E<5#&`MK&05L6T"X. MVK&`]G'0G@64QT$Y"^@0!QU80,6@.1:^#I M-1#!!IYB`Y%LX&DV$-$&GFH#D6W@Z380X0:><@.1;N!I-Q#Q!IYZ9XMZNTY9 MK)^][77KUM9\&TZ*%O%V_C'@^I1Y*FE8U-J'32CGZ^J?CGGJ)T3^^J6Y?`!0 M2P,$%`````@`N$9P1R:6BY1*`@``PP8``!````!D;V-0&UL MO551;]HP$/XK5I[HPQI@TZ0B&HF2;$.B@):L>S;.!:P&._4Y#/;K>TX*#6W8 MUCXL+SG??=^=[SL[&2KL#A9&%V"L!&2[3:YP0,YK;VUM,?!]%&O8<+PDB*)H MILV&6UJ:E:^S3`H(M2@WH*S?[W8_^["SH%)(/Q3'I%XP=%5&19%+P:W4*KB5 MPFC4F6713D`^]%\"*@9ECD&41MI]T*TQ35>%B07/84RU@HSG"#7JV5EAQGI3 M<+7WZ]54JGO\420ZY!::K--`G7W-#:14]"3[T5EAONVIS]QQQVNN5I`VL:^# M!RWNP*#KM->_[-)SE.#@KW,#3Z5:+;@T&`RW=K`%8;5Y&M/6OG=*J19NZ'B7 MT/[08TN.X,QK;\N-Y,IZ#.5O6O:]NFSMK>R\0&N"G]KDXLHFJ2]'PFI(ZX3MFIQ5T#$L__N&'$KF9W;4AF0)_0-*GK&ULS9--3\,P#(;_"NJ]2[.Q"45=#X`X,0F)(1"WD'A;6/.AQ%/7?T^6=2T# M+KMQJVN_CU_'22D<$];#D[<./"H(5WM=F\"$FV<;1,<("6(#FH=1K#`QN;)> M+?S=8))0:`& M#08#H2-*LNK%;(UM3$D&?55&QS4/N+!2K13(VW8H^YV*G1&\#DY#ZJO:IIFU$Q271R8DK?%XW,ZFUR9@-P(B*J@&+8.YMFI\^OD[G[Y MD%7C@DYS2G,Z6Q8W;#IAU[/WPV1G_@;#NAOBWSH^&4S;184U7+C;I)%IN>DS M@20$X95#9621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DO MV]:[MR_>X%#BVR]*+41B1%G\@MNN01 M.+5)#3(3/PB=AIAJ4!P"I`DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7H5A) MVH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7`\:V@S&L%& MKQMUAVC2/'K^!?F<-0H MACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y`\FIS_I,C0'HYI9 M";V$5FJ?JH,@H%\;D>/N5Z>`HWEL:\4*Z">P'_T=HWPJOX@L`Y?RY] MSZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA*]+', M<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^`VVZG=PZ.)Z8D;D*TU*0 M;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#AWE[ M7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+:`'@Z]1`O)256`Q6\8#*Y"B?$R, M1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*POFH] MM!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=WP6#R M_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41`71%`B.5'`86%S+D4.Z2D`83 M``>LX=SFWJXPD6L_UC6'ODRWSEPVSK>`U[F$RQ# MI'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X`Q\U*M:I60K$3]+!WP? MD@9CC%OT-%^/%&*MIK&MQMHQ#'F`6/,,H68XWX=%FAHSU8NL.8T*;T'50.4_ MV]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0````(`+A& M<$=*CI5`1P(``.`)```-````>&PO+RD%U`DNFP0O`>HO0=#D2RI(,U$UE6:E5%H0,%-=!4VM*2D:&R1X M,`W#62`(DSB-92OF`AJ4JU9"@B\'"/GX6U70!#^>?_S5*KCY@/QX]NGL+'R\ MN-G'S]W"!4:>XUN1X&AVA8/GDT["\#"Q7=PCG[V0_&_<>]37ECKH"Y3&I9)C MG:;8`VG M3S"IM,OM,^SGF81C)EUE"0[[Y_GILI'=#79[C//=[1D@C6L"0+6DY,[Z*X5 M&=5SUQA?+NGR^OB1N;<3[\E\VUMS@H17*([]L+U;:;/W*^U?[U30M]^M'K_3 MX0<492WCP.1&`['?Y#NKF^\TW[&[&\ZB&QN[6P62F=^MG2R&K*`E:3G\9"L% M;C'!H_W=RH]F@]=BH$CP:/^@!6O%9Z=@_*=+_P!02P,$%`````@`N$9P1U01 M1L[3`@``@`<```\```!X;"]W;W)K8F]O:RYX;6R5E=]3XC`0Q_^53)_TY:`( M>#+6&83J,8/`V([W'-I%,J9)35)0__K;%#D7Z3G>4Y,T^\G^^&9S:0=;;9Z6 M6C^QET(J.S!1L':N'+1:-EM#P>T/78+"?RMM"NYP:AY;>K42&8QU5A6@7*O3 M;O=;!B1W0BN[%J4-WFGV.S1;&N"Y70.X0NY@!15D'[2:_>"EH?M0UT8END<=K!T+>SO M]Q\!RV'%*^E2='9_;A2$G6ZGT]\Q_+8'`5M+@7Z!\9+7!YN!P(&9Y.$N510TFL_&\2R)QPQ' MR7PZ&0]3G%P/I\/9*&8$U"&@SO^"S@CHC(#.&D$?YDF*G[MXEB9L?L/FB_B> M@+H$U/VV1WLD`?4(J-<`TD7)U2OCF.MK;H5E>L46!BP6`---0'T"ZA^#IN*Y M$KFOE4?=:A0>&VF5@:$5.R>0\V-(S(U"0\M.I+;VE"W`L&3-#1#$3X+X>8R8 MX:T89IFN4#CHPL)HA>,,O*(LP5P0S,4Q9J(V:(!W`JA1V*:*:Q^;C6'IZ/X# MA39(=`J/7'HG,X#<1TZ-J2K#!EDFU=+"<^6O2KSY%%Y(E1@V2)$$R$[P>DNP MI]2>"C!L4.`7]68G8UJPD$HP;-#@/ZON08Y3%!5AV*#"@ZB\L9"'85$!A@T* M;`*P%%Y4!B,HP;-"A5\+7!*K`\.*]/WZT1'P5A(+9UD]R1]^_&U1]02P,$%`````@`N$9P M1[==5]E1`@``\P<``!@```!X;"]W;W)K MYP`>R#K*/GE!B`!?==7PK5<(T6X@Y*>"U)B_T)8T\LN%LAH+V657R%M&\%F; MZ@HBWT]@CK!XH,9?IBT;W7;F2Q3TMGD#Z@UH-(3H6T/8&\+1 M8)8.FLSTO'Y@@?.,T0[P%JO=#C92SE00&1EP'8V9Y9(SXW+TGOL9O*LPO0)I MQ=Y6!*,"RMBS`.2Y=F39T1S@8"O"YX!P`)CN+K3LT7-[--@C8X\L>^SF9Q1[ M6Y$\!\030&S94Q<0&X!1-&:%?5EFJP7+D$PPB859S<[#5JR?`]()(+7_`W^6 MX$@6_"NK"6)E^]$LPI$L6*;U!+&V_='<=AS6UG8D<1REX8)=#_P)2!TA#]+\ MG^5JEE""*<6ISG2>XFA6"RAH2K%+-%C/4YQ"]Q=0PBG%KF04N)2DIS@:M(`R MK??`+F<4SA9DKVGZN5B[9SC0.F-KPJ[Z[N'@1&^-,$?L.#K>;SM]J,.'/,]: M?"6_,+N6#0='*N1)KX_E"Z6"R#3\%YE.(6_@L5.1BU"OJOD5>DL4CDMN+:;]W1ZW[X$=3G[JGS;'OSX]A MV+T<=5-V'\Q9GX9_#J9MRGYX;%_#[MSJZ-I>GC=@L+[Y4K\=^?!'NMN$M;E\U^M15YA2T^O"T M^2@>"U2C9%)\K?2E(_?!:/[9F._CP[_[ITTT>M"U?NG'(LKA\JX+7==C24/- M_UT+_57G&$COE]+_GIH[V'\N.UV8^ENU[X^#VV@3[/6A?*O[+^;RC[ZV87+X M8NIN^@U>WKK>-$O()FC*'_.U.DW7R_Q/&EW#^`"X!L`M0,@_!N`U`)V`<'8V MM>NOLB]WV]9<@NYL0B>!$A262:WI4.4X4=9*Q3A2I)(D!62=4E(%* M[CN)'2BD MCI>4>F%KR5-:"V9\GEBBF&2E3&>[%$L5PQ/D*X7BC14/%>!.W]U.7.8L929?$*J@APW5`^ M8LR[`5*/S/C9[!7YO;BH%92UR+8Y%V@E+SOI"TNT)G6%2UM!<8L\;H6T!DG% M_$02-I:!9+G?SXVYUZ^8H-#%;$4)+BL%A:7D82DL6BIDX5Y8*@'Q&C9=88[WB"R]<9`K*3,DS4U@\S#RHLE6XYELB7&P*RDW)!$M%=90)DI>68"6/G"$J2P1=&*;`&7F4"9*7EF`L5A)CP??$N%:;2F9UQL`L6F MY+$)%C8]8R2MJ1^M6!N"NTP%BDS)KU/!6H.R.57X-'XG+GJ!HE?QZ`4*5<\< MXB5^'S?H+ELA"MTU;`*7E$!)J7A20GJ_);S$[\-E)%!&\OC+@>+/,_]XB7]O MZ/(1*1\5ST>TT8<9WR>.3.**3$.7D4@9J7A&(N7?0R8]^T1;)J-LS=[9)252 M4BJ>E$@A^#!\-'DD_$'F]_/;9I[24O&T1,K!AQ@%OU6S90FH->/E\A(I+Q7/ M2Z0LS,"SRK14`A-]RWD%EW*HW)&=)Y_)5?RK; MU^K4!<^F[TTSG2$=C.GU4%CT82CLJ,O][:'6AWZ\3<;6SP=H\T-OSLMYX.U0 M&PO=V]R:W-H965T M&ULC97=DIL@%(!?Q?$!(J*HV3'.=.UTVHO.[.Q%>TT2$IU% ML4#B]NT+_F21@;8W0?`[YWQ',E".C+^)AA`9O'>T%X>PD7)XBB)Q:DB'Q8X- MI%=O+HQW6*HIOT9BX`2?IZ".1A"`+.IPVX=5.:V]\*ID-TG;GKSP0-RZ#O/? MSX2R\1#&X;KPVEX;J1>BJHP><>>V([UH61]PDF).O6D##H\/L\MOTTCO.; M`BQA[@"X!,!'0)S^-2!9`A(K()K-IKX^8XFKDK,Q$`/6NQT_*9SK)"IS(*9L M?/Y$.B!1*J^4P*N$NDL`4V)>%LBGR5F MI)^0>.]DZ@V3Q__V2"R/Q/2P6BUFC\2H`78`Q"ZJ]E->E]1R24V79%L%S2ZI M404!`%Q0[86\)L@R0:9)ZC1!9K].#3?A=<@LA\QT0,Z=R?YK9_R4UR6W7'+3 M)7-^C]RH`KU;XZ>\+H7E4I@NN=.E,*H4J7L#:R_D-=E;)GO3I'":[(TB&4+( M:;*!H/'/]YK$P%+1I_>'R][ILC#K@0*<5+VA(`30LHF,PW;`5_(=\VO;B^#( MI#JWIT/VPI@D*A?8J9R-ND\?$THN4C_FNMA\P\P3R8;UPGS&PO=V]R:W-H965T&ULC9C+DILZ$(9?A6)_!@D)$%,>5X5+*EFW/[B1E[_RNJZ9[<4]]?W[VO&YWDG71/:FS;(;_ M'%1;%_WPV!Z][MS*8C\9U97G$Q)Z=5$V[G8SC7UKMQMUZ:NRD=]:I[O4=='^ M262EKB\N=6\#W\OCJ1\'O.W&N]OMRUHV7:D:IY6'%_<3?--IK*J1D]#Y%_:Z7O,T1!^OWG_/,D= MTG\M.IFJZD>Y[T]#ML1U]O)07*K^N[I^D5I#,#KK^F;B.G7Q M>_XLF^GS.O]'$&V&&_C:P+\;W./@!DP;L'<#_J$!UP9\;81`&P16!&_6/LU< M5O3%=M.JJ].=BW$_T>GF[RU\X(,<]<-HV_;B&R\M]&/1OP)20R$ M8D@&D7?"&^*C2?BN&<$'YCX6((5$A"+90R?Y@I/%--DM33[/%8/VS`P1S4IF MI)F0("(<@U((B3"(,2B#$`TB'Z5R2/F,A,%C5=Q2Q:$J*^'9(N$@"H\9Q:`4 M0@&UYV>&,@A1GW""4;E!<<:CQZH"2U4`506HJ@!$B?!\4\@P+D)4E`&%(D8U M04A$5#R6%-XDL5E2""6%C^TC:THB:!^A4Q(94X*J32$C".HGBXQM&?OHC!A0 M0,AC1<)2)*`B@2H2<"L1@J^R`=$0W=\9A!@1Z)[*#2AD*\["V-(40TWH5DIB MX_Q`F=1DT&2SV%B`&)W`W(!"QA\KHL22--;KNR:!OO*)9FYQ.)I,:E*"X8>, M00U;%%\JDXK6')V4VLI@X1/HODDT,\?YAPH\G=3`PF!!F>&+,_Q`RBULQ?%) M?5L9+)8"?8$3S>@P`G^W3`C?K9D)^1P_0DV*@H#+NNP:3F$1QU-.*#/BQ,'" M9C2*O4!+9V;ZXB%;V(P&-E3R%=+L0DYA)B;F#Y&LL=(OH`LJ[$+ M.(45W#YM=;=%@X\72O=;!O;70NE^R_3U]T+IALO$UBU4:$N#E=Q^A6,M+81Q MR!/#J-2@R!.),2JS?=D-=*RE61A9<];;30:%78;`NPP:&4==L'`@&I3OX[V7 M27&\'\EM7VM6S6XV*.PV!-YM4+%*F4$Q?^$E$ZN4B8^5>>`Z6,OV.%W$.V>G M+DT_WW#NH_?+_B=_O$Y:XPE]3BDRGHT_#DS7SW?WV\VY.,I_B_98-IWSJOKA M$CO=.`]*]7)(FSP-Z9]DL;\_5/+0CU^C4==\H9\?>G6^_3YQ_Y%D^S]02P,$ M%`````@`N$9P1RPK*O;G`P``)1(``!@```!X;"]W;W)K/]:NJV?_//QEQ>@Z#?GU53]M_T1;7# M/T?=-:49/KM3T%\Z51XFHZ8.(`R3H"FKUM]NIK;OW7:CKZ:N6O6]\_IKTY3= M?SM5Z]N;+_Q[PX_J=#9C0[#=!`^[0]6HMJ]TZW7J^.:_B]="P@B9$']7ZM:C M=V\D_Z'US_'CS\.;'XX<5*WV9G11#H]/5:BZ'CT-D?]=G'[%'`WQ^]W[[U.Z M`_V/LE>%KO^I#N8\L`U][Z".Y;4V/_3M#[7D$(\.][KNIU]O?^V-;NXFOM>4 MO^9GU4[/V_Q/%BYFO`$L!O`P>,3A#>1B(+\,HBG3F=F4UV^E*;>;3M^\_E*. MO2U>!W@W.AD\>_WDK9O+-636#ZV?VRS?!)^CGP4"$V2'(>*!"`;G;`3PJ3D@ M<^`"%!B1PO,(\AYA_GR7R#X/G]M'=_MHMH^PO:`4TSF)&=).D)J<4CQ3PBED>*8L@D M97D0C,R?\\@L'AGF$;,\,A0CD2S7`F-2U/FK/'*+1XYY)"R/'-<\!!944%#Z MG(@(+2:CM'U18)PF312ETQ*(]=ZF+KF<""AE2(<(D%0@*4B==R.SIF!$Z+AG9(B=RXH)??D1.^CKC%R"*BD.':0"VTD%( MZ/"K$&`9>XDBG@Y%R<1A)0)ATR'[J)!?C!;0$BB1?']35)8Z]#>`U=\`A([# M&@^VYH$D+OBY#5C/Q#`X^8PD49K488D%6_8@(G38GMP!E;1PI<`6RD%LP!8^ MB`D=?DD`K&DKI8E)`1V8V+('1/8$+WM`]GQAPF^$"&K8"+N,/%OX@`B?X(4/ ML*2E_()`,$(FTH&,O4$$(GN"#;0#O/\#N<*&;"1="F/K)Q#]%+Q^`E9&R:M: M04`B^]#&Z&8ZR!^U-FK@%GX;RG56Y>'Q4:NC&5_3L8[S M+<;\8?3E?BGSN!G:_@]02P,$%`````@`N$9P1QZJWL*C`0``L0,``!@```!X M;"]W;W)K1I"0KLNP+4UQH6I6Q]F2J$DSX@O(?G9'&D6+("$V@4%[I<+/(*40<@W_CMKOK4,Q.MX4?\>I_7NS]S" M(\H_HG&]-YM1TD#+1^F>.7U*-UJ!8*)8J_IE7HN$[ISWTV MTSXF%#.A>$=@J5&T^8T[7I4&)V(''LXN/WBX"2)>F=BH9M+TWJCUU4N5YW2&D?MTI:NU?5V/A3Q3-[@53GP#GYQTPEMR1F= M/]EX#"VB`V\BN[FEI/?O9TTDM"Z$=SXVZ4JEQ.&P/)#UE5;_`5!+`P04```` M"`"X1G!'*E?Q'*,!``"Q`P``&````'AL+W=O5HIRV#U[H`$K?A#;#-F_7S^`#%&D MY(*[FZKJ:C_*29L7VP,X]":%L@?<.S?L";%U#Y+9*SV`\G]:;21S/C4=L8,! MUD22%(1FV0\B&5>X*F/MR52E'IW@"IX,LJ.4S/P[@M#3`>=X*3SSKG>A0*J2 MK+R&2U"6:X4,M`=\F^^/14!$P!\.D[V(4?!^TOHE)+^:`\Z"!1!0NZ#`_'*& M.Q`B"/G&K[/F>\M`O(P7]8K1.RX6"D61O:>4JKE/Z0V]FVN<$.A/H2KC)HO'4*-J\9XY5I=$3 ML@,+9Y?O/=P$$:^,;%0S:7IOU/KJNJ?MJ!X2Z<7 M=/HU?;?0=\GA;N/P&P+%(E`D@6(CL-N.F##'+:;XT(1<[*D$T\6K8U&M1^72 MEJ[5]7;>TG@F[_"J'%@'OYGIN++HI)T_V7@,K=8.O(GLZAJCWK^?-1'0NA#^ M]+%)5RHE3@_+`UE?:?4?4$L#!!0````(`+A&<$??-A@0I`$``+$#```8```` M>&PO=V]R:W-H965T&ULA5/;;J,P$/T5RQ]0$Y*T5420FE:K MW8>5JC[L/CLP@%7;0VT3NG^_O@`-5:6^X)GAG#-G?"E&-*^V`W#D74EMC[1S MKC\P9JL.%+#\COH;D5WVD6;``$BH7%+A?+O`(4@8AW_AMTOQH&8C7\:S^(T[KW9^Y MA4>4?T7M.F\VHZ2&A@_2O>#X$Z81]D&P0FGCEU2#=:AF"B6*OZ=5Z+B.Z<\V MGVA?$_*)D"^$^RP:3XVBS2?N>%D8'(GM>3B[S<'#31#QRL1&-9.F]T:MKU[* M3;XOV"4(39A$.:TP"X)Y]2];Y'1-SZ_H^??T[4S?)H?;EQ6 M`G?K$1/FM,;\+'K>PF]N6J$M M.:/S)QN/H4%TX$UD-WM*.O]^ED1"XT)XYV.3KE1*'/;S`UE>:?D?4$L#!!0` M```(`+A&<$=@S'0;H0$``+$#```8````>&PO=V]R:W-H965T&ULA5/+;J0P$/P5RQ\0`S/)[HX8I$Q647)8*E>S,D;;6]@?&3-F"XN8*>^C0.!YI2N?"LVA:ZPNL MR-G"JX2"S@CLB(;Z2&_3PVGO$0'P5\!H5C'QWL^(+SYYK(XT\19`0FF]`G?+ M!>Y`2B_D&O^?-#]:>N(ZGM7OP[3._9D;N$/Y3U2V=6832BJH^2#M,XX/,(UP M[05+E"9\23D8BVJF4*+X:UQ%%]8Q_OF93+2O"=E$R#X16&P4;/[FEA>YQI&8 MGONS2P\.KKV(4R8FJ.DXO3-J7/52I-FOG%V\T(2)E-,&LR"84_^R14:W]&Q% MS[ZG[V;Z+CKY#UOX`_7C>@,.:-U)QN.H4:TX$PD5]>4M.[]+(F$VOKP MAXMUO%(QL=C/#V1YI<4[4$L#!!0````(`+A&<$?8/!E[I`$``+`#```9```` M>&PO=V]R:W-H965T:,"*3;.V&9*_CQ]`F"A2+KB[J:JN]J.84#^;#L"2%R5[7PI-H.^L+K"S8RJN%@MX([(F&YDAO=X=3[A$!\%?` M9#8Q\=[/B,\^>:B/-/$60$)EO0)WRP7N0$HOY!K_GS7?6WKB-E[4?X=IG?LS M-W"'\I^H;>?,)I34T/!1VB><[F$>8>\%*Y0F?$DU&HMJH5"B^$M<11_6*?[) M\IGV.2&=">E*^)$$X[%1L/F+6UX6&B=B!N[/;G=P<.U%G#(Q04W'Z9U1XZJ7 M,OU9L(O7F2&1<=I"=BN".?%/.Z3TFIYN.WQ-SQ9Z%@UFV^Y9]K5`O@CD42"_ M$LBO1XR8TS5F_Z$)VVRI`MV&FV-(A6-OXXZNU?5RWJ;A2-[A93'P%OYPW8K> MD#-:=[#A%!I$"\Y$1_K(RW?`%!+`P04 M````"`"X1G!'G`U&!:0!``"Q`P``&0```'AL+W=O<.>-+,:)YM1V`(^]*:GN@G7/]GC%;=:"XO<(>M/_3H%'<^=2T MS/8&>!U)2K(\RVZ8XD+3LHBU9U,6.#@I-#P;8@>EN/EW!(GC@6[H7'@1;>=" M@94%6WBU4*"M0$T,-`?ZL-D?=P$1`7\$C/8B)L'["?$U)+_J`\V"!9!0N:#` M_7*&1Y`R"/G&;Y/F1\M`O(QG]1]Q6N_^Q"T\HOPK:M=YLQDE-31\D.X%QY\P MC7`=!"N4-GY)-5B':J90HOA[6H6.ZYC^Y/<3[6M"/A'RA7"71>.I4;3YQ!TO M"X,CL3T/9[?9>[@)(EZ9V*AFTO3>J/75<[G9WA3L'(0F3*(<5Y@%P;SZERUR MNJ;G%_3\>_IVIF^3P^W*X>WW`KM98)<$=BN!N_6("7-<8^X_-6$7>ZK`M/'J M6%+AH%W:TJ6ZW,Z'/)[)![PL>M[";VY:H2TYH?,G&X^A073@3617UY1T_OTL MB83&A?#6QR9=J90X[.<'LKS2\C]02P,$%`````@`N$9P1\H$S2&C`0``L0,` M`!D```!X;"]W;W)K&ULC5/;;IPP$/T5RQ\0LRS; M5BL6*9LJ:A\J17EHG[TP@!7;0VRSI']?7X`L5:3V!<\,YYPYXTLYH7FQ/8`C M;TIJ>Z*]<\.1,5OWH+B]PP&T_].B4=SYU'3,#@9X$TE*LCS+/C'%A:95&6M/ MIBIQ=%)H>#+$CDIQ\_L,$J<3W=&E\"RZWH4"JTJV\AJA0%N!FAAH3_1^=SP7 M`1$!/P5,]B8FP?L%\24DWYL3S8(%D%"[H,#],ZI3^'?*9]3,AG0KX2OF31>&H4;7[ECE>EP8G8@8>SVQT]W`01KTQL5#-I M>F_4^NJUVA59R:Y!:,8DRGF#61',JW_8(J=;>GY#S_]-WR_T?7*XWSC\C_[% M(E`D@6(CD&]'3)CS%K/_JPF[V5,%IHM7QY(:1^W2EJ[5]7;>QT-D[_"J''@' M/[CIA+;D@LZ?;#R&%M&!-Y'='2CI_?M9$PFM"^%G'YMTI5+B<%@>R/I*JS]0 M2P,$%`````@`N$9P1Q]W5+2D`0``L0,``!D```!X;"]W;W)K&ULA5/+;J0P$/P5RQ\0`\,DT8A!RF2UVCVL%.60G#W0@!6;9FTS M9/\^?@`95I%RP=U-576U'\6$^LUT`):\*]F;(^VL'0Z,F:H#QEH6H?:DRP)'*T4/3YJ842FN_YU`XG2D*5T* MSZ+MK"^PLF`KKQ8*>B.P)QJ:(WU(#Z?<(P+@14KZ*VG3.;4%)#PT=I MGW'Z!?,(>R]8H33A2ZK16%0+A1+%W^,J^K!.\<\NG6E?$[*9D*V$^R08CXV" MS1_<\K+0.!$S<']VZ<'!M1=QRL0$-1VG=T:-JU[*-,\+=O%",R923AO,BF!. M_%NXW#_O4"^".11(-\(W&Y'C)C3%G/W7Q-VM:<* M=!NNCB$5CKV-6[I6U]OYD(4S^827QN5C'*Q43B\/R0-976GX`4$L#!!0````(`+A&<$&PO=V]R:W-H965TVFP9,F9I22Z[\7$#B=Z8$NA>>^[:POL+)@*Z_N)2C3HR(:FC-] M.)PNN4<$P*\>)K.)B?=^17SQR8_Z3!-O`014UBMPM]S@$83P0J[QGUGSK:4G M;N-%_5N8UKF_<@./*'[WM>V81SAZP0J%"5]2C<:B7"B4 M2/X:UUZ%=8I_CLE,>Y^0SH1T)=P'`HN-@LVOW/*RT#@1,W!_=H>3@VLOXI2) M"6HZ3N^,&E>]E8?\OF`W+S1C(N6RPZP(YM3?;9'2/3W=T-./Z=E"SZ+#;-L] MRSX6R!>!/`KDNQ&_[$>,F,L.RI!M^'J&%+AJ&SM.-AQ#@VC!F4CNCI1T[OVLB8#&^O"SBW6\4C&Q."P/ M9'VEY3]02P,$%`````@`N$9P1^BRE8&ULE57;CILP$/T5BP]8L(&01`0IFZIJ'RJM]J%]=H@3 MT`*FMA.V?U]?@&"+738O,39GSIPS8<9I1]D;+P@1X+VN&K[S"B':K>_SO"`U MYD^T)8U\ENJS%Y:E]"JJLB$O#/!K M76/V[YE4M-MYT!L.7LM+(=2!GZ7^&'0CQ0XW>SEHU> M._,F@7W8?`#J`]`8,.:9#PC[@/`>H$OG&V7:US8O5OPZV$,T4B MF0'7;,R42SKC\O26P1BF_DT1]1BD,<\69D3XDGTV!?+L<#0)1W,)#A8B7LX0 M#AG,=A]:)M`R03001(8@L@A"6V1B;!A,TXL,-W.@PQ0$T6JS+"5VI,26E&B9 M8.448_5H,1)'06(1Q+;/V!0CF18#!L%REK6396UE62T3;!R?FT=]PL"1H+I\ MT6D/,E:3^`M.(73SV$V6?($".68A>MAMZ*H(/_O(![?A1U_YQXG<9H)V-ZUG MNPE..R5:ATX>?S+%:L(N>KISD--K(\P0&T_'&V2/]!2\P[.TQ1?R"[-+V7!P MI$+.4CWXSI0*(E4$3])V(>^X<5.1LU"/B:J'F?IF(V@[7&+C39K]!U!+`P04 M````"`"X1G!';[]_EOH!``!O!0``&0```'AL+W=OV2\'SE_,XCE`AE0:H1TXC^#YC6E(<[WH_HW6ZUV?R02,DY_UX6JM%G?0P64I*/J ME???82AA901/G$K[1*=.*LY&BH<8>7=KW=BU=V^>_(&V3`@'0C@1ICS+A&@@ M1%="_"DA'@CQ_V98#83570;L:K>=RXDB:2)XCV1+S'4*MAHNC(A61M*J"?=! M=.^DCE[28+5)\,4(#9C08O9SS#I8@N0W,A,":P.++D+O-D,XHX=+";(Y8KT( MR;\4.7P@\J'-:+09N69%\RH?_:\%XE$@=@+QC-1$>N]$]@;VS)N0+MVG_0[BL]_:8#A5*9 M[=J4Y0:".RC>CN-MFK'I/U!+`P04````"`"X1G!',14[E44"``")!P``&0`` M`'AL+W=O^`CI+8AJKK2D3:.=5.9?L^G? MG#K0["_NKV.Y"G]/!"U9\[,^RDK1AKYWI"=R:>0[&[[2N0:L#0^L$>/3.UR$ M9.T2XGLM^9S:NAO;87J#X1SF#H!S`+P%`/3?@&@.B%8!P40VUO5")"ERS@9/ M]$1_;;!1J3*C9:P%BF`=7;31KX*C9F1JGHK04^"8)%("3 M`BX4T_`96A31?8-H,4"30609(!LRFA\&A"L:?0@;.,[_ M=3>+ENWPC[_:5L5PC1,8AV9/SO0[X>>Z$]Z>277^CH?EB3%)E5?XI$JLU+UX M&S3T)'4WT;5/-\4TD*Q?+K[;[5O\`5!+`P04````"`"X1G!''J<1(`0"``#> M!0``&0```'AL+W=OD:A\JK?:A?7;")*"U,;6=L/W[^@($1VBS+]@>GW-\9K"G&!A_%PV` M1!^4=&+K-5+V&]\7QP8H%D^LAT[MG!BG6*HE/_NBYX!K0Z+$CX(@\REN.Z\L M3.R5EP6[2-)V\,J1N%"*^;\7(&S8>J$W!=[:I%;`:KE`!(5I('?QWU+P= MJ8G+^:3^W62KW!^P@(J1/VTM&V4V\%`-)WPA\HT-/V!,P3@\,B+,%QTO0C(Z M43Q$\8<=V\Z,@]W)@I&V3HA&0C03YG/6"?%(B+]*2$9"")FI MIJRO4[A1<*Y%E#(21HW;'Z)J)U3T6H9Y5/A7+31B(H-Y M66+R<`U2.3)KB+U[4#QC?&5RU6GDN2ZBA<"JS^HA8K=$K">[=T32QS;CR69L M"QHO\\R^D&D:9N]BLL=&TCLCJ2.0NX?D]J=83&$#A)/&ULG9K=(!@N9_Y,)4Q79L',=5J5QD MKV4C&RJ`6$DVV;=?"0FB/HRAE5P$A$]W3\_,I^X1C+=9_JN8IVDY^+U:KHO+ MX;PL-Q>C4?$\3U=)\2G;I.OJ+R]9ODK*ZC)_'16;/$UF.Z/5D2*^SY3^+63FO1AL- M![/T)7E;EC^R[31MS^'SR_%66VVIL,!ZOD=_.Z6.]>M\U??-2: MA0UD:R`/!D*?-%"M@>(:Z-9`K%S$-CDLMF";[)=;L-=;[!=)<'X\>J\]M1JYTUQ131S27!.-CT*:&ZH1 M([C$6D8D>Z.*.9X,#`KIO>L6!B#)6.`K=UHIE0C&5$<1''$@V)X\)"I[YUI M#&.(R1AT,%.J,8PH(H(P]7VWXP.8,2V>46<#:[S'`S1F*$/K]=KT'$V:_"8"!"5LRY8PF+4VO[3RV"(]SYJ;UJ M1?NIY<3Q&,>?G]@K$+$F%BD4%+$XG%#<38A3+9!"V:50LC:;%+!^4O1>/REQ M')*,0X32?6Q%3;HVVOWC!$,.I2+!9/#6([L<*GXP1%$R4/Q&1#+BW/@EHB@- M\:$Y/A!%V1]%B2A*QUE*!WDQ+I0LLX5:2;]+Q%5,BC M(CQB?VO:4/I$@WLB&#*I*).<\JB02=6?285,*LIDL)I,59=)P6P]%!*I")&" MY2/&E./>*6MD2$?G87W046]8-7:7FIPAA>#XP.Y2]^\N-3*DU?F$K[7JG_#1 M<8P4*\%I;S0>R'3_$YG&(YEFG,FNB(B9,-*C"3V"4YTUGLMT_X.9QOJC&?7G M`42+A$;)*3`6:;3]:;1(H_7G]^V- M/3I-<4(ACY8!W]*18KUN/_H>3_I+%6P*MVZXVV?;D,8CBM)!>8=*J?])(HS_Y?*.]H?GN M\PT53'K4^9YYD[RFCTG^NE@7@Z>L++/5[NOEERPKT\I=]*F:RWF:S`X7R_2E MK-_6,.;-SRF:BS+;7+:_#CG\1&7R/U!+`P04````"`"X1G!'/3I?0P<8``"C M50``%````'AL+W-H87)E9%-T&UL[5S;;B-'DGV>^8I$HXV5@!*; M%U&M;ML-4#=;'K6D$=5K+!KSD*Q*DN4N5M%UD41C'OP5"PRP^S/[*?Z2.1&9 M=6%E%4G)]MN^Z,+*C(R,ZXG(+'Z3)*EX6@1A\NVK>9HNW[]YD[ASM9!))UJJ M$$^F4;R0*?Z-9V^29:RDE\R52A?!FWZW>_1F(?WPEO7AF\3_\$WZX2QRLX4*4S$*/7$>IGZZ$I>AINE'H3@0R5S&*OGF3?KAFSC^YN[ MR_.QN+P^;2%Z"D9B&8`73SV)OZE5R[@+/U"Q.)6IFD6Q-6B\D`$]OU/+*$[] M<"9.H\52AM;`TRR.:>L7?N)BU?]2,B;QBC,0KH\]..CU#P:]^L?WL?1HA?%J M,8D"2PIG=VT[C18+"'J<1NX71XQ9Y>(F2Y-4AD2P54WWJZ7%6Z][\/?Z9R., M]GC&12`M_;+0H(U9#[0(?6U;]]\&VV:R4 MQKFG9&'7X_,S@;_&-U>79Z-[_',RNAI=GYZ+\??GY_=C^-.G\9G8>[TO7@L_ M%/?S*$L@8HO:F7*QJ1X[R6&;H<@D46GRWGHLD[DE?]E$W2:18(F4_!D->]=ST!/O''VZ,Z[+?N-4@AY\YC*YH02^G/B!GT)DEK5P;(4$ MW%AYOL513H%#%\2!@4$4S@Y2%2\@J(DUH3"TI5R1E34\CS,(V44,A.`:99J/ MF:A03?V2?2MB7H8@HT0JGU3K@D9VAJ1ZHE5M0UTWO(J\+'%MW/V9FBJ0\.#; M)6>63!%L_91MAA^1Y%'@J3G[[]5]LNNG*TB(J. M.'8.CP[S!2Z3A)1`FSYRAL.A^:M_-&A@0>\ MZ[YCKOM.O]MOP5+:]I)&13>/O2KMDZE7C>0_Q'GCS-WRT^=;21XP5ZF/=/>/ M2KXR"JHF+6=+$AMM22Q[F.Q%02#C9'^K01?65ITF$-HU9]L)F`V4IKKKC)W= MXKDLKL_>RE_C<)]=JF7H&IYS-@&ZN@DW6^J:Y8SO\>OC^36LYN9"W-R>`U%? M8L#OLYG!SH6%Y?S72.6)#)H";L))?H;TFH@$?F(EWAAN+99Q-+4CP@T4*!FW MY\G#BKYC%00-0OT.^8OJ!\80WL(/N41)$4;J(^]4`F#ISGFHIQY4$#$^:79_ MFR,+ULLXQ'.X&,6K?3&-HX6(]+0HM(;K''FNB;U'O8,$IR`S0U[L`:M8UEM? M8Z+@Y6ICY@,6>_`3PA%[)K?OTJM:7LNH:F?BN%IT?9!2Y0WM2Z8<[ M>J>F^JC\V9Q(R@=(;P9K;LA41%!_;%$Y,QS5Z3R33$OT7O?!T]'X>W%Q=?/C M[G4&U0HHR:+'1%R0C92F-7)AJ,V0D532E`='WD]98H!-&E&I$0'3`/*&9@)] MZM**2S($CR#>2NQE"0.F_=Q`*?6W+\XQ;0T^YF9J@[$2Q]OU:#ND+ZU4VZ8N M-U;83Z+BATU6W9CF.I;,YR@%=%BL[)@!/!OQ)K3>4,=M0^!.`7[7A%:69-NP M,:G[F5K;9F94PR7;S.Q4@SC-%VJ3K"$CC3P\P'8P+-"56#O[AF/6:/),AB_\ M$$!F![^81'$JX0\7OBMT!4@K!X*9*ZZX8O+W(@L6Y2B&7<5Q73RIV_81I M<_J&2AK#_!9%3HL]MLN%2"!:$UJ@4,_DFF3G(!W,_)`",+&UY*9+\T!%AM@V M9)PMEP'7U=!PH91J=["Q_2&XZZ#=5^>R;:,VEFO4K6.'H9S`^KFE8`"FFN+' M33R3H8DMCCB%(J+`]TJOJ\XE6L:VL,$Q/M1-!/%Y-"&PX*96Q[.1!UT&^+/0 M1U5#;0X3!4C^MUB>2DOQ^5X]I>(D@(G4J5*/^7VRE*[Z]M72!+I7'U`;IDKT MD$VV"H'(`K'%XAZ6"P1\)>$),F_3H%#OB+TTFBF..(]^.A<^=ND6PB'4G4T2 MW_.EGH*!XK=?_Z=8^1[_8[TLP#12&3U/YW[LB9\S&4/)Q)&N$I'BPRA%UG%5 MDH!+:,_87>+_?$X"$!)8HLCK57(\[+@%M/6C(KWJX4 M4^G'Y5IU">'?$CKJC@4YSY2C8RXO[;Z$H=DF3)5/3UHV.9$!EX9\6I'7^FHQ M@2+S>K\C3E7,F_8KIP%$=QI%:4BVZ4%#0!:4&LR&6=END'DZV#?*1!``J M'[D&ZO>,^NU6Y<\9`D2JP]!WD3Y+@>;BAK9L/K0]D%;&O"PP]L7__;?8P!3' MK#77;]1%:2B%70(-9@N:P%JI*$%0>]AT##/J)<-[9[RFJ]=TQ./S/5&K>[59E_'@TT`MM&;@D+5%,E@5#[!>W&1Q>1$J"B48SG, MG7J(@@>E\\<]`;JK2(9:C4!?&([02T`O83=2$X1HQ&7M`D<.D@4V#O$]I2S! MCK:I2023(95%*&'!!Y1`V1.%9$K&Q34(C],A6B)3[A5)8:3Q5,_9*?YCZ,6+G7`;3?&<5@+'N"/["P%ZVY?0Q.EC. M"7)37_F@]`$`^5DL%\;G_:3DE^MO#%,F5G-O/J_PR/+D$I.?@!=2A:SV6O2= M7KE0_2#UA?&2-)3@R2#L[HO[("VX,*J7L?:O?E4'P$;4,E^QTQ8@:W!9HY M$J8M@>'@G3@\'E0E@`V$9.ZF9-+FCN@<,V)@:_13X\[DF-K:8J5=1\LF/U:B M4DY$D\"?Y=G](O5 MN0W=.K`8L2%C-PU^6>H>'(A6%JTG9>?0)YD%KCD?:D"/H_$I*J"E[XK^49?J M%YMEY[=?_]_YL.)WW2VN#L"-V[;.^`FN!- MF%GW3'-@31N$,7++$D'"0T3CUF130U6G+[NS&6;L>-3I,"<6=JMSO6P`:C!M MTF*-DE?X08"8YI"X\RJ#:)7<0 M6UHH.@_F;67-T(0"L7HR$N1NB&E0Y!N=4C1%'"&)]ARJ27O.X:%UN>1:/:[5 MZ7$4XF]7Y]EG#>:5*GW%M8%%$=/N6'\$\9=8BA*A#3V)]KS M6L;W,?Y[P/94GPO]J((IV5^QROKHX?Y[<2M1CET2)*52U0P\N-/8AEQ#-UZY MRF<.8`Q?FUF8QANK##DKJ^MB%(9]U(E&#T$DA,((_!"2H3,DCQ(("=;(/!<= MR;Y3$7X_)RD2@CN`?:94*8MZ;@P24P8F3J@+OT#0-(C*I,.%R5B8*&SF:QB&]#Y08;5XH9Q]PCH,MC%]0X==CW;THJ5++,DE8?B'+85 MK53,6+;NJ3<%AM&M6?9L-A,R8)A4@?OP5[ZT*I;F8L>@,7"PJ'#@&0[8H,VJ M^86FJDGS.4P5$Y(--JW%U_0@8;,=K>"J'1Q0)]TS!3\LTQ1J;D0QVLO;6X0Q M%.E+5^8\">P;UL72A")B:ZF+C33WL!W8I_+*;+IA'98)^UZ2YC*K;4#OOS`I MX^#4/T@K!:`B1*`!1(.DJ$+CBM12"G4J=M@$691;"=!DC M]6UX&=HE'V985I!W0GD/NJ:J=I:+79.];W3T7?UW8RBH$NP0U@U\:D\T.WLU M('H1`\;4%)GE%&IZYK'JD*1O`!E55C%%-1,O3>C;VNO6RU(DT#'A?*'B&6V: M[X\EXEXF7ZCCZ):BI08BKVI"AVL:QY58G!3X(%MJ+ZDU6XWMVJ6CZ8WJ&H\/ MBDH546\JFR0P4[XFJ07^M9A'C[`1%/7E24#N%Y8X4;GZ&&S226AZ)*2JG-%' M[FWP_BI62"&:^5!K?0]C7[E8*Q(H"D0ZIJXTSJD89B#-34CLR(!FT[I@$6"* M[MSR-8OMK"_7,5R9_^2:(Y664=_!]A,1TQE-_87*V5]7CE657A9G^26RV8"* MFX>_#.<.">=6KB[7S*S>(A^RM,6=?!0?C1^+'*/[" M51$=!R<)73(<#,3`Z1X."5+XR5Q11YHBP-`98.+0.3Q^*WI]YY!*DH%SA!KE MBF;F'8KRLL/>6^>H/P!N?N?TAV_W>>4^?A[VC_04LS^.4=0-$P:6Z5@*U:E4 M5>D-G,-N#_3Z('1,UU)ZS!+]/NH?KXF&0"[KV5PSW!C'TJ[(-]NJ_<:0+!49*GC(V_"=-3EKKS6G MI=6]ZC-1)I8Z"M[U-QTZU('.I%``W"? MPLSM#M=9X_7O2;I;:+%&OBRJ'%%485HWP*W9C#`/OUG5/:YMB:]!,#*@]K4^ ME>"C*KZ,XE2.)O@F`1T:4WMWE+_6H-%CV8X]D>$71UQW1AVQ1V>SBBJ&+R&U MQ&$"8VKY*\3YRKA],!1'V4R?_%=&F*,CD=_WH::3OB1(%7RYY#%?+&_J")>? ME?P>.V\1W?1E].(09L`?EGO]U-!H+DAH"19SRV)PPE@LOUE",4H*:F]STXK: M[0NZO4U%960P*J4H0L/$;*PAHCCQW!`]G0- M%6EP>=AX5E_E5D(8%P/A@2#_![XV;1L]@]_Y/ MY;5.O6!T6'%59.)=.+WV_TQ.Z]3[7>+PHUSMK'?J__Z)6J^3+T39&VI.Z=)` M>?LB MOY^P12SC/]D;;/J]8^L`&GJN<0E>N: MY:%C>6:/S.QEIB]8G69N!B'$Y]>8:BN)1YD41XK0"[!VO\]DFG*5N=M%.!Q@ MA@];8[6LW*[3^.51QO2&,T-D(#]%-\$2J@%]OAOUH,S]AIG^A\[=D2$)D>KS M'CZ>-0"RK*B*89WG\&RB$,'BG3QDZY%T'4S`$)SN94;NKGP MG#*'TL4H?1G9'$4^SH$K2?;6K1UL+Q#F!BPI;MOK=:?5U^MV0V=Z#11>*?79 M;"(O1&MO^;Y0G?\U(&R.>26]2V0N:92(OYBA&WI\Y&2"#7=D22_EE1Q"6?FU M'-8!?\K'9DX.Z_-*I>7JHN$F\+\0>&]H["!4*EHN/V6SR_B2@ZK%A?K0VFF^ M8\A56GG'T#*!<=EP.7]H.BNS!FS0=T@;D\;7IF.]\4K=ZJ:VV!D!GOW=,)J/VRR=B=*R\+V%Z*'H@C\G>! M/_,T\6PI591TXC[W>__OU&RWBAYQJ5(L7>F$#L@ M$-(5"I+]G=\+JMR-W/#E&_PRM(8!-.AF:K"!]=K:MOM+GS^R4NT+'_EU)JB] M>.=@I"^?GC>_]7//=\++U<3NJ]4A3HD`VV;D+\_7QCO``?3%*T3J)$<85-_B MN?UF;OM%E";]-;^9.4)Z*NX_&"A&?G;^9.[RGZ$Z?4WOND+DW3)U&8<5B[\:52F(N3;L,A&%U$L-NNDU^UVNMVO MZA\?'35]6B[R(UQ('9Q%C];EZL$^`%NRO$>H/F\RA7JH^.Q$4[U+3FDACB1O[RZ:W MQG8L>>T768LO5E)V+JPU"%K3K-U8:QM*2D(HUU_,9&JZFZG8R,9'^>0OLC+O MBG]:+8!GRS6GN3V]MIO!:$9%+9!ZX.NOYBF=/_^H3FS8&$H^(OZ\<(.#9K,K MFR;N1">_RV=_:\IV6(3][NR5-5=WR&`PC:K^%RW<8%PO MCQ`[+K"K7[UX`[O[XVY+V/;Y!\O(7N"/E5'#!G:74=FHW!77/^O\Y/G+47S8 MF7O+88!<=:>UZ=OP+M0$B,%\&9[U56V[IBE]AGS;^$IVMRG.K!\,5C=:/UYH MVV8[A3^P++O,7UW?RPO*?4?PMY\XXMK^/K;UJK9<=UU:YAL%1W0(JS2HM676 M>]<*T/?PKAT[%T#.:B4_'%CD!ZT)IUQS_60E3[T%*W^D$3S+ MJ=H7>DZP>),DZ8=_`U!+`0(4`Q0````(`+A&<$>4SP1@@0$``(0.```3```` M``````````"``0````!;0V]N=&5N=%]4>7!E&UL4$L!`A0#%`````@` MN$9P1TAU!>[%````*P(```L``````````````(`!L@$``%]R96QS+RYR96QS M4$L!`A0#%`````@`N$9P1QCIY9TR`0``Y@P``!H``````````````(`!H`(` M`'AL+U]R96QS+W=O&PO=&AE;64O=&AE;64Q+GAM;%!+`0(4`Q0` M```(`+A&<$=*CI5`1P(``.`)```-``````````````"``3$.``!X;"]S='EL M97,N>&UL4$L!`A0#%`````@`N$9P1U011L[3`@``@`<```\````````````` M`(`!HQ```'AL+W=OW75?940(` M`/,'```8``````````````"``:,3``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0#%`````@`N$9P1\M< M<0XW`@``P0<``!@``````````````(`!CAH``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`A0#%`````@`N$9P1QZJWL*C`0``L0,``!@````` M`````````(`!)24``'AL+W=O&PO=V]R:W-H965T&UL4$L! M`A0#%`````@`N$9P1V#,=!NA`0``L0,``!@``````````````(`!L2H``'AL M+W=O&UL4$L!`A0#%`````@`N$9P1YP-1@6D`0``L0,``!D``````````````(`! M8RX``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%``` M``@`N$9P1R/0%CRE`0``L0,``!D``````````````(`!\S,``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`N$9P1S$5.Y5% M`@``B0<``!D``````````````(`!;#H``'AL+W=O!0``&0`````````````` M@`'H/```>&PO=V]R:W-H965T\WP0S=P4``*XB```9``````````````"``2,_``!X;"]W;W)K&UL4$L!`A0#%`````@`N$9P1STZ7T,'&```HU4``!0````` M`````````(`!T40``'AL+W-H87)E9%-T&UL4$L%!@`````<`!P` *=@<```I=```````` ` end XML 15 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 16 R9.htm IDEA: XBRL DOCUMENT v3.3.0.814
New Accounting Pronouncements
9 Months Ended
Sep. 30, 2015
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]  
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]
Note 4 – New Accounting Pronouncements
 
In July 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) ASU No. 2015-11, Simplifying the Measurement of Inventory: Topic 330 (“ASU 2015-11”). Topic 330 currently requires an entity to measure inventory at the lower of cost or market. Market could be replacement cost, net realizable value, or net realizable value less an approximately normal profit margin. ASU 2015-11 requires that inventory measured using either the first-in, first-out (FIFO) or average cost method be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Adoption of ASU 2015-11 is required for fiscal reporting periods beginning after December 15, 2016, including interim reporting periods within those fiscal years. The Company does not expect adoption of ASU 2015-11 to have a material impact on its consolidated financial statements.
 
In July 2015, the FASB issued ASU No. 2015-12 “Plan Accounting: Defined Benefit Pension Plans (Topic 960), Defined Contribution Pension Plans (Topic 962), Health and Welfare Benefit Plans (Topic 965): Part I. Fully Benefit-Responsive Investment Contract; Part II. Plan Investment Disclosures; Part III. Measurement Date Practical Expedient” (“ASU 2015-12”). ASU 2015-12 Part II simplifies the disclosure of plan assets by removing the requirement to disaggregate the fair value of assets disclosed by general type. The Company is currently assessing the impact that adopting this new accounting guidance will have on its Consolidated Financial Statements. ASU 2015-12 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2015, and early adoption is permitted. Accordingly, the standard is effective for the Company on January 1, 2016.
 
In April 2015, the FASB issued ASU No. 2015-4, “Practical Expedient for the Measurement Date of an Employer’s Defined Benefit Obligation and Plan Assets” to provide a practical expedient related to the measurement date of the defined benefit plan assets and obligations. The practical expedient allows employers with fiscal year-end dates that do not coincide with a calendar month-end to measure pension and post-retirement benefit plan assets and obligations as of the calendar month-end date closest to the fiscal year-end. The standard requires entities that elect the practical expedient to adjust the measurement of benefit plan assets and obligations for contributions or significant events between the month end measurement date and the entity’s fiscal year end. The ASU is effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Earlier adoption is permitted. The Company does not expect adoption of ASU 2015-4 to have a material impact on its consolidated financial statements.
 
The FASB, the Emerging Issues Task Force and the SEC have issued certain accounting standards updates and regulations as of September 30, 2015 that will become effective in subsequent periods; however, management of the Company does not believe that any of those updates would have significantly affected the Company’s financial accounting measures or disclosures had they been in effect during 2015 or 2014, and does not believe that any of those pronouncements will have a significant impact on the Company’s consolidated financial statements at the time they become effective.
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.3.0.814
Earnings (loss) Per Share
9 Months Ended
Sep. 30, 2015
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
Note 3- Earnings (loss) Per Share
 
Earnings (loss) per share is calculated in accordance with ASC Topic 260 “Earnings Per Share,” which provides for the calculation of “basic” and “diluted” earnings (loss) per share. Basic earnings (loss) per share includes no dilution and is computed by dividing net earnings (loss) by the weighted average number of common shares outstanding for the period.  Diluted earnings per share reflect, in periods in which they have a dilutive effect, the effect of common shares issuable upon exercise of stock options. The diluted share base excludes incremental shares of 2,183 and 1,015 related to stock options for the three month periods ended September 30, 2015 and 2014, respectively and 1,799 and 1,443 for the nine month periods ended September 30, 2015 and 2014, respectively. These shares were excluded due to their antidilutive effect.
XML 18 R2.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2015
Dec. 31, 2014
Current assets:    
Cash $ 304 $ 232
Accounts receivable, net of allowance for doubtful accounts of $191 and $176 2,171 2,425
Inventories 7,623 9,257
Prepaid and other current assets 284 651
Total current assets 10,382 12,565
Inventories, net of non-current 1,391 1,628
Property, plant and equipment, net of accumulated depreciation and amortization 3,744 3,923
License agreements, net 594 645
Intangible assets, net 1,827 1,962
Goodwill 493 493
Other assets 130 28
Total Assets 18,561 21,244
Current liabilities:    
Line of credit 2,539 1,269
Current portion of long-term debt 3,673 286
Accounts payable 1,944 1,351
Accrued compensation 553 513
Accrued benefit liability 260 260
Income taxes payable 24 24
Other accrued expenses 198 101
Total current liabilities 9,191 3,804
Long-term debt 14 3,607
Deferred income taxes 95 95
Commitments and contingencies 0 0
Stockholders’ equity:    
Preferred stock, $.001 par value; authorized 5,000 shares; No shares outstanding 0 0
Common stock, $.001 par value; authorized 25,000 shares, 8,464 shares Issued and 6,555 and 6,263 shares outstanding at Sept. 30, 2015 and Dec. 31, 2014 8 8
Paid-in capital 26,390 26,435
Accumulated deficit (9,471) (4,096)
Accumulated other comprehensive loss (1,354) (1,354)
Treasury stock, at cost, 1,909 and 2,202 shares (6,312) (7,255)
Total stockholders’ equity 9,261 13,738
Total Liabilities and Stockholders' Equity $ 18,561 $ 21,244
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
Company and Basis of Presentation
9 Months Ended
Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation and Significant Accounting Policies [Text Block]
Note 1 - Company and Basis of Presentation
 
Blonder Tongue Laboratories, Inc. (together with its consolidated subsidiaries, the “Company”) is a technology-development and manufacturing company that delivers television signal encoding, transcoding, digital transport, and broadband product solutions to the cable markets the Company serves, including the multi-dwelling unit market, the lodging/hospitality market and the institutional market including, hospitals, prisons and schools, primarily throughout the United States and Canada. The condensed consolidated financial statements include the accounts of Blonder Tongue Laboratories, Inc. and its wholly-owned subsidiaries. Significant intercompany accounts and transactions have been eliminated in consolidation.
 
The results for the third quarter of 2015 are not necessarily indicative of the results to be expected for the full fiscal year and have not been audited. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting primarily of normal recurring accruals, necessary for a fair statement of the results of operations and cash flows for the periods presented and the condensed consolidated balance sheet at September 30, 2015. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to SEC rules and regulations. These financial statements should be read in conjunction with the financial statements and notes thereto that were included in the Company’s latest annual report on Form 10-K for the year ended December 31, 2014, filed with the SEC on March 21, 2015.
XML 20 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 21 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814
Liquidity and Going Concern
9 Months Ended
Sep. 30, 2015
Liquidity [Abstract]  
Liquidity [Text Block]
Note 2 – Liquidity and Going Concern
 
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business. During the nine months ended September 30, 2015, the Company experienced a decline in sales, a reduction in working capital, reported a loss from operations and net cash used in operating activities in conjunction with liquidity constraints. Furthermore, the Company’s Revolver and Term Loan will by their terms on February 1, 2016, unless extended. The above factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
 
In response to lower than expected sales due to a slowdown in market activities experienced during the first half of the fiscal year, the Company implemented a two-phase cost-reduction program which is expected to reduce annualized expenses by approximately $2,100, including a temporary reduction in certain executive salaries, a decrease in workforce and a decrease in engineering consulting expenses. In September 2015, the Company then developed and implemented a third phase cost reduction plan, which is expected to further reduce annualized expenses by approximately $750.
 
The Company’s primary sources of liquidity are its existing cash balances, cash generated from operations and amounts available under the Santander Financing (as defined in Note 6 below). As of September 30, 2015, the Company had approximately $2,539 outstanding under the Revolver (as defined in Note 6 below) and $483 of additional availability for borrowing under the Revolver. The Company expects to either obtain an extension of the maturity date or refinance all or part of the Santander indebtedness prior to February 1, 2016. If anticipated operating results are not achieved, and or sufficient funds are not obtained, from the Company’s expected refinancing, further reductions in operating expenses may be needed and could have a material adverse effect on the Company’s ability to achieve its intended business objectives.
 
The Company cannot provide any assurance that it will be able to refinance its current debt obligations. If the Company is unable to refinance, it may be required to take additional measures to reduce costs in order to conserve its cash in amounts sufficient to sustain operations and meet its obligations.
XML 22 R3.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] - USD ($)
shares in Thousands, $ in Thousands
Sep. 30, 2015
Dec. 31, 2014
Allowance for doubtful accounts (in dollars) $ 191 $ 171
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized 5,000 5,000
Preferred stock, shares outstanding 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 25,000 25,000
Common stock, shares issued 8,464 8,464
Common Stock, Shares, Outstanding 6,555 6,263
Treasury stock, shares 1,909 2,202
XML 23 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814
Inventories (Details) - USD ($)
$ in Thousands
Sep. 30, 2015
Dec. 31, 2014
Inventory [Line Items]    
Raw Materials $ 4,791 $ 5,151
Work in process 2,233 3,045
Finished Goods 5,391 5,487
Inventory, gross 12,415 13,683
Less current inventory (7,623) (9,257)
Inventory Value Before Reserves 4,792 4,426
Less reserve for slow moving and obsolete inventory (3,401) (2,798)
Inventories, net non-current $ 1,391 $ 1,628
XML 24 R1.htm IDEA: XBRL DOCUMENT v3.3.0.814
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2015
Nov. 06, 2015
Document Information [Line Items]    
Entity Registrant Name BLONDER TONGUE LABORATORIES INC  
Entity Central Index Key 0001000683  
Entity Filer Category Smaller Reporting Company  
Current Fiscal Year End Date --12-31  
Trading Symbol BDR  
Entity Common Stock, Shares Outstanding   6,554,736
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2015  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2015  
XML 25 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814
Inventories (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2015
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2014
Inventory [Line Items]        
Percentage Of Fifo Inventory Non Current For Finished Goods   100.00%   66.00%
Inventory Write-Down $ 1,008 $ 1,026 $ 107  
XML 26 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Net sales $ 5,704 $ 8,659 $ 15,729 $ 23,065
Cost of goods sold 4,931 5,173 12,040 14,347
Gross profit 773 3,486 3,689 8,718
Operating expenses:        
Selling 776 807 2,392 2,500
General and administrative 1,003 1,161 3,085 3,631
Research and development 869 865 2,598 2,634
Total Operating expenses 2,648 2,833 8,075 8,765
Earnings (loss) from operations (1,875) 653 (4,386) (47)
Other Expense: Interest expense (net) (83) (69) (249) (183)
Earnings (loss) before income taxes (1,958) 584 (4,635) (230)
Provision (benefit) for income taxes 0 0 0 0
Net earnings (loss) $ (1,958) $ 584 $ (4,635) $ (230)
Basic and diluted net earnings (loss) per share (in dollars per share) $ (0.30) $ 0.09 $ (0.72) $ (0.04)
Basic weighted averages shares outstanding (in shares) 6,555 6,226 6,407 6,220
Diluted weighted average shares outstanding (in shares) 6,555 6,320 6,407 6,220
XML 27 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814
Legal Proceedings
9 Months Ended
Sep. 30, 2015
Commitments and Contingencies Disclosure [Abstract]  
Legal Matters and Contingencies [Text Block]
Note 7 – Legal Proceedings
 
The Company may be a party to certain proceedings incidental to the ordinary course of its business, none of which, in the current opinion of management, may be likely to have a material adverse effect on the Company’s business, financial condition, results of operations, or cash flows.
XML 28 R11.htm IDEA: XBRL DOCUMENT v3.3.0.814
Debt
9 Months Ended
Sep. 30, 2015
Debt Disclosure [Abstract]  
Debt Disclosure [Text Block]
Note 6 – Debt
 
On August 6, 2008, the Company entered into a Revolving Credit, Term Loan and Security Agreement with Santander Bank, N.A. (formerly known as Sovereign Bank, N.A.) through its Sovereign Business Capital division (“Santander”), pursuant to which the Company obtained an $8,000 credit facility from Santander (the “Santander Financing”). The Company and Santander entered into a series of amendments to the foregoing Revolving Credit, Term Loan and Security Agreement (as so amended, the “Santander Agreement”), including the Seventh Amendment referenced below, which, among other things, adjusted the Santander Financing to $8,783 consisting of (i) a $5,000 asset-based revolving credit facility (“Revolver”) and (ii) a $3,783 term loan facility (“Term Loan”), each expiring on February 1, 2016. The amounts which may be borrowed under the Revolver are based on certain percentages of Eligible Receivables and Eligible Inventory, as such terms are defined in the Santander Agreement. The obligations of the Company under the Santander Agreement are secured by substantially all of the assets of the Company and certain of its subsidiaries.
 
Under the Santander Agreement, the Revolver currently bears interest at a rate per annum equal to the prime lending rate announced from time to time by Santander (“Prime”) plus 1.50% or the LIBOR rate plus 4.25%. The Term Loan currently bears interest at a rate per annum equal to Prime plus 1.75% or the LIBOR rate plus 4.50%. Prime was 3.25% at September 30, 2015. LIBOR rate loans under the Santander Agreement may be borrowed for interest periods of one, three or six months. The LIBOR rates for interest periods of one-month, three-months and six-months were 0.19%, 0.32% and 0.53%, respectively, at September 30, 2015. The per annum interest rates above became effective on January 21, 2015, pursuant to the terms of the Seventh Amendment described below.
 
On November 14, 2015, the Company entered into the Eleventh Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Eleventh Amendment”) to amend the Santander Financing. The Eleventh Amendment (i) waived the Company’s failure of compliance with the Minimum EBITDA and leverage ratio covenants for the measurement period ended September 30, 2015, effective as of September 30, 2015, and (ii) increased the advance rate applicable to Eligible Inventory (as defined in the Santander Agreement) from 25% to 35% through and until February 1, 2016, after which it will revert back to 25%. The Eleventh Amendment also contains other customary representations, covenants, terms and conditions. In connection with the Eleventh Amendment, the Company agreed to pay Santander an amendment fee of $50, which is payable in ten weekly installments of $5 each.
 
On October 14, 2015, the Company entered into the Tenth Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Tenth Amendment”) to amend the Santander Financing. The Tenth Amendment extended the increase in the advance rate applicable to Eligible Inventory (as defined in the Santander Agreement) from 25% to 35% through and until November 30, 2015, after which it will revert back to 25%. The Tenth Amendment also contains other customary representations, covenants, terms and conditions. In connection with the Tenth Amendment, the Company paid Santander an amendment fee of $5.
 
On August 12, 2015, the Company entered into the Ninth Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Ninth Amendment”) to amend the Santander Financing. The Ninth Amendment waived the Company’s failure of compliance with the Minimum EBITDA covenant for the measurement period ended June 30, 2015, effective as of June 30, 2015, and also contains other customary representations, covenants, terms and conditions. In connection with the Ninth Amendment, the Company paid Santander an amendment fee of $20.
 
On May 14, 2015, the Company entered into the Eighth Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Eighth Amendment”) to amend the Santander Financing. The Eighth Amendment (i) waived the Company’s failure of compliance with the Minimum EBITDA covenant for the three-month period ended March 31, 2015, effective as of March 31, 2015, and (ii) increased the advance rate applicable to Eligible Inventory (as defined in the Santander Agreement) from 25% to 35% through and until September 30, 2015, after which it will revert back to 25%. The Eighth Amendment also contains other customary representations, covenants, terms and conditions. In connection with the Eighth Amendment, the Company paid Santander an amendment fee of $15. The Eighth Amendment is in lieu of the Temporary Overadvance Facility, as more fully discussed in the next following paragraph.
 
On March 30, 2015, Santander agreed to provide the Company with $500 of additional availability beyond its borrowing base under the Revolver (the “Temporary Overadvance Facility”) during the period April 1, 2015 through April 24, 2015, for which the Company paid Santander an accommodation fee of $2.5. Under the agreement, the Company was required to eliminate the outstanding balance under the Temporary Overadvance Facility on or before September 30, 2015, which was accomplished prior to entering into the Eight Amendment.
 
On January 21, 2015, the Company entered into the Seventh Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Seventh Amendment”) to amend the Santander Financing. The Seventh Amendment (i) extended by one year the Termination Date of the Santander Agreement from February 1, 2015 to February 1, 2016; (ii) continued the installment payments of principal under the Term Loan at the same monthly payment of $18 per month for the additional year until the final payment of unpaid principal and interest is due on February 1, 2016; (iii) increased the interest rates applicable to the Revolver and the Term Loan by one quarter of one percent (0.25%); and (iv) reset and modified the Minimum EBITDA covenant to address the term being extended by one year. The Seventh Amendment also contains other customary representations, covenants, terms and conditions. The Company paid a $15 amendment fee to Santander in connection with the Amendment.
 
On March 28, 2014, the Company entered into a Sixth Amendment to Revolving Credit, Term Loan and Security Agreement with Santander (the “Sixth Amendment”) to amend the Santander Financing. The Sixth Amendment (i) reduced the maximum amount available for borrowing under the Revolver from $6,000 to $5,000, (ii) increased the interest rates applicable to the Revolver and the Term Loan by three quarters of one percent, (iii) modified the Company’s fixed charge coverage ratio covenant to eliminate the testing thereof with respect to the trailing 12-month period ended as of December 31, 2013, (iv) eliminated the fixed charge coverage ratio covenant with respect to all periods after December 31, 2013, (v) modified the minimum EBITDA covenant to (a) eliminate the testing thereof with respect to the fiscal year ended December 31, 2013, (b) change the manner of calculation thereof, and (c) impose a quarterly building minimum EBITDA covenant test, commencing with the fiscal quarter ended on March 31, 2014, and thereafter for the two fiscal quarters ended June 30, 2014, the three fiscal quarters ended September 30, 2014, the four fiscal quarters ended December 31, 2014 and thereafter quarterly on a trailing four fiscal quarter basis, (vi) reduced the advance rate applicable to Eligible Inventory (as defined in the Santander Agreement) from 50% to 35%, with a further reduction in such advance rate to 25% effective on or about June 27, 2014 and (vii) reduced the sublimit on advances against such Eligible Inventory from $3,000 to $2,000. In connection with the Sixth Amendment, the Company paid Santander an amendment fee of $45.
 
Upon termination of the Revolver, all outstanding borrowings under the Revolver are due. The outstanding principal balance of the Revolver was $2,539 at September 30, 2015. The Term Loan requires equal monthly principal payments of approximately $18 each, plus interest, with the remaining balance due at maturity. The outstanding principal balance of the Term Loan was $3,622 at September 30, 2015.
 
The Santander Agreement contains customary representations and warranties as well as affirmative and negative covenants, including certain financial covenants. The Santander Agreement contains customary events of default, including, among others, non-payment of principal, interest or other amounts when due.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814
Debt (Details Textual) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Nov. 14, 2015
Oct. 14, 2015
Aug. 12, 2015
Aug. 06, 2008
Mar. 30, 2015
Jan. 21, 2015
Sep. 30, 2015
Dec. 31, 2014
Apr. 24, 2015
Mar. 31, 2015
Jun. 27, 2014
Mar. 28, 2014
Debt Instrument [Line Items]                        
Long-Term Line Of Credit             $ 2,539,000 $ 1,269,000        
Eighth Amendment [Member]                        
Debt Instrument [Line Items]                        
Revolving Credit Advances Rate             25.00%          
Sixth Amendment [Member]                        
Debt Instrument [Line Items]                        
Line of Credit Facility, Interest Rate Description             25% effective on or about June 27, 2014          
Amendment Fee               45,000        
Tenth Amendment [Member]                        
Debt Instrument [Line Items]                        
Amendment Fee   $ 5,000                    
Revolving Credit Advances Rate   25.00%                    
Eleventh Amendment [Member]                        
Debt Instrument [Line Items]                        
Amendment Fee $ 50                      
Revolving Credit Advances Rate 25.00%                      
Installment Payment Of Amendment Fee $ 5                      
Maximum [Member] | Sixth Amendment [Member]                        
Debt Instrument [Line Items]                        
Line of Credit Facility, Maximum Borrowing Capacity                       $ 6,000,000
Revolving Credit Advances Against Eligible Inventory Eligible               3,000,000        
Revolving Credit Advances Rate                     50.00%  
Minimum [Member] | Sixth Amendment [Member]                        
Debt Instrument [Line Items]                        
Line of Credit Facility, Maximum Borrowing Capacity                       $ 5,000,000
Revolving Credit Advances Against Eligible Inventory Eligible               $ 2,000,000        
Revolving Credit Advances Rate                     35.00%  
Revolving Credit Facility [Member]                        
Debt Instrument [Line Items]                        
Line of Credit Facility, Interest Rate Description             Santander (Prime) plus 1.50% or the LIBOR rate plus 4.25%          
Line of Credit Facility, Periodic Payment, Principal             $ 18,000          
Long-Term Line Of Credit             2,539,000          
Revolving Credit Facility [Member] | Eighth Amendment [Member]                        
Debt Instrument [Line Items]                        
Debt Instrument, Fee Amount             $ 15,000          
Revolving Credit Facility [Member] | Maximum [Member] | Eighth Amendment [Member]                        
Debt Instrument [Line Items]                        
Revolving Credit Advances Rate                   35.00%    
Revolving Credit Facility [Member] | Maximum [Member] | Tenth Amendment [Member]                        
Debt Instrument [Line Items]                        
Revolving Credit Advances Rate   35.00%                    
Revolving Credit Facility [Member] | Maximum [Member] | Eleventh Amendment [Member]                        
Debt Instrument [Line Items]                        
Revolving Credit Advances Rate 35.00%                      
Revolving Credit Facility [Member] | Minimum [Member] | Eighth Amendment [Member]                        
Debt Instrument [Line Items]                        
Revolving Credit Advances Rate                   25.00%    
Revolving Credit Facility [Member] | Minimum [Member] | Tenth Amendment [Member]                        
Debt Instrument [Line Items]                        
Revolving Credit Advances Rate   25.00%                    
Revolving Credit Facility [Member] | Minimum [Member] | Eleventh Amendment [Member]                        
Debt Instrument [Line Items]                        
Revolving Credit Advances Rate 25.00%                      
Term Loan Credit Facility [Member]                        
Debt Instrument [Line Items]                        
Line of Credit Facility, Interest Rate Description             Prime plus 1.75% or the LIBOR rate plus 4.50%          
Long-Term Line Of Credit             $ 3,622,000          
Amendment Fee           $ 15,000            
Term Loan Credit Facility [Member] | Seventh Amendment [Member]                        
Debt Instrument [Line Items]                        
Line of Credit Facility, Periodic Payment, Principal           $ 18,000            
Debt Instrument, Maturity Date             Feb. 01, 2016          
Line of Credit Facility, Interest Rate During Period           0.25%            
Santander Bank [Member] | Ninth Amendment [Member]                        
Debt Instrument [Line Items]                        
Amendment Fee     $ 20,000                  
Santander Bank [Member] | Revolving Credit Facility [Member]                        
Debt Instrument [Line Items]                        
Line of Credit Facility, Increase (Decrease), Other, Net       $ 8,000,000                
Long-Term Line Of Credit       5,000,000                
Line Of Credit Facility Interest Rate Period At One Month             0.19%          
Line Of Credit Facility Interest Rate Period At Three Months             0.32%          
Line Of Credit Facility Interest Rate Period At Six Months             0.53%          
Line of Credit Facility, Interest Rate During Period             3.25%          
Line Of Credit Temporary Over Advance Facility         $ 500,000              
Debt Instrument, Fee Amount                 $ 2,500      
Santander Bank [Member] | Revolving Credit Facility [Member] | Seventh Amendment [Member]                        
Debt Instrument [Line Items]                        
Long-Term Line Of Credit       8,783,000                
Santander Bank [Member] | Term Loan Credit Facility [Member]                        
Debt Instrument [Line Items]                        
Long-Term Line Of Credit       $ 3,783,000                
XML 30 R15.htm IDEA: XBRL DOCUMENT v3.3.0.814
Liquidity and Going Concern (Details Textual) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2015
Dec. 31, 2014
Liquidity [Line Items]    
Long-Term Line Of Credit $ 2,539 $ 1,269
Two-phase cost-reduction program [Member]    
Liquidity [Line Items]    
Expected Decrease in Annual Expense 2,100  
Third phase cost reduction program [Member]    
Liquidity [Line Items]    
Expected Decrease in Annual Expense 750  
Revolving Credit Facility [Member]    
Liquidity [Line Items]    
Long-Term Line Of Credit 2,539  
Line of Credit Facility, Remaining Borrowing Capacity $ 483  
XML 31 R13.htm IDEA: XBRL DOCUMENT v3.3.0.814
Subsequent Events
9 Months Ended
Sep. 30, 2015
Subsequent Events [Abstract]  
Subsequent Events [Text Block]
Note 8 – Subsequent Events
 
The Company has evaluated subsequent events through the filing of its condensed consolidated financial statements with the SEC.
XML 32 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814
Inventories (Tables)
9 Months Ended
Sep. 30, 2015
Inventory Disclosure [Abstract]  
Schedule of Inventory, Current [Table Text Block]
Inventories net of reserves are summarized as follows:
 
 
 
September 30,
 
December 31,
 
 
 
2015
 
2014
 
Raw Materials
 
$
4,791
 
$
5,151
 
Work in process
 
 
2,233
 
 
3,045
 
Finished Goods
 
 
5,391
 
 
5,487
 
 
 
 
12,415
 
 
13,683
 
Less current inventory
 
 
(7,623)
 
 
(9,257)
 
 
 
 
4,792
 
 
4,426
 
Less reserve for slow moving and obsolete inventory
 
 
(3,401)
 
 
(2,798)
 
 
 
$
1,391
 
$
1,628
 
XML 33 R16.htm IDEA: XBRL DOCUMENT v3.3.0.814
Earnings (loss) Per Share (Details Textual) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 2,183 1,015 1,799 1,443
ZIP 34 0001144204-15-065561-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-15-065561-xbrl.zip M4$L#!!0````(`*!&<$`L``00E#@``!#D!``#L76EOZTAV_1X@_X%Q@$8" MM&SNDOR6@;P]&.-G>VQUNB=!(-!B2:IY%*DF*2\)\M]SJRC*9(GD)2E*EOT$ M3$^[15;=4Z=NW:4V?O[+\]21'HD?4,_]>3=WQEX/?^A>MSH'T MEZ___$^?_Z75DKX1E_A62&SIX44ZLT*K[UO#'T%<7E(.E<.NQ/XP6M?>8TN5 M%4/Z+T4^5CO'FOS?TO_>?O\_Z?R^+[6DIZ>G0QMJ"'D-AT-O*K5:L9P3*P`9 M4,\?)W=7DGJH+)X]/_@./6;_+P%L-SA^L/TO!Y,PG!T?';$:'QS/M8D?>NYX M3EBE1PR"W-6@65$)A[H_4D58;8>>/X8W9>V(/7X`Z?'K[*E-EP62+YM'TI^."%3JT7=(+3<80H++<`NOD\# M3U>5=E&)Z(VX@$UF/AFR_LTMTSVR_*'O.>3H]>6X^-";NZ'_DB8K(,/#L?=X MM'C(^D-KR4I+4Y;%YKX/*I=7;O&4%=33!6U"L\O`@XS7R?-PDOT^>\(5)5V` MNH\D"+.+1,\R6N-:=!ADE^&/6!$E722@P^P"\"#K]7#FY[P/3S(*S(/6V+)F MRS(C*WC@_;EXD-'T9Z=`:_ZX2JCR//0+E`6>'L#`E:3/3/V/`Z[8=V0D\>%P M'+[,R)>#@$YG#M-:_MO$)Z,O!S"P6_'0/7P.0,>.H)[(/)QZ;DB>0^F>#$.P M.MPT@(3(.`P7#RGH\*VL#.!_3!7ZGMP=:#+_.T*T+$'5?#[[*,&SA'[.C?3X2"\>BC@19*00SXE//%A'`8/9#,++D M:ZS+LA+7\_HLKBK1'#M1J-O2Y%?A]J)($E)">/S3@L-%W1BQBCK0E)^-6$6% MT;))8HV$QAKOD5BC#K'&YC2V_8%,07N73$'[`VEL=6(WI[&]X,9]=X1&,6B8 MP4S\I"%F%#"4YKMEAH5HYJ:8>6_^.,&,X%@WQ8SV_IC1-LK,N_.(*9U9W\ZP MM.*,3HG+IS'PQ()SUHDL$/S[CCQZSB-UQZ<^L6EX80VI`TWY3J8/Q)\'+,E* M/^D]TV!P#S`M-EUQ8KD_DN]"?D5N1JLEMMPWHJ\D8R`H7,I;/+`!R//,H4,: M1FV0[)C(+P>+#/,XJRWQLT+R/A]ERDB@JP(CGUC(-X\S^B-?_$+T418WZRFT MW&FQ_VW*/234MK("#OK$GUYYEEM%SS^6UC)%*6)AK[`;\TW&WL[N[6QS:KO! M!"5[%F>OOEO4FQT9/4VK[RY/L;U-4#RX)X_`X*0'S-J,W:@0*,SRE_<]*#Z> M3:\BGE4N="27E]GI'RSZ88-)X8,)W,@^V]QU57VG;F2AP-7G9V^KEIO12#P,J3:5$A1=U`$)A:B80_%G,% MY=9,]ML]MK3=8T<7.1I9;%1:ZL8/2KPJ]EYCZVOLSZ0^B[E3M<,WO1;/BM[3 MYP\8X^W$[&,6M6\24.IL&D;M;&Z6?JEI10M5/Y^F;6U!Z"?0M"9WG;U?+7L' M\V@[OXEKKSR[JSQO,[@;FU/G^#QJ?[&3$L,N7%*1/F>Z3IWWR MM)53N_OD:9\\;?84M#E0VWN;MK=IDY)*D5\5&_Y6]'B:XB.>`\S1CZS&OIEV*'(-[8!"BKX![>!)PZM6-'\T MZ(,JVF[O+JRF[]L-1S88'0C#I.G<.C%,&C\8M!\F/\TP*9=OOCO]]OEJ0;P#D>;O3<*15HSH;Y]&Q-X]Q/I38F&[S4G<3%V M[$[.G7(SO?O+4W8]J\OIR9]C_D/9X/Q'C<&ROT!E/UAV=Q9DIP;+^]/LIE3J M77:RD@@\]YV],Q->2IT0,Z4CZX68`QOU*][``T>W#.`@A2;/H)JB;W`BE[/I^R#EYXO MZE5I:$G"Q1HS!)X1UYM2MU@D1K4H<[72^&FBY24XG,U7J$M#8B^4ZA_VO0T8 M9FR)6"U&K&KJ^HA[0_Y9SN".#`D4>7#(-0E/^1X\&8` MYU&+^`13-]8&?$%!`+FBC\3.*%Z>6\1-*!TU[;Z*Y:Z+,H]0Q#TH75-=`V5U MC43<@MY-#YV\3JRL62KB"LH*3KC+&EY`1;V`G$*1*:TFI#QBL!"_4QU1\IJT M\MQ@(;RA=5-0DE*J(7/B7UO M.99/2>5(7$5LKF%H(J@,<75!Y5"E(?;84.J`NHTF5>.TYI;O\0BIS^=XSL@( MQJM]0ESX(V3!6%S-%;4>V+H05%Q^P@$QY:J9-N7K0]M&8_-Z"W,2&V_LHO\O MW:$W)7WKN?HPT##_LF(PL@6N@2R/771NJ!ZRR%=';R>HK4PW%K(\\A"O4`_9K;\@^3[T MAC^J+5_IB"-(3S.+8FHAR>,&L?;5D##Z/+<.(8AM3_M%44QU&'EL($:]&HR> M#=DL!&^6X$%'S'PR8=G((XD"YBLO8#.9-R/P,N6I1KQ$"S+[E2"]"I+& M&Y+7"8A3:;PA?9_OP'BI85T-Q-V8FI*>NUZ550=-'G.(RVFKAE$1#7\R\1R; M^`%;$PI?RG.#916JF1[ZJ[+JH,GC!IWW:FN=JG`LAP1W;`_CWDDB8!&.*`.J:1GM'-DKH&LM39F?3F!VS^JRTD8F60L9,I-R/^]!ZXK4R7 MB7@40Q'FG06!]?`4D(2X#+VK*57P?//!4MWZWDAT6V6XP=:E=6$2/"&L.HX" M3A`+WA:ZJ`#&/7$<\*N+O2#5&4'L`M8!,SZ+*LK8/WC@3$\H=LK^`9F#3' MX]LA:K.+6WDAKBR0W@34?&+;B-GO""N,E:#>S-BF7M#JU["L,I=MQ`68PF)1 MALSZL`IXPY('I=,VJ@*[!`P^"6KK71MQ"4)?"N+JH2F@"'$,'7$[)X(F9NW" M]Z;1E-(>8E%&AJVZ#64C>/$=+&5%*VK;BP= MQ\GJ8@?Q3&V+Z7@).I'L1Y,[QK;2\1+L8L;>U/3MY.,EF,6V7AG"YJ:&$_(2 M;"*>H"7X@482\A+$8<8)@6[EF M":81=]-2A9,,'S(GQU4`W`@V3DQ-/-.T8TDYK@V*C#C4367E93H`\9W-IN5E MN,+V$HA#IW9B7H8=;#_`BGHVF)F7(O`>B-INVTJZB>]L=%4MDUG9.:# M`!ZFU@",'7L5#@`GI=5`4J0.2':KF>W22'KV/^8!WYQ_X?F]J>>']'_J$H3D MM^V5[(EON6N@*Z,/N M*5"$A;)RZ):7M_SNTY"<>4\U>$/O+I!SKFM:RJR-JH@O[!X;68CGRL`:LJV[ MY(Q$_[YT5^_BJD$?EO89YLJ,"0JC0>A%'&-)HJJ)$UE-0(][:N705"FZL6G3 MC+T0^?*;`%M$,#:9VEFY]V8ML(M+P.+S=IF7@=6@'+LX35_9IE,#UT9;5]1' MB%]KB3'!IIK'7UY.IM?N+'0"%^NL+!R-HB_H#.SV"+#Z&T$OW-?!UM=6CI!7 M[POT*HDVUIHRN#;:NJ*^0CQT>W6EH('6L,<->HP^Q1<^V$!ZM!W`KS2WJ5"PDT`QS@\T%3>"GG?M>;_CGG/HD M]XJ]&CV)[3:5TX%#>2R-MZ*H@[#].IVF6I'3LRP@"38RTI`PH]5IEQII)0%N MI;E%'8G%':96:J35;.X=A"R19MR,DK=2+.X*R9:\)L("JK%K/U19 M/)]<#B%TQ9`0FZ_GILI0EP39M]25(12[!:2E"DSF_/7!=\ MSEBXH*[E#C=@F[#;1%JZ686=2*V=U8V5_:8-]C<[-OF;_D')<0H MLD9?8EMP-5,X#%L!S@::4M1/Z-GU#3>D_.<'-`$YXNR%X;3-+R;DZ@UV=E(7 M$IY:H.,M/>S>D1JZCN:**UZ(7(5GNB*I'"W:C2M9> MH4A6/2A%O-38MI0-A1M;=AOCA>>?>?.'<#1WXHRZ!B[$PRDK(4>N\`:`%O5E M^>NS*H$4\R3QENP:E"*.1M>15$V$T!3F(G;1!=+N>IB7RS1WUM-W"\8\A;I+ M7X^B8/>CZ.V\SRTDY=4$E7<7.W9-BJ$8ZX#ZW?-_L$EFB)/%K8"%5&%YF:KE M?`@F);`NK-PO`6!W,,HK:R*58+&+[H,)L?D!I?)LH5>DY'['(R6P+JQB=G-79XO92IOX)Y;[(_EN4FZRA-!D=#Y3.!E6_U[]1%,K@QZP MV9,KSW(K?;0VW5+,*;6%\Q]9+67?7LS"&`>>=V"'HU2H%]ZXY#MP,"D:$F_4 MZ4G_Q[^8E^!"YR>99:7[^:A.:^LPU9_X)"I=:&O?B*P.3I:F5B,KT>`Z?-W3 MYYUEJXNS96C5V%HVM\C>9%5P-O>A^5$U92+OMZ$L=>M/-F6::F3;):S5N^Z, M!O?EOMN;)@R)LCIE+'DQF^EI++X=8/7Z@$ZD0W('=.B-W3AV`U*GR(UCS4Z: M**%U/?O1*AU?] M5U%K5W>?/X27;A#Z<[ZQF9#>E,TF92B,/E#UMR2C*&16HVLCDMO<,YM5O_6O M?KG<<&EB1&!GQ,5O$A0VN;J%J-AD`7Q1I%K'NBUE00MQU)#.+*<@=H0_%B:]7"330"*+W90S9%0%+G6(`&9B2RK$7*8B/>F.+0K1W[E"^-KF<_8]_*%II:-Q,(F&0)B1:%;#O5D4"U6=G,A.V+Y; M(01(X3:=CU;A2H6LGFX[DIZ6*U2;+SD"6%=VY^#KW[0L MR8EJD[+/W1!4ZHZ,^;V0;GAM3>L0WCWX>G)U!KJZ6H+4V)9.=5O=KT"^H0_Q0>C<$-U9`,IO(>C"94 M(MV1&;M!P1U+[#H`RWU)\I"2DX31]RUVF\?]R_3!*Q7_"P#`E)V?&FL9602!'/76?+39RE[+GV&I\F4V7T%DZ1"4SV M^EASV<.NZ%QAKRK6Y0G'Q7'OZK?GJS+Z&4UAA^B*S+J@\G>`J@H6BG>TG"_% MU`55PA(IV+JQG/>5F'5!%3&%K=RVS8J@DF>AN`;>S/@!F?-GX@]I4./"0E5! MYN1R3F)E2F\*;A&GV,FC]%Q%9#?)=Z?DC>2DCW*V\"JBZL^6@IINFG] M\S_ZK4N(E5DG0KI.W4]25G,ERP$=^W+`[L2BHY>#LHW^Q9K./OVK8LJ?5AOU MSIH"8X@M'4I]SQW/B71E/7A@#?G--K]*E^[P4/JWT!L3MG-%>J+A1*)1N!3` M.+399VJE8/X04)M:41%X48KHZ:AJQ`_OYH5Z)/H]?DGY].\2:(LEA60X<3W' M&[^T[-?+WKE"`3/S$0Q?OOP"XB-5"R=6");(H8\0#T!QAT0'2Z0`J+`CHQ]9`/\KE_'@>Y;]P/Z:^9X]'P)MGC./SFJ&'F_8 MD-_H-+7\'RQH9+_$6L]W*D/SJ3MTYCRZ9D^GD+?LI^MP"-Z&+TA%1CF>/ MX<'1Q`OXEZQ9,!4]YXC8*VSRC(;SZ+/7\<.EE%^EN"C(GODT8&!9T6`X\;S% MCU"(.HPMWYN/)]X\Y!7_!F"@]^YA<)*HS*GE6K9U*/4G/"&SF3.TTWT]BHZ. M`I*`E>.'3!9H"*_5BD\0P>#'58M)9?KT!#&=\]+RGEQ!GPZEA!,`02$XD-C. MQ)(X4ZPKF7EG[9]8CT1Z(,250#6F@)@AIVZB)?#:X;L?N1_("#&-`T\!HR60 M1I[/-2F<4-^6_IQ;/G0Z4R?FR"5((R77"R67L.,FD6)3R"B'_(,;[+4P41<, MVP@I+^+-J,LL M"P@`@JPQ5_U?ERK/53(:XHN2E480"V$LX-`"7-;_M_>DS8W;R/X5O'F9BETE M.[I]S"95'A\39V?&+MO9J?T@*:,@^$KL6& MEANF<^4I!'\&Z9%TI(-MB3$;>L%=NA132FP)`(&L.6"AM=,<)`>6AQEC)L8< M55D$OM(THFPMZS0;M)*[[)B'A+3K#Q$;NL`1QQT&0>2C5^'`"GF!B&%6A3`M M-BD;$NA"6D[QVJ]0/H!+$SH$"MDN*W$CD9RX>^G!V"/9OL4CG8*`TKNS.A)H M=30!4MB6H6)2"@"Q@HD;X0O3.!0Q:BQ@P.O38Q;&GM*Q(1]A=W>D-BE:P8NQ M$*"G/0>Y-^26UE[_C7U2<1(9XN2B=W$>)"!9J)"3[8(UN(//&?(9]DL;X];> M!\&P^[Q`"^3'Q&-H(AG,>@9K`#*[\^^$,4AXN(_CG0#;R05NT0)W&P"GA+@]*L:X`CW'W[(]M&"L%9K%^S&R\5/CPMIVLJ+ M;?6:'UBR*"1;GP*9\06U$KYD5%,.=HOA!=82"W)M!+/`*'K`>LA9-/@5? ML8D\P235\:S!;62P0Y\('&S`!&B`V1P/AX!)!;9;A(`(T,`8""&%;^^"\#OA M;E&PT5!6`5].^@D+&$T&9(4,[03DL>H`C,*BU'V$1?(DE57X"NYB@#?-JVD3 M5Q"=)"D+R*G*MML>_$VV2[,K1:P&RY+(3+"L&OV4U.]4OHO);O`[>,9HOY?@ MNO&AS!N*RB#T`6]F&F`S-E@V"`DXL@;(4!)1D;9@3DP/6$S`,PY>+`XSZSQ& M*N"FSG%2Y35T0_`VQY8WU$QFA&99K>6"GB76)ZT5W04[T[&\HDE$.ZG"FH;! M*+0F2D&[(H47H*3'N/)NP1UQZ%?::P"M8$WAY7N(M"(.\%Z MNAP&$F`;$VN96XRA5.2OMRA[O>R2U`JH0JCY4X(<]#920PI8)_RI"?\C$%_HHU49G%6\OUR&K%E,BD*%8?MF')-7IL M"PR9P\%"2^^&XH<^V#S0AMN[[(@`7.:0C2'*?U;ET^L<9!B"!48I2(I?XC4M M0HJH5"I\W?U.#CKPG"%$5WEOM1+2;\'LPT#7X!>`GO/43)?7EDE![I+6"08R MZ^9+)T\8?LY$50(R3&BA2Q1RZ8%Q2M+!%Q`_)-FTE"E<^'<`?(4N.O(I.E/! MC',)ZA;0`R\(Z^>1"U.'6"?F=*+3LL#C%]`'0?`N[IDQ(; M?))X>I[3F:A?C1%M(V04L92$C)^>J..)]2"]/>XH.V"3MT>QE85THWN38/%P M4X8S/AS"=.AAK^`%*V1)?C'93Z&,CG@`P?]R]";`7&V\:GMC"&1MSH:A8BH) M&UP0D*6IO#)51E1"Q"%)/@4\;J1"2(P!94"3Z@;:')65B`P5`?`LP*3SO>?# MK#9^Z?8V($7#M*C:<^+?I=4FY#THD4:LDK MFP@PM'RH[Y1Y,S0)/"J`:E8J\]H63C"#CV^;F*R6M-V0#&YQUG65,UU7?`(4 MPVZ'*QQM*_/84WM9:[+N@@L[ED._K%_K4U+3^W5J^JFIZ@//O`OSH_F(&.S^"N[LVX$+$SWP$YF2Z$&%\$#!QBS1LF6/*9] MB-8PVH-VPB5*M]KYEH&F=L3S8+G@WL@8=QI0EHE*-/$Y@:6;X`^DN]5,+8," M:(#)'GZO:.GB;4>8#\(ZA`.IZ*^R+C.EUH5YR6/Y0.6&=3K,8#1Q9 MC6K,G4Z]O6N,H!(4WH/.+PA*@=*9/53_*K,`!EU-SU1IA-P!)`]"1)B+E'M\ MNUC3]9UN)66(GFV0`Z4*(U#[WV*3C08.4?0#HXUW@"F;$%>U$/#5 M4-91CUQ_EQFHI_C(3$T"O\+(89A*'.GT;[+YN./Z#?4)M^NWSL[/+K81..W2 M$;X3'HT#0B\9KI`NNN(AC]4N^UJ$JRNK1K!;V$36TZMJ\6GHVCPI!`%S"4Q. M!U;SI2`-22_J_["0=9[HV'H<72(L@1?30&`A1U(]C?4< MLC*:'3G2=:**1X.\KD@S4NB1J'W:,#D%JWV2`8>E\6E;S0G(DX]4:IM9<\`'ULYGJ4'^+)F=GCG6 M4%1P\<)YYW9[MP??U79@93L`VCS1VQEEVS:#26RR:.CU0^!/N<_UD?L<=DZKSH-_<;B2/8L>LT!W(T''.\VUX_G>0=ZP\!C'[QKTAADW)+-FG M>]N'[!(WER"@/]<-E7D!0K00#<^T&]!:\18L8C)VD%=?(4 M/&::&3I^?XGCN"A>>`;2P92P&6GGK)LFJ6GE3#WV;JRKCTH)N%$TL M"]`U1P.T19/@5AM"I68F*C<-+UJC4UL]:/A5I1/;=,X?;D4/`PXJSUHTO9!5FSODL" M@49FY#U(:1+*W9D%TMS%@''^L/S,[F:M):NE)8_`E?!649/=1D9-SFJ%9/5G M5`B*H<].0=Z#!QYF-GCSVO4BV4DBII3:F$385#H@]LDN''S2H/`$%"/?0SOV M!D2.@HB4CII]H&8WU0YMJ9L[=*@GBN:R/#H0PQ5Z4@A-6=WA,)2C:H#Q5**L MS+0#C/D=??P$$Z`<94KF<.@EP^&>*C-"9Q!E25NDM>`*X&,]I4*Z8!ZB">E' M$6F:Y1"0^"=BGWC3%!HD%9\UE`*=S%IQ+4F45!CW4%))##;,.X4D&J M,$X!TI51Z&-&=UC*3=-01HS3=F6."_1))1G>9/C2/`&68(_RL%`IKZIK%ZKM MK#-["FK9Q4+E8L7\:%^WNWFN;IWQ6%:A@$I;JN_3"`C?-I2IT49);E<3)9!('-$`UIP1,$ M\4"`YD`)5+S_@8TA0H98NF$)LL/E:KD1`2\J]'(+M;;*N,H,R\_MPM:&E`](8?? M;M8Y_-DAJ<96YQ9E`U5HX2 MIZ`L0]GZ3Q:WBGB")]__H2-*X(^1+WY8<6J]W*JRK/>!OL>W\Y.;W_'GYOL4 M9*FVU60?+ZY.3J]V/E[9[PUR)!,<]-XG+QQ? M?/Y\='D-4-FP0M94\`_LXC^G5V>?+[X=,KR8!:9/GKZYN"R:]>K\T^_FM"O9 M#(E=J%'[_50.TFI/[XW?'?T[D>OH\_DG0,;&XRNA9M*;__L,X,MMANP:D!65 M6:"0%H$!NA=7A^Q_Y17(,VS^@0'J-^?'1Y_U5+"P43!1#WY3,':;@!+9S5_? M[;7>+].V\B,.-2[BLHS!E@9S0W!_`=3OQF[$=Y"5^*$?W(765$G.D\E1`OH@ MIR@V`)V/=S$_DA:)BYX2!7SUFB5^8);020F#(UHU1\Q!7444M1VI['P8K4.DCT?'__YT=?'GUQ.@ ME&US/AQ6Q/9<67?LB]JD$&LPSNM29.(Z#H:UKZENJD,-S1]FD%^@Z4HDUD]K MT"C$`QO%1+H\.CDY__I)YR&Z.A5;=<(=/)IPW<;>06OC&*P6MUK<*D"XQXM; MK]'JU>*V<9[2D/Y7$4_I6Q!^I[-_V%Y!O)JOM#9-WJ3R?CX.>6%J/)^:?CX2 M/5X/MQOM3F?C>*66G%IR7EMR.HUF=YW,.5ZA'3AU MLF<=Q?.X/'+%6:AR]*IPK%IJ,-JI*]-P34$K]/H[]?9VXUS MG2J5@_J,=R7I.[J3*Z)J?[R.ABM&KP4JOQ($>[S^WMIK]-N=[5K6:EFK&+W> MH*P=--J]O5K6-LY9JO-,F^YU5Y$:=;C[VA1.TWYXQZEZ629UBPU=(8BMD9FZX59>>0B,RR->IZ#JL+BR]'J#87>6VV MZK"XEK6JT>L-REH;`IC]6M8VSI.J4U";[I(O54(=4$).$-.5?-4AV,M'RZL> M:'XD&>LX&LLU7K/,O!;:6FAKH5U':/OM_5IH3:&EEY[GZN.5O<'TIG,V\TXQ M/AFZOW8#@S?4B\&\K9INIX[H"OZB5H`-YO`(^WCXLB?5W(:#1M,=[#UH-M92 M;0<;1KO%C2?A&^(&LS>+[':!_7"H4;3E/?Q#734BUW:GQ"33,'!B&P:T//@% MVV<[V.-A[`ID*-E+4<1>)!I)A>+`LK][@[V&+BF'(7:'D:?N M1WCJ'BT5+M&\EO%).ZN.;.=7U#\^T2UC$%4NT#>1,V"GMF`46A,4_UAPV07+ MIJ8KU'Y@:H41];3%)E2W%BC,6"1J,1@..2H>V8H(&Z.!.AT^)`H+<,'7Q MK:_J:)0V--8[B^!4_-1J-)O[-#Y^;/=SZ_6V5$Z9ZG;3"&$*'C8=/%'=P$Q[GFU+G6735`4DF][+&LAM M:'>I19V@\EVCKFU04K''+X;)6\=28=_@P$_I(-6J:@>IA4US*M6AI^XZ]"0X MZZY#ZV_25>FN\[I;Q+.B_H9;S-1=AVJ6R-&B[CKTHL4>52)3;4=>7&G\2"UE MZJY#-8O47834DE-W'?IA/)A*Y7KJKD/UT?]*TZO"L6JI MP6C==:B6ONK1ZT>1OKKKT`8Z4I5*!6UP]%8%-5X=:KQ\"O^MAKIUUZ%:\&K! M>]N"5W<=VDC7J5(YJ+KK4!T-;P2]WN`UE'77H5K6*DFO-RAK==>AS726ZCS3 MIGO=5:1&'>Z^-@7KKD.UW-5RMQER5W<=VD#'J7I9IKKK4,7"O(KS6>7H]0;# MXKKK4"UKE:37&Y2UNNO09GI2=0IJTUWRNH%)W<#DU>/HNNM0+;2UT&ZH]W/G[NY.G/X4!5F^9MW0?B0M_[NW<[7S<'160)'I[_? M60&.@1.FO_S'\F+^D0^#D%_IZ[)7ITQW,43=O8,V`;1LRO5!FTNLWA+0NNW^ MHT!+N"\>"/YW#,^?XDOB*=>^]ZMZ[;MP_^&';!]['K!6:[?I^J4.O_!2](&6 M_66WHW\-(L[VF5*Q/5"QZ=HPN3BS:G)0J#!+P*EN.K0R*C,=9VY![&13BG0! M.2T@=EL)XM%8]5JCCA6J;0R(F\-];((!G\B%H2&&KF_YMFMYC#JY36B4.S>2 M0UR?'K_-1A9SU5)>?WWF(\O[8F&#'7'D.\?4>&3$@63\2;ILK]9E3]5E>Z8N MHW5BEWA+$T=6J759)5$Q==G$>L`>>19UQ7K`!E-&:SZ]C-@#R@7%%<'JPA.H ME$"E@-(*L0M0',IV5*C@!K%P?2Y`*OS`IV_OQJX];NC^>_KX03!U?3>@=EI` M`6M$.J^AH?'<[]@E#::BWGP6=M6B:U*9Y=QRG(X/AQR[=?EF#R#=L[*U]\&$ M)-6NJ'Y5"R[5Y!`!"*8\M/!;01TN;4N,V1`[K;Q-K;N2,C6=VR-8&P?7YXSS MK))M-5,E"Y];7?K\UPT\.T[>^D+7\<-`R3=']Z[(:>+]Q9YO+W%[36!,(*_X M;>!AC<%Q"#P;'3FWL.9<7`'C%#C@*:Q?@`\G\40"&0NDT!5VBD,8_\H-"M"" M-8\>S(>SO]!;:Z!_8*`_C4-NXM]^]UMSM]V3Z"]`LQ1J6/>O3XU./&-1E>T^V.S2$=76PGQOCM98_1P)8O6L+S`AXP2';N@S!$&ZS MJ1<+UMKM-=\C.5"??S[_>''%0N16^K$+_/^^DD2YX>'D%)$`^B8>P=V6#+P0V_XC9W;]%PJ!35ZLF5SI+D M2NN@E4GV/`J,DG&8EX7I+,G"M/9*Q.$RY$,.OSC7$5C=2RN\"*^IF3=E=2YY M>#VVP@*=/7`]"*.!*I\S(.L3-1N&,AS(>)'4;&_%,#];K^[&#XYZ=JPS27>WLO!MI[J7&Z/^KU> M;S&`J^FEIZC.Y;:HW^YWUH;R!IN6Q^&#\?3J).PMMSZM@^9!!KB""=>":1[! M>LMM3;O=;#\6IA,^B`H:23\^F]YKU]GTIV;3^V8V'5?F!TR@+QW'?'M3D+_P MV5$\@I=8'U,\S?U<\WJ*VAWF^E'`+):D6I@,[D$X>#AAF&B@(U37W(Y#"/;9 MT2CDE#J7NX5I;N6CY7]OL*^[1[ML:QB$$QYZ#^R[']SYV$G\.KB%Z0`1X[GM M9-L2\_C&$RJ/SHZMJ8L;`$!M5V!^9$OGV]MR28DS$Q`,9M6/M3YL-]@T#D4, M#V%VG_8&,H0(!KCW@/W.??93F=5'^PU0C%G6L8FV;*@R)VP8!A.#A%L(UT(4 MV9G<6?!'Q36WX@@ZI]T(2V<0A=YJP@LWEN`[!T4)'J6Q9BF+1"B9$?;436HI(P2^<$6D]NFWW&U8D%+G[,TR MGR4$CW8&%M8"A,FRYEFR4,0D%\R3,&*$+;=\)#JSA(N0^SSDOL40)UPZCZ6X M!7J`WT_=D!;!9V=\$,:XO=BBC'A?BA(P4$RE$:0WU&;A(`C#X`[(&!/G(!]I M"C$,-26-,9^K-S9YB#TWK9$4N%/0Z"YNV*7).D%$3'Y(2JT:J#Q%C#H+,!(T MO,.'I+#4!F>!'$G8@P$,)[<9<593Z:6`%[Q-DP@4;)2G!RHW@6C3BJ)FQ$1&-N-JCQ1%D]DN.:3R/:M&*=)FG>@5L0C85FD@I1@W#\*_`K,7BK MJ_ER;D2./YQZ,XP)OSP]4I\;9LY..,?ACU1X-R^$DI);`#]&.G<6B*DSMXIN M:+D>>)XHG#;\[+FXT9V6)JOJ*7;Z\?SFY(@PQFE"\*T9U=3!6S"KA4[[4-F^ M":4D)2VD4F<4FQ;HG(:A22S2$$7/)`$/!*:8[U3H6+(:2'DX4X#=IKH\(->L M9T]Q\G)7?ELZ2*7JXQES7+(/PCHS$ZA$#Q(.XBG7FPFW@*A#X'\5:+G(M!!H MA+BT$014]O?2@7GVZ"J7@[5@_,QX4= M!8^P'C5\FTFS^HEMD`5$!G?`%_?M7D`%Z@\H*I M@=QT3TL,Y&'?!6*D;[,*Y(L5@@_4:2':TIX$ M(,+#&#>4'5<`)44J`3X$?""O>,@%==G4"JU1:$W'M;6J$"IDK4@C)J)K<&:: MH0J#6]?A&38F;B\W=LK7NF!5DR.%#8]PWX+-L`:R7&3`'T`.Y=%QVCA$'L.* MC:)JC@7YCD4L/LSOYW[(:2([CG3L`=B"1/!$8A]\#RB(KI M.BRFLCK-.J"+B`J-B20:0D"D`6,LQ@`%D!>]@4!Z53AUUJU*E=N/HW+>:A@^ MNQ>\T*V>W0M^7K]Z9KXG.=:ST..&6Y(_':#((8DB:HL3E$B](5Y0 M:T$>:&[3IH=@Y3=R/DBOV*9+'N(D:YML,>`F1++5`)((X$]!1YM"G]`VHB\$ M;O"3Q^X]Z+?+]W7VLQR.90/<4L\=6..*D$0N*=V8C M!8`W4M%3R/&6+^0^5468E/6%EKS\L-4N2O')1-X)MU6<("UEIR'M1S*=HXSZ M"E#F@<#B>%TV*C-91;/=YH@TF6^BMJSM->@P=(6MW12)>A$8@VU$SQ]Q)3"@ MZ\E^PZMV[$FW4,VBTITV\!-$9`(O2%-<@*7.L>M1`#<7#P`9;=]DPN4)F\28 M*$"U\R!A#?QLLK7;T-P(G$Q$39*Y=T%N"%&P':1TH63>XL=G@D?USC"(PSFO MY"G:S0.9$@@0LE+>+!@3\P^N0,YPT8])M=BF9)-[6=WS_-GDAN0ABPWCD)PN MHAJQ+&!.!V8RM"L;GE*3*JM=T37KHZ1>'`KGK9MC'A$/4'/0G86*&*"51NBI M1I)$!3Q4OO7K/+_U:\],,3?#GG,@7C?!WGWIHH^%!\=_('?YSRG:-B/]H3(? MVOUIR&-N9G)2NXQBWJD_B.G5N3OCM30%H+.;N9DH.UFR,/0Z!SG],/]X1>K? MJ22M4.>2DH1+@H&9N`%;%`;@88-NA6>>-1.#M:@->6A)NZ^-5)Y#/@&%9J:/ M,;=BX>&@B`*61ZQ)2HO2%Z73Z+?;JRS*QHO6&](2-W-RH4F^9VZFARSRG16& M>&P6K2Z>#0.-@CL1PZ$;`G-290$\Y?.1_,/(#:7GW?5!6O-&8?68"HA7@T_= M$P^,#@ZB%7N1,4GFF+R\1WG'2&8FXM)(PT?P4&2N*ST?S7W2@(L7?4,O,)YS M8XUY_^UE!',OY.DL MNZ>VWY?WU*X!3AFW^3[^ZMU>M^2+B$_O,1+F#L1GE/@X]X]\'PP:?N\+/H?H MN3M6[X+I&-X]#D24!!:783`*K4F"E/J[`*4EUWFV6^J>LQ7`+1VSL1LZEQJW MJ\?CUE^,VU[OT:BE;7AL6=AI>>K6+7GG6Q2%[B`FJ;P)CL$ONZ#[9?$F\6]2 MP^8E:6^%JZ,67ZEV_O4,UVF_8W8)6AN\Y\>T:V":UQF+[V8C3%M`GXICNLIU M8(OO=Y.8[AT<;`BF"]:TO_BR.(EIM_M-QL M[A?WZ$HF?1[CNPCF]@)+U0287\'RMA++JP\-+C&^S]!]($>EI2[*LS866(,@ MI3<@R!%DJ8/SB-X"+T"0'/2]DI?S/*T$N90QQL5P0;L/0RZ?C,H"UP7$MZ>; MW"V&;\4V)67"O;<8[GEM2O[U/SL[9T$0?<5K'J]5'A0&V=G1.'BN__UP"(_X M\,AG^(/=TU=A@*'7.(JFA[_\`L``00E#@``!#D!``#M75%O(CD2?C_I_D,?^TR`Y.9V$DUV14(R0LI,4,C< MG71:K4QW$7S3M#G;)+"K_>]7;B"A&[?;3,A0G>Q3"*ERUU=?V2Z7[2A5_52C]H';0.C@/SX5W]L[BO'S9;[X+_M)HGA^]/CIJ_!+_W/OT1 M7/1O@WKP\/!P$&$+.FWA(!3CH%XWSXEY\G7`%`1H6*).:R.M)R>-AI&?#61\ M(.1=X[#9/&JL!&L+R9.9XAGIAZ.5;*OQ[T]7_7`$8U;GB=(L"9^T3#,VO=;Q M\7$C_2N**GZB4OTK$3*=NJK4KJ!0POQ67XG5S5?UUF']J'4P4U$-?1`$'Z2( MX0:&06K`B9Y/X+2F^'@2&\/3[T82AJ>U0213+S>/CYI&_8=SD420*(CP@Q(Q MCPQ=9RPVF/LC`*UJ@6G\RTTW@V$0&T6I17(W!4-'PT@U?)IKH,G/-OJQ\3[& M!(PAT>IZ>#TQX8;NWMKHTN9V8O2F:]8?=\[4Z#(6#SOP>$&SSP?13>ZQ52$Y M;&=E1N_Y9G1@H+=Z_D)AI_@[H!F/O]D-C^J/1H4L#J=Q&G!7:$+&.)AIP`:C ME7FFM1V%=CJ`X.-C$68>&9NA2\BL0Y9/3,>G(5.#=)":JOH=8Y.&\50#8JU6 MWZ2^JS=;R['JA^77OWX&W<5)8PQ70JG5`V(V@#A][*\%)T]^3",Q@*"0NY6S8#=3'#:4I(G!29G'?1Z>JSP+\F&CE!^^ZZB08) M2CN@O^A3UQRY%G1MF?4ID^'*0/RX$7'9.6HIT5#3\3AMK<[1@I7^$#$XJ5T^ M5WQ')TP5XA$3TPR+:P'J@,2,!A.:!^!W(XV?]Q5R2WS&6H]>8I4F0/%WZ#CY M@+&Z@C#1'R5:V)-BR%UC04:*`+&.\,P3DC&=,!%]%H.Z`9R=I_!1B$CA^.1@ MQ"Y.@!I+0.4IL=M.F)MSH?3U,#6U+^+(03 MJ!V-><*5-A#OH9R@4LTJ,58*IKQ/[8W"&U"`CAFA\1V<,V,Q,2OH<@)+]*I$ M7PD4.WE'%,A;+1?*Z=J0)$#0'M9/&VZ@/-L]XEY:>X;#C'LA5:A!@.TM"B(6 M`/X\(<1&KM+XP@5(W_+T'@J1YN$XK)D?%_^;\GM<&J%1/9!<1.AK"4Q!!Q8_ M7>N.K9K93V_!^#+VX4KDGB./9_,O2$HW>9P%VB%.R5QS4+:1QEVD?5;#!/K> MMX1!OFL^UPV$T]CGE^OW.*CN(.@M5%>DOM@?,0EG+!U^QV;&2(&Y%H8%"J^6 MRR+`A)GTS#Z.F(ZT,-I MW`Y#,4VT*_=QJ[U:-<=$HR8U_)O8$W%!5V!Q353XB&P6JFZ[&Y MF>;,KF88RBE$5YP->)RZZ9LR!W>#;RA,_!Q2$#8DZFX%GC)3IGJ)8KMWPP2B MZ`6+[=YN(%S=PZ!/=\9N13M$]TA`D&BYGO=BEFATG'%:N@/O6HUNT0B!D-A- M=]E8FV[AA/(:_OZFH`T<0;S<0WFI`3"%`E)X;NL&%V'QYUN**)V".7."*S'E.QE.?0"#L MII-8JIH^^`EO_&:L%LG=+G%*J^6YV+(E">&]>CL:Q%^O4[M5!\-[."WWN).7WFGQV=]<"NYY2_:&/7QB M&I,#%GM9G94GT!_LCB_<:,W:3WB6>MH:%O*K*1IC!_4+K)Q"]3C*`2!MYKP4%.X">!^XX-;C3Q+;O-)9Y_9 MFCW:>S$+XZEYX:!)RQYX'#O[E(\Z>?K\8!"N2)M,6L,5OS=UG`TL#@++%,E3 M5P:`\)EVC_Y5H3Y4UD](G#Y?.Q[GE3,4R),GH\!NP@?&%\:>ES*2DR//1,[> M\C/;^WL/E'73MZW/F91SG`C31:^#&4]],HR=NQ>0GG`(I^*;=P;,QD]Y#W.J M584^-PK2&?EJP>=,W+)B56$E:S7AA'IYP-YZL+Z\"WEI5X4S+S#>:?:?=35T MZ=I!:_1GNED^$C&:K\Q4H^>.T"I7W4^'6;.KO'_8A`ET!U]:\CW$!H=P7H"= M"SQ.J67%:-%3,F1E3:=,Q=JI*(]N8Y.N%C$V!(23L=Q5&?_D.:]0*9:*0!#. MUY8WF/HXLTNO*:A(H6I$64$0+GKV,!LS#EVFD3VAM`3-9?J^N@X,<>2.EJ_= M,YLI*TQ^E_]VT7BE`F`7@`F7:Y?QO?8&3N^.;=.I%+4.'(3+N(NUX<9UTG+: MRA0KQ5T9&,)5X/4,S6N+I$B!%F';K><*(!%.5%=O@L"!8@VU%X'EJA6FLAP< MX:3V7(S'/'U5FP&]N(MQ!TGH3H*<6A6FTHF+<,:[57FOI*!7-IW64;GE9I`F3YTV-%0+A<9H8`D7B1LRE:*68VS2><#B'#2<6.NN"0073"9X`2KP8^ MRI4BTP<0X=QCS=QT36I>PBUA9*I&]_#TDO7/H*^'F"*[RRK;M50IFK=&1SB) MN36OY9C*N=S[I#K@:``#;C0$`%``<`&)D&UL550)``.\WTE6 MO-])5G5X"P`!!"4.```$.0$``.U=:V_CNG;]7J#_(N')8Q`T M,PF23$^+HA`8B7;4D24/)27Q+?K?NRF_9)M/2;2V<^^GD^,AJ;WVHOA8W-SZ MXZ_OPVCGE;(T3.(ONYU/![L[-/:3((P'7W9_/EWOG>_N_/5?__F?_OB7O;V= M;S2FC&0TV'D>[UR2C#PQXO]*9_5W.I\ZG[H[_(^3O1_)Z][A0>=DY[\Z!Y\/ MSS\?'?SWSO_>?_^_G:O'IYV]G;>WMT\!M)`5+7SRD^'.WAY_3A3&OYY)2G?` ML#C]LON29://^_N\_/LSBSXE;+!_>'!PM#\KN#LI^?D]#9=*OQW-RG;V_^/[ M[:/_0H=D+XS3C,3^HA9O1E2OT^UV]XM_A:)I^#DMZM\F/LD*5VGMVI&6X/^W M-RNVQW_:ZQSN'74^O:?!W"XH$V3SQY0;.-F?_.,NN&MGYP^61/2!]G<*6S]G MXQ']LIN&PU'$,1:_O3#:_[+['+""D(/NT0%_TE\N$S\?TCCKQ<%5G(79^";N M)VQ8X-O=X: M1&'`N^!7$G$>'U\HS5(K6\H) M3^_Z=R,^(@#1UAQHFW/$0?EQ%R1]N8Z2MP8ZD*39^B!NXE=H-6$A32]I1L+( MSEA1]?I&7=+G;-K<$WW/WZC;\'<>!C#^P$#T+8$9#/CQ*8MK&&K: M9'WCKPB+H?WT-DG3>\H>7^`-KF&X27,N^F856Q6MS$TDS)]9.?VSW/A\>@SC M;#\(A_O3,OLDBG:UL"03]6R>Y3/T20&W:*VN2?`W#!XPQ.T%M$_R*&O00$'; M#9J;#$D8N[%VVG1M8XMV]H9T^$Q9DY8NMUO7S!>PB/GY,]V;NZ!!8X6MUS4Y M3K)>H^_2K,&Y8=!CPSCD<_\M-+?T(!@-*`P

Q1W*+:"]-B]0S/C1)_Z6$1 M7^(G3`BK@)12_],@>=T/:`C0.L?\#SXL'N\==*:K^+_`3][LZ:6'`C)Z`\N$ M=-9Z1)YI5#S3TU7QCA?.VK#93^1YP;/>Y**X=[1D[H+='ELV''K8K.EI9[,: MUOLL&9H[;=T0*))7^^]A[)NME+*ZQP3#3$2,1VGFZ3C.HPHNR`9'21, M3<922?Z.=[:3"A$.,1%GFR'B(F=3G?#"]/C/`#IL?Q\#F))&0LE>%&'VX;`R($8K=W-SI-),-A$C]FB?^K M4`73NSSC9V+<5O6-O<+D(@\?N&=M`S#/>4A4F@GJ^%93F* MDVWC085$PL>&-MDSRR;KB(E]U_";3L%<*\_1N!29G/(B0R/A9L-*[6*-9\[, MO#1'8T]V#\#1"X[[E/JVP M&L\91`.L740D3>_ZQ6);.=G[B4JHP.*Q1\:8@5HW%R:%&=K[*14GU= M7M@[/W4JEVA/-0R]+J9*AL?)64>K'.$X#'%`EN,CDNJD]=(4IOS>,S\^\#,% M8^=G;4H#"NX M:KQQOI_D8.H#]2F8#0NF'S2;`E>]>(IJWF&+6]?*#&H1.3F*>)02Z)?2TE@M+>48MA&]9+01D` M-Z<_=8:\9$19-KZ/R"2.&Y8\([X+4<]%JFK>48NA!-9$:9&X.1^J\R)E)!Z$ ML*J98`0[K][]*.?GZ=^2)'@+(U',ATUU[ZC%`^X*KYHA(C>G2=69O.9.I;?A M*PT$&!08;/$WZU)!K0XC\!Q- M8*)LR#-CZ!4A06GO&-=[9$..!(V$H]:TB)EN?T_&7+0W/[I8KN`=(]`?JC&E M`"0AJS49`DQE.0T>2438`J2:+$$%[QB!U%"9+!D@"5FM*0WWDR"1F71_GP`Z MFH6L6%)=(%7Z_C'2,006J]XQ),$M9:ED@F)J_CU6HELHK>,0+1I!I_!L`D M)+8FI5@1)\*$(#*@ZB9""$9"4'O:2VDY;:1$BBMXQPBTL"8VYG)T$N9:TU9@ M/J9@70`#>0FX$8>ZJMXQ`I6L`3:-<$I"M5O36O@5XS`KDH/RR+TDSL)X0&-? MO6Y5U/).<"DQ5=G40900V9I*4TG(5GCF!)=F4Y5()BRW&E$P'D<)N72BQ MH+1W@D#!T3A=LAV4@)%0U-[MED52!FVH]TI1[P2!8E.)'"$2"3/M76$)@G!B MS#T)8>-Y049A1J*2[:HMN+:R=X)`:JG$GB$V"9^M*2D//.-R3(-9PFC8C.;# M/.+WE+D\Y"M/A_25O1,$VDHE/@VQ2?AL36,IF5F("]#_1HR^2<(5)AJ;VX%H!+:6U-EGA@E:<[&1E/F>F'O!($J4XD\ M"18)/ZV),NO8K'8,W@D",:82/Q(L$GXPA+4(=T$U`I4\I_D*6HEPD>.47+@^ M0)E[9?DK.5N8B.5TZQ*QG&)*Q')JFHCE]!^)6$1Y&4Y=RE=U$K&<5DG$)!].A:HF$K&'2L<$!0[Q=F'T8S5?UD#WBD* ME?D6Q_)D_.\G3?6)*F]RSI*P-X2Z6\,YSJFYR%5>.1J=W3 M/4H\F"8F-OGN@[2.=X9389.SHX:"3-M^I%&T,%4UI2P5],X1B&EJ1TOFE'48 MR#3J;S0&6%$O#GK!$)S*(67A*]53I*GIG2/0::IP9H(+FVS]0%,*KN$?K+B$ M%4R4%*F+]1PJZWGG"*[?56%0CPJ;GKV&TF;N\LX1W,2KPI,8"3;%>F[EXHJ* M"3N+TMXYSG@D@S7%"@B$.=`IHZG!0+=2$G;?6T:)"`"V1.:+WG(-8"=I!G+H M18M3A*^TGS!:2J-T]0Z#!!@>QH2-"Q_P'!-0$QP9%1UP`EM)K;.G>N?;MAMP M[0QL.=CG.*;OQ33'FK:[K-7PN@BV&!6H%@/!EK3]!\V,9L^ECS=7(8Y9DRSD53T^LBV"Q8D64""%N^]S]I.'@!XWJO M,)P/Z(^<^^.NOQ;\46!1D&G5CM]#/Q58W$Z'9>+?]M@G,*!$I%9 M8/<_PG'63^==1G?6"<)QG*HRC<3CR,^J)7@^7#S.Z?;$XUB2 MA38>AW^W&F;_>Y:\AK"T^#K^F?)DY'.9MN=GX>LD8;)`\3$X#V_F`3!)X=RQ M*R;/)I$C"Q2J)KIT#A%LY)MDQ42J*4`CBRSJ!?^3IY.DO4_)`X45FQ\6G[!? MV/V4&'K)8`AP\3CP*X)]I/O.Y,YWR&*M9D(9WZ4.N>I<^$BU'A=6`&P(SM_< ML299S"M\@2Q.ZY*.&/5#';OE8H`#@4BX:4[7/8`LOFOAD.N$]88)R\*_Z6B5 MU@&$"*Y(;IICC3NPQ8+=Q*]@:L+&?[(PHY?)FXKJ]<(`"D&`\J8YEOD!6Z!8 M`9=OC`69@A0TJZH!4`11#ILF7.\1;'%HX`A^D9A>TLE_2]"G.=`-5OGFC7B= M(P0;PAXQJ^ZQ7AV`(]C4V1)E2K<,+\)8NQ7+9U.8^FM' MRGH`%<$:WA6U:T`1!K.MF'S/Z(B$P>QK7--(K]E71GMI2I73?K4&P3D(5OFN M>H&Y![`%T0D\PDU>S'3VW4'4`(!'(,ZXHE^.&%NHGGQNFGX6G-]06OND::7) M7=4@.`?!M6'7T[W>`]A"`>NIVL[.`L%9"':3&SD_JNTE;`&'$DQ\W92Z/&:V M?(#7.<89JV]_S%P)N3IHL05-BHRG&_2>_SL/&0648'HVYE^ZSV!(Y=\M&0W5 M&;[-&P$G(!`FFB14HE!9>D32+=J3*E?MOXDS$@]"/LWJ5JK:N@`9@0C10B<0 M.T+"?6M:93W'.)M!P%D(=K;N>TT37I)TJ=:430FFZS`FL>]P<6+Y`'`>@MUS M(XN32L@EW:8UG11`^90&Q778!SJ:#J=W?>X8?JF"T4!Y7=2HOG>&(4%-DS1* M#\U,G2'I!RU^?[=D;A(/GB@;7M)G]5=WQ57`0PA.R-VSK<8O(;C%[Y4L^F81 MUWU7V)9>O5/FAZGFDR6:NE[GY._N!5WQ28AN M[R,M0@0]Z-&,C:&CZC[R;50?H".0*YJ@5@A,MO2N_^6@TN=E*HMFUZ9NX MG[!A,>08;`8-6P#X"`0%R^O"-M`DS+8F*LZ2$=V34+6@*Q<#(!AVY#9>EYU> MKH*2L--FB.(LJY26H*62``?!(7,C'`EP26AJ[P[P%!O/\P5_+F3!.!"LV2[# ME&<#R!DU&#?K-@T.0["WMI\HZV.6=)+C%E*1E`+E+FE&PJB5E"/SD/Q;@Y0C MZX6]H],69ZFI-=-/]NHRCPC+>T=.7P5E`A*9.V6#GM3\#Y6'Y-&G,8&=C6D. MDG)Y<(?+N!BK_",*OB1+1CDB9"E(9@;^C-,1]<-^2`-ME@MI'>CS3E4_^X0D MZ_Z7$*:&A"PG2>.D(5!_+V'1"SD$1&4W:Y/"!$H(%5G/[6 M@2#+"+*XY9BP7SP4/O&I,C6(N`)@0Z!F521)@`19XH^YJ=?\ZQ,O-"@^@&3" MTE(%P(;B,D\EE@1(D*7"F)M:?![)A)VB(&!!H!A69*6$`%G"BKF)ZB_5E8L! M#@2Z8$4FYO8WEF[B.6"%%:^&'Q?,*L7^2.IY_786]"F^:Z*J`R0AD M/C.7FV%!F_SA]N;Z;FJJD6RR*`[`$$AP%=^+-1S8$C@LWN`D]B?;;Z/Q:EX: M8"&X8%-UV%J!HYKA M2C?3M*:0/M#7)'KE^5*6+)=.4D;U`#&"*4O^WHBY,X#D5E;E-ZEN$Q(;4J&K M`B8C.%,P9<$,#39A]3%_3NGO'.;9*ZYE/<'S=&%`XAH`S^6Q@\L%A!(1-J%5 M8*P^J$16QSMW2II%))"*`F/6RJ"PI;EMG#=SC,AUI*ELH!)`1QB6N=74R%P')LR4V_@_.,2"B7`R@(X@Y-25BW MO+D4HL)=90]>Z(!/69))=ZT,6+5MYW$2#,UETE1[5KH2%93RNF[C:+3SJ,17 M"H>6#6\NRV2S+L4Q-=;QK6YJK)*R4>CC*_Y)])>Y!4I]25@6K&TQUDC:-=>] MK+"^N=2(XA,_RO=DADX6%^;?HF\QXL["S4K[FTL8*'9T^&[L9D%1;N1V]&6% M])9[W(9DB6E`93V_P4CLW4IP2`+5/;K2"Z9+I=_9HPEKQ-/N@`_Y*-+2.; M9,UXQVT._#7"2NU!8DNB)D(PRV+S0#)Z25.?A86]EF1+6O&..P@R[C7$M1(C MMC1J(@"3-'"A/TUB?L_"V`]')++D6M8,.`*!'-00V6J0V!*LB;OK`*BN21KPN6J;N2?#`R]["ZF MWQ-8YTG6L;;-`#8$!QH6!%4'V5SZM5H$/D$;$[-DXGR%E@#A=LV!M7"J&P*8%EO@V^IJ)+AZM%P"8$EYTM/;\.0.+4 MIB25E8#97O!*8I^FO0&`2[.K*"P^2#2_Y3O[0>+_BJT!TNW:Q]?&*F&U@GAC MPRI_=^V8XS6\\S:UWV;96>"1,-":H+*,[SO)^<;T. M2<(;*G5D2=X!^^/!9,:LHX25FO'.N]O)K3U(R9W.ID(5R@8]T>$H882-[UXI MFXX7,R,-5H.JZE[W;+NVS/;@)$2U)FPL@X755&_(OP9M/);.:P"\[=I-&^&1 MT-64\L&?2Z*HD#LGJN==WV#YKJO&3[ZV:^2S0"6AY*B%A#FWX>\\#/A5R3CX MEO!%5`(O/(OK)-&1C+_3!\V=*!UI5POR$^>F@@#GK#ULO#)B?(*R3.*4KOR$KA_(!<]L`+ER#8#--)>VH^OT6[X.9BTED,;RVV!,^M!U>ZI1 M.UE'P8`Q:6506Y`5IQYON&:VI@G47HIO30FW2];1/=DVL6/9=&PY;RKDB'#[ MF7A:;1 MV_/M;NXEOE(XM&QX^Z_69:_8\.=.7?OC$#UUP"FZU@$\>8Z9I6;:*7IB+4[EDR8&2H6%V52H!E M6[)[$QKN.&?.]'G*1B%I/0B23,8A_+BZ'EJCSJSB+8B!])B,*JLNZZ[WQB*X]0Y3R\A"^YG MECQ8L6%0E8-H,<#4@@]S,,UEVFGOEG/WH,7OF5I$^LF-;RX9C[N%YP/E?@CC M0=T4,?*&P!DMIV"KP:0IO.:2`8D3+[V/J)_18);4X";NQ7%.(OY[G,HB9C6U MN!-:_$RS932M&1AUFIZ-!G%?$<8[3'J;I.D]98\OA-'VOX+:BS-P>)1GX2M] MI#Z_W!72].K=CW+`>`WL7"3#49X1[HN[_@S$#,"M(DZ\Z4=XW?;4L4?_!2;8 M",:!FFATGVAM]D'@,I=OM/+KKLW2+AZ:77CK(X3DU_3&U[&X`8T>[/"I0(W+ M18-5_FP7G4[ MC#E:S29`50VF&X],&2K:9G!1J'C^LJ`V6DF/>,5M9X8.T)7 M(2);%&^`5EP+8[?\.EC;B@_H86CBJZ4!O>M?A_UD;LZ/))X.0=<)NP87IR\T M^)8D@33`Q+XE`(H@3XO9]%H+(K)[PG.[_X0E.'2Z-]6[N5Z8']\BN+M8<5FT M"D-Y05BXX/]CGS_AF:2T\,#_`U!+`P04````"`"@1G!'?,=@&'\J```.2`(` M%``<`&)D&UL550)``.\WTE6O-])5G5X"P`!!"4. M```$.0$``-5=ZV_<1I+_?L#]#WW.8F$#DBW9239V-KL8ZQ$()WL$2=F]0[!8 M<,@>B1<..2$Y>NSA_O?K!\DAV4]R.%VM+XD\4]535?VK?E97_?FO3ZL$/>"\ MB+/TIU?';X]>(9R&612G=S^]^N7V_/"'5^BO?_GW?_OS?QP>HI]QBO.@Q!%: M/*/3H`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`\-J:O`6-O]WV!Y)(,[@D'ZNPI M+A38$*B<0D*4L8\$1E&/)K]2(F``*,S:[G>M38=V]S(H%DS037%X%P1KVN?? MO<-)6=2?L.FHU?G5Q_\D"[T24_S-E^=Q2C8I<9!<945LF)2&L3N#RT"M^CAJ MV-!\B1I&5'-Z,3F-Z;@:=^-[#0"0JLE*10@',M4$M843^*RDMZX2'Q/,1!,@ MX20)BF*^O"FS\#?%+&7!`XQ'`)]Y.KZWS5<3S9Y3O>0 MMJ@5Z('`*\HMQ\0!JB@]`[-9_EKN@-%_\@7<"L#(,:Y%BSNHGP3%_2R-Z/_. M?M_$#T%"A"IFY4F0Y\]Q>O>W(-GHUG^6_,Y=P58O`5J$`05IA-@?+=8#%)2H MYD:,_0"QXVY8G]E%T3U)OA8N+_8B_0%:X+LX36E_D#4;_]6]JK2]2]J30I@` MSZ"*RV%MT.#0'^9&C`P.9_@PS#9$G&L<8B(:V5]]Q64U).LF>BV;^_E>KX4P M[5?D:$M_@`A'LQ#P8D`;JU3>4BK%)?6C($FR1WKECY99CJ)LLRB7FP0%-0LA M^E'UH M-5]77N*!W<&>UTZB.IXD(5&QO*&2/J;7)A_78W MY:A2&5,J[.Q\X1UF`!#[?C08A1"S%[&"T9VDU(!S65MFW936T'DVL]G(3R:X M9I679NEAN%9OX3@*^>!A6H=SD;9F3'7#Y?$4NSD!^RW5S3 MZP_]XE//!C#_:;40YP9.?H`8`YLC&A9_%JRCM5HW6N&M5O6^+@PWJTW"PM$C MO"8[OYC''5'R8)7E9?PO]@'D>#!Y?\(/#S:.)D[SME[FECLE/FRPTB MRME3F&SHTX>?LRQZC!.A9SNCI`T[P`K`2BMQ1JK9FB4SX42O&UY4,[_Q8D09 MJ>9E'/(-PEV.V=TXGW_AG6H(&,5)>"@2W3G9>9S&);Z,'W`D$5/C7B9&YXYE MU*2/-NLPG0IT;)NMZ($IO.O;N4C? MZ8?XASMWMY@W`>=&S<10?P7KBJ,%=(E7TW0$/>6T3I"L3FX4],[1J9*[CX3N MP>:6%!:ZPZ3WY>12BY4^L"V`X@[EEW&PB).XC'%!]E,LMO,^2R(R6]*]5?EL M$;!FWX1S7QB@G;C$;UC9]KG-C#BW-Z%N>U+SC]_\\/[X3S]6VL)[V5"L]AUO M'%!!?-$^7%3'!.EOYL#+%K%_T:.#-*F%3[9,'L21FN&D<1!/(DHOXQ3/ERI;>'=[B?(4H(7V(QDFA$:X7FHJ:+5&H$=4MFD4DB/A5 MP<`A8DEGT[X^Q0N+&$`IM7O\2F66PKBD,*9TVR'[2U!N\FH8]^`*!JZI=0/!8$_[=1_%>!<\T[-$^?K?/ M`!:Y*TBN#&^M*#V)9QHN_YI3PD-=#QI5<*T.,4X!GV]P=!,D0;Y=\>D!+V6` M`+Q<<@E@*"&J*?T!_##YPVQ%`]LT80B.0:\!C@3T1M0X#.\A9J0I$:H(P:N, M[&]P&>?L%O<4+\D*,OJ,4_)'28,,:G%;.R.-@TS1N/M0H2DL(@2@\$9;$;3= M=E'5,*I:9G$JK6.`5NO`(4?[L$[MUHM*^?KB`IYDX3BEQ?BG*I MQ--"X^VHFA'HFE2CB>*^M/(/V>&U#S>G@Q4**H4P?SKAS66J"6/R6U4[@$%> MZ0RZRO'B"L?RZF:_AW]64=)6LC,IF[=/B6FA"7MC8W]3X\-YMU6!C._@"-P2\WV<>0]R'6'B(QNZ\XPQBU!G7N;PX!L_,"=&Y,-&"8" M1&21V1I;K!S:S.K M^EXS#&P.4U]EJU5"DU!!))"0R2_(J5",L(SNH MT[E=%`79BD+.%D/E+[C\?WA[='2,UD&.'BC+CRC8E/=9'O^+D'QW<'1TA(K[ M@`C](YD4JS]1MBEI/22Z*(;W&`W6)'DC]$!S.X-DJ95[B*0@ M>86]Y!;^\+[M$`?HAX-OO_^V]@FN*IM2OC_X[KOOJK_>?_]!XC4T(>0-P?9; M].'H`+&"9Y3\%(?DDV/VR;?PGJ7"J&P"4@/4X=7U/&@HYIZ$$M23LPHHX]SK']S0TX@'S M:][+K*!/K^?+V^!)'V`PK"6(L(.!NNI@R6\K.VW400JO:3-O>*:1;$D/\+PX MA9]6_RIE7T?_A+##^^E(3$MB'<8#VIT'W^8X*#;YL]5&34;LW`^E$@NWHA51 M9[L&^P9BF-S59HULH\*L*`_0\<''HX]L#_7^X/W1^VK+!>\M:OST'<($'I=E MF_I/9368EQ$#%&J22"P6\VJ_=?[PL7[IC&9EF<>+34FCQLA,0C9-T/D@K?3A MD0V%Y`4WUKS@WEF!`14:K-3X'"0TS3IT\87=975;UDOEHF(]+[U_0@XK5N4I M/85_&C]N@./!X_AAV>+F#(_A+1X>#5VW-QC3)^$T8Z_ MQV4@M;_MP>;NWB MYT.QYO`HI:['`Q#A8"0L62>L]JR$=O;7N'\ MAF[1K:-"U`T`!XIH-#/&CA!>-,\1Y^:',(CP(]8`=/+UG96LSFB:J_2V*](Z M=?R0Q@.G'`95?5")'4ZAW)")4LR:B`9K]Q,9@=U.HHG1W3@/VC+YY&*#%*I< MJPHL"0P*P?F2"F]Z']*##=9WYML@GH'.T^'TPGNZNMBZS]P4_`?I/[8J=1W( MXWA&)>IL7$@).9`XQQ%K0"MNR&C(`0NC;H"DQTN_G=1[,8N^`<#4Q#OZMMQK MB39@K:?E@G0OBT51UZT\6^*-4L7?Q9T%NC2^XLNR3A")AVX/\8^:`]XW&MEM M_&+/`?ECG<*D0]'?3K?[E/&#V5'`#5\%2R*Q)/-:3&FTR74#)T@5@0SL+^#L-% M@@07U_@!IQM,BP,9*K_)R=V'B,BE%H(G*!FJZ`Y8E<1"4ZC3U3#OFED=1J4HD&T$(YBA+/+I4)1SI=,BILLT:^3>Y0`"X*^K.(:H"AI409& M@R@1]&K82N)LB>Z8Q,7^)+9\4#N5O&Z755(,BRLI#8`=%D3,LZ*XRK.E]JE= MA\I]6<2.C$+A0?HMXE]#1E+;2+G62.D2HY)>%ZHDJKK<84[0-Y,>H?M=25]283_""6J8`^]"+*4%W7WL)*/378<4I<)^0P-1A^L>G!(?3V9I M-(M6<1I3_R[C!VQV,2.G^_6141=A-<(YV"O&+H\??KF;1D&'!])W]Z^'TU6C MG<\(*\DA#N,R]TB!B0'NB5RG^`$GV9J>19K]W\`'D'%$KX>8;(335VF@&@X_ M/'\G;:(M!Z37[U<'MYE2+'Q$3))B[2"`>\DA>T@?]HY6>T;(\P\;B?E#T-P1&]3F-A@NDT-A^J.S&I<=_+P>`%NK>#;]%TT@FZRIQ:[/JLM6DEOL0Q0-4<1M-(<6[&$6A`;OK\!LZ/IP3 M37A.\`T9-^;-N/<9+[,SK_#!BO\RK6&Q_NQDD(*=L MMS;M3_T+;CJ_:F,X<%5YJ)<#/W4]X!%1JX&WJBUJ'*PD'$`#C4QVQ2!!B]:< MU=-C10VAZL\>XA9N>#7547<-RQU@]DK70Y1OFMBM_C:OR;N1TJEC\M' M.8.#NQNAON+2ZE"@1^=\-.K+*8NH["Y6_$N@:*,#[BX.8(=/&X'5^7_=#">[ MR>ARH)"Z6G]XT/B9NT&A7J'6[T8_!T4_M`VA*:?;<:A$N7V4>K=RWSY4E0 MW)\GV:--Y**>#2`#J58+,4=G_2YIOD24`3$.KUXIV72,F*S3ME><+N^H+&PE M'>'H\_,O!8XNTN;$?A:6\0,OX2S9;UM`<:H?@%A03F,9V8*#H;IN&BV>T6O: M.MFXO&G=:&Y_X4!QJ.9+6._>;-7R?G:V*#..!U'!TWJ19,DWN0NY+&_V/YN" MU_F\S:XQM6B#$\`QBPSE#?&3*LM)OTTI#9 M;M_>ZW#M7NTC<$2K!.&TD*;Q;J\I%0SNU^LJR865.B4\9)2H30K\$L-:?)I[ M@I6KJHGJZWMXK].C1]A:6$#''?)/\9H,?K$)[UTRYRCO2=D'1_MK6#SO+*A+ MW,KZOH]6=<=#+$O/LWRVRO(R_I<)L!H>P`6B*+^P,&E][HT=NT,-Q7)0U`"5!4@/1!^E8]?P8:Y\*&O@\ M<*6N'I8^U&+RS7=,^A@$AW46":C,7J)$%*1[7.5X'<31:54)HHI[G*6\Q/JL M*+!V\3:V00\&N[.\`0_<5Z&9I;MRUVQ=G'KII)8ZDM^-@$2?L,G343D[?H`<.:*GYT-U>U1Q/ M:<4;1*T6H4\7)[)"H^Z:\QW04Q:F:^=&=#O-UE_[DVEC-U^PWU3:.\)+B=S4 MC`>[-OS"(C4EGC%=A.8!8FEJ@!\536^=@5%,\"/%--XR;62F9R,'/1LH]AGS M/?@'?!E)AEMFX(C2_,#+C_G>W5;]F&^9<3P(BYS6BRQ'EIU;"]E MI;RW%?*+6QGO=47L[QY[-^NP/7:UK68!@L5+V54/](]IU[Z>C17G<1JDX1YW MU8-_P)>Q8[AE!HXAS0^\_%WU[K;J[ZIEQO%W5SW2BRQ'EIU0XTJ8.M.2'"'>VTDL2*\SX>&[LUUM6E"W?(,9-"SIR M?O`HZ%$JTA%ND>5Y]LBS\.0-[QN4I63MGV*J8JA1T7%LM#U")4'20^'ILL)+ M2Z`LO;O%^>H4+W3NIF8!J.NBE%XL(-)XT7R)*/$AI4:4'':?/$X)XAT)5:*D M2D1*)=Q60M%C22R"8@,DF'F(/:&>K]G\>/:$\S`NM/G?+'A!YQ^5/LJYARVF M^$/RB@TU?/[,.8/58E,JKBBI$Q5,Q6SM2?4):PSJ9AD+`#JL5TX6IK,THO^C M)\5SH=I*=W%T)L1]D>KA0/$VT"2V"[(DZ$= M]:7KO[C6*$[9F1"\\XV!JE"S?#1.'69PV:S7"55#*]U1?^UO>ZFFQO9W0S:-NW-\FH/MB%- M\8OON&.196,1KU)C3N4JLLW1='[BL(YL?A>D59JKDRPMLB2.^%HRC:YH9B.R MU*3_G"\K-8*D28INO0Z9P%(.OCH(6ZE@LN#Z35$G*;$'+`DADDL:+]@M"Z/T"! M93/AZ-E\@)9N=)1CRYNYP(TVP+YB'*;M(>8R)?JB'#0"JQ@`TJ0K)!?SD"]* M7X=7COAIKIBI7NVAOD`5>P$@[R^L4]('-J7 MPL7UJ(X$6!JWI;)9$W?IX1;#/;F5Z\8^S#S`EM;VRI6BVO``M5YO0IP&>9S- MGF+=&U(%/5QUUY[Y;S(9?@E+=8XC)0!F/K7\XE3':0]0BQK]RNE]0)&I+\2)S*HC`&:NRSC%%P3E M^L21(C'1PD5BCITL,! MI2>W9G%#*%%#ZLG)GD%Z"Y%!`"X#BQ+C:J1`5,O*\M]HRNTLQ(45SGL,@%6S M>I)KD$Y)>0IY1NP)UDT*,*GCE":B5$L-`G9S&!=E@_YQE MD17@>PQP@.]+K@%\38H8K2=X-\EO(S0(W*604<)=@Q<`N/^<9W;C>D4(!^]: M4@VL&0GD>[??QPQ(!(/M@V^K<@V>#/ M>)GE^+HJ`"F!I)G%&3@MI%=OPA@]X@SH6EOP,L/6)[1UIUJOQ[F M2Q`G,!?G\TH8JS.8-CG@*4Q':LW@?QDOL]IGH&O>6,E^2=;F`]W!H[E-@B;U M$9,*2FYC'B[2HLS9F&>Z/Y-2@\0ZB#+KKFLOF\0T+')@RUSX/L>9WD#-74WERLF3JBCR&[ M7H`%TB5.(YP;;]G,K%X`JZ>-)<#(!,[X/+I]L^TJ&\BI^\GA.]PAHY<7XY;5 MB.7K2&4_1ODS.G4E,8Y(W MY/=,49LJ#H`,<"K9Q61H-25BI(C2>K-P,_2!F/7,H@-@-YA?@J=XM5E]KA-_ MGP1K\DWY/'"SJ6[&BXVG1DOK36C5!FH:074KL%?Z4^B;3:`O]/[;A&2;O;@= MC&$]MDY`=QV4^!0781ZO91.YP5K*5KSP5[6.UN[:9$.D;:!6(_YYZT!M9-U(,##8"QU,U[XJD9+:V>MVT!5 M(^23NAG_W'6HPC)_':PPM,>:L&SCLG9`=N>SQLJD8.5'U<4XV1<>E"%42L@D MTQ8[=0EE?3%0V(J?EW&PH'X1XX*F=J(%(NZS),)Y0;/4&[9@)E:`J<&HC3@Z M-BP\ZU>+"7$N2(B/T(B#7Z?7'[_Y\/%'K7)N1WH["(JC^Q#\N1[1JQ?6QH&] MH0,:W[=RJH;YBL*;\5XM,4=^6#W1#[P:_GMXD,\"4C!`[_2[M4GFY3W.OV(= ML(C+^1,&V^^HI^5\Q1_ MR=+R7G%)-[P9IQ=W([2TC8WKGLM4=:-F)2)-(=86X!W?!&K?WF.$ETM,\X/C MII`'RJFR08D(&%%&-%U1=I3C=9:S2/\U:QDX@G\LMMOWA+L!>^]N>4O:X#^L M>N(SJB4OG;.KZZ[^R5KC'@KYRF8:Y2V\M&3Z,C\M7JJC2M`^QE>54-^[N][$ M3Y,X:ZL=+UVUK>>NCDK:>CENJE/J7E\B+Q2YSR3QUYY$PMM[`N+ M^*NQ4='2B7U&)H:(3@[G6/9F4"1Q.AWWI!/.&.NO$?D>O;^L/%-@=W9I3F(_7V1B[7[>%JL90S;S-?MQ\!.A!TUG@HJ0K M2UYS!N%:V6W.!NIT>6.ED%MI6:W5@-UM1^RW/7,2X$_MQ'0)/,Q1.87M,%EX0DBLJ#R-7P)2C+ME\^GB&G%T;=HZ]G2TAU.K&)6*US.LFT>(9O::MDMW)&VD5TA\-IG05Z.BOU@,7=K3%+T`&1W^IFO$D^DNI MY=C'3_P8D#<##_,Q73OX_9.R7UTFD^Q&HEVDE5NQ5Y0Q&1:M:@';-P*0>'*` MAF(Z2B%"D2;!;UI`51/&4I8[JVF=*7P';4_NZ;U=01/F9XV&/"B81<0GV_CQ M3_`N.ARZ8C[+<;C=(:3D]TT,Y/.8#&6H MV)#.#\A"DHS<4;99E"A89!ORWQ01,$@:N,O8 MT3#%9)[R2TU$AY`L9;4T^44FE:&,5V3RN,,I&5>2Y)F0/>,@1Q2X[,IS$23L MW+FXQV0W$)%5P1OPH"`5D*5NM$,I38,?*5+ZRHB`_$>1P+?M.\`Y>M46E7:YS09-Q704X$R8.TH-M>LKO[_-S^QA3`-:`1@*QT`S04;]T8"6(T_H2" M#>XT,4/=N!Z#`:;Q$%E&#`HTY2%R#U#>G"&KS:V##NP9LFRK?XVI1&2=L&N6 M+EU#7IP&:36U/@]J6GDQN:O,/6QS)&3;O>[0?!;D5)[B"N.R)&[,5FUK8?^NBRZP0X'.FVQA8\X$C2;3UE4#+NG"'!I-S> M#>P)EX7,>6&4^7)&]N)1G&SHHYL;'-)(E!@79T]ALHEP=$YT/\E6ZPT_4)@O M!4T,U6*F_B&`DND36TI7HZ;]$VC[&ZC^$7[8T?H9RB1U%T\*VNP'9V)E]_V! MS&'JEMUD__PL;\"PR]_KK[I/*[-7&PH/2!3NZLN)@@-$":ED7,'IQ?CEI45$ MY70_\=(\[E(3O3G9;'CI4^SGU'":V`,56()VMZ_!ROSLU,SJB7MTM+&$_0&B M7!X=+MIVE!U`5;WD.'Z'W9TFQ$-66%M=A(DR9SE6:9Y M__X>Y'F0:C.H[M0J3(3/:!M(0WYX:X@WQT?D`K4;I%?"IS7>SU@""':H27X% M53_#0F;J'_(@*@C`0@/-X3QZ:#?'D8833>$U+F/?'V=A2)]ITTC$/$O)GR'3 M@4I7Q8-=I&T:EOTY(6J9#X4G:1T@"GX*FXC!WH]HRX*Z[3+?:$7?=0CKQKTZ MFIX0.&(L^,2H>1'N9',V/DWS+\FA="?N4WB45R?T4Z)G0J<"/_>GDVE<-K*R M0+P[3*3#Q3;@SV(Z&MB.^Z=_`_44PK>W_!S^[190*S;2IXED5.<*CPG']ZS# M&!%\%R1?@K+$N2"ES>AOR>\^(L12+R$0A/*ABE$"6+\&YT&])X1]#.\Z=[B\ MVBR2./REK%YV-/E1#'

C;G*#1H(>YAZ^0XOMQ[V'1#'U?V?0`/)ZLE#@G&Z]H&V;84FX*7MM-*6QV59I>,"! MI-L^29#DU8;)V!7)!GV[1 M<\TO>+7`N68(Z%#!Y'UO9%1D?O=F#R&QJ#3[N\R<[OJ]J@AO[/D>G?.^[\O9 M[_WJ>_0KI_"@_Z66[2-`8U:'&"`+6RL,=.G<8Z`GIX`!_KU/&)!95L"`VJRC MI_";@&QGT@CGGX/T-V7'*BF=3N=R68557$V%*)D'?6PP7:7!RO-NKM#X?80KB.;<,#$O_5BQ2VQ M8N>T1V5"J!S?EQ9O")0"_F;:VYVV.%A:TG*9MXBU?K+`_RY_D#SJLJ M!'7:`P4,[-G!BB0:M#+41FRX$66O:V3`\J8:]>SG=NR&PMO$&+$J7V;G(4N MT$_."ON[`]#?,9TV<#0CF`[N\-<-G37F2_[*8;XI:4K%B.:Q"8HXU,!J8#O. MP394SSX$:WY4-8!X"ZQ>`W\GTVKD`+%F8-\'[:HQ^QP]UGH'O)D"%5S=;-L" M>AVGU<=OX/UQ%*+[7KH#G,%]ESUAPY$@ZW#O5;?DB_]J=-W1@ZN6O?3A`5I7 MI((?OU0W-H';TI'MD#W^3!O3VV[+3;**V.W)MDIBX7";$WJW3]:;O'/$;6'O M\3T?/UGWNY34;:_+I17ZG)+YU^,:4W?ZVVCGT;W]-;;V+Q1."`#S(+E((_ST MGUAV.*JA!0"#**\"#14A8I2(D/J`!X6U14!H3;U?1)S'"#SU* M`#3T955@@9&AFLX'($B-+,)`8^%]@:`.T(^+,$C^&P?Y61HIJB7KR9W"02.U M\%JY?I;":!$E1H0:N#ZRC>G;^+"S^[Y`M()!Y;5UXA^#XL"F1W;_:TV MXKYZMMG7GB>!:ICHT3CMV[Y\ZNA)2@#;NU);MKM78\A]>RZO'ZM?'2IH07RY M+Z_2J3FA)VM"K;5ECJXQ];X1P1>C7(!S\IDL`--`#X(,F=Q*=%3;A@HDC-P/ MA"BM+T.)P?1ND$*W+?8X:5$#HJ0MLPDC;&OI'4($JZOQH3#YZ*N(6_L+1SFI MTZL(A;3"7M++JT:=J=M7$68[NXL5N:65;#?YA%QJL],,KC$`9_\S@:8W#$D?;.NZS--T$"?T\+51% MA(U<;I\>&'403D$5^>!Q1!L M[7N5=Y$NLWS%.NM2\R;+S`*RWE-(KUSTM>@]>9IEVQ>R!:"Y(_9[]JQ\@"N2 M`)PG*Y_>5B?'\.]N5984SX(G?7';5'37.;R*T/'#*HFDXA.JBL@3C]:;N/LH M2&_?7=]4:Q_(]V@@WE4K/;1Y60WNHDIK2EY73^JDMX_9^IXL#DZRHLQQM&%U M[ZL?TF_*+1C=;M%M-!&V-(_9(>-"(6$[;/C0NH:&'SMXZU[J[.<'=M%X$-W' M>715_]3U(!A9L;H%DITV`I0H&]J""7D+I@&]U8'3X*X:OYE.ACQ(4%*[W3PK M9186AHFG;Q(,9N]L+FUL/KK_Z8/3($G8'5;P3/\W7VZO-['J-,7,YA01%EJ( M&;L;%E3QT&?[K7MH#'F@,D*C:[PFTF":&Y2^L`^:1_I!H],28[0.XH@>NCQB M_%OR3/[:VF$1%#%T-F1;0+9=Q`Z-1!.N&5F<_T;^3?Y%_B`Z8Z;J_P-02P,$ M%`````@`H$9P1VMK*6^U'0``=\L!`!0`'`!B9'(M,C`Q-3`Y,S!?<')E+GAM M;%54"0`#O-])5KS?259U>`L``00E#@``!#D!``#M75MSX[AR?D]5_H,SY]EC MRY>Q-;6;4_)MRA7/2&5[LTFE4BR:A"1D*%(+4KZ<5/Y[&M3%E(2K"!DM[CZM M5P.`_?77N#4:C5_^_CI*]IX)RVF6_OJI]?GPTQY)HRRFZ>#73[\]WNR??]K[ M^[_^\S_]\B_[^WO?2$I86)!X[^EM[RHLPD<61C_S>?V]UN?6Y_8>_^-T_T?V MO']TV#K=^Z_6X=>C\Z_'A_^]][^][_^W=_WPN+>_]_+R\CF&%HJRA<]1-MK; MW^??26CZ\RG,R1X(EN:_?AH6Q?CKP0$O__K$DL\9&QP<'1X>'\P+?IJ6_/J: MTZ72+\?SLJV#__A^]Q`-R2CA>7HLW(ZK7:K?;!^6_0M&\_&W(2/_73T\Q*[5\V#X^Y-7_=I5%DQ%)BTX:7Z<%+=YNTW[& M1J70G_9XL[_=WRY)_Y1D:4Q8D:6#">%$'/!2!^J&#D#,>H+^("^=*,HFT'8Z MZ+$LA3\CPK^86\FI;*>^F+?I,S25,4KLQ%JJ5U^,*_)4V-%75JC_X3LR"!-0 M:T0('Q/LE+!>N;Y`#Y.GG/PQ`>5>/UL;RWIEIQ;Rï]O)O+8#TN@?$QI# MGX7.^RT#S5]FT"=8>D6*D";Y(WDM)F%B1Z5AD_6%OPY9RHWE+LOS'F$/PY"1 M&H*;-.?4"&:-;VH%B^K;$&H3!2I:J2_B)?]DFI,8_LBSA,9\=7$1)GR*?A@2 M8MF_39IS,QC74*BH^D=HL@>6GQ9#4M#(4F+KMIW`67SI`9:)TQF]V^^.^0H4 MUB#6AJ%M;DL<5#]W&>;#FR1[<6#5DF9=@!B-PY2/\Q=A3J'U'B,Y?,=^":EI M:7OSG).9;5MS6>W9JR+8N*+0.Y!C24(86PBT&<]EY`W67OF7VQ/X&!:-3AZUX^IG#.=E+NTG$2?!]GS M04PH[-9:)_P/#N)D_[`UVZ/]#7Y:R%(1H5S`"417%0^.E\2M$MIARZ*'+)HW M#G^NL;F\QYR5.!B7`_-^-*3)PA#Z+!O9*W4F2F:&:9*#=-F8_\8GA(R!H?WZ MJ?5I#Q#V"6,DOILJ2(J@%+_4XL<06FY6IAKHO-)'3FDT$=#^NL MB1&(^3I"S-<4PE4V"FDJ(:M:A.,\]\V46/?K'`D$%Q-TC)@@@5G"'$5N8=DB MZUVJ*L&);_;L^ID.BYC0$\2$3JWRG@PHGQ72XD!L]98F$PZ4R'.G1[A$GPB!FJXV8K=E4D(U&6?I0 M9-'/TJF2=R<%/QGF`-7SH:(BUXG7_7RMR5$/3+*I/T3,]EP;C]"L9M/!B_`E MP0XR*(`@X0JS!Z8#$&(.XR8)99UPJ0R'BG%7J&%+A$%"%V8'S!QXCS":Q>HE MC+`LAWZZ>_2IL$AHW`4WS70]-@5U`[_I?#1KY;D*,/I"#>F4X9%0BME1LPR) M+['-"5V4YO"_[#J=JV@D9-9QV8!B#E;/X;9Z/J>*>+,ZGJN:5C_,GTJ,DWQ_ M$(9C;E^G!R0I\ODOY4E>Q=!F/P<*<3II?#D,TP');]-J&9I&=)R07''B;L M*>5,99>^A"91"A3>\15PA:9\>^.LZR1"9]1E(#0'CU`IBH6-Q3E(": MTTG6[@%XZ##Y%;]R*H=6#"<^NI>I=*_AT5!V)JD)IW- MJ#X`]+I'K,&*N$=:H&[`.G#M/HR'CKDJ@T$?E%4)VL?GOKK;JDPF74Q:!X!X M#;(P4[2X!VE`-:#7K-_9:L0>ZNCXT%OGB88DGB2DVU\(.(L2*!5LU)<,FP"8 M7J-?C)F0]"XKF`WH;(87#^O?2WC_D/H2PEJYH'VX@7]1+8/L*L%Z(?BZ]RL$ M$I4L6[!,=#PW!38?O^Y)PN]D]4(&T%B8YJ`#?JGLXJWZ+Y)K!?:-@.*\;GAE M5(J'+%M<>*XBN#$(Z14%>6%0A->#\4VITQM`%1^>*PTUW`H@)2UNPH@F\HM# M\L*@"*_[9[N>+),?SU4&5T1J^ZRH>-`^]1K5J:/)A-0J$CS7&^H,Q,]9\LR7 MC4LPOY/1$V'*,5E1#]2#XLA43IUL(-:"PG,9PIDKA@=%:@9F20U0B=>]HMWH MK`2!YY*$4UZUX[2T#J@%Q1)+R9HQT55,>"Y0U!BV>3B&;K\T+P.P=VD[M"PV MG@L4-=G23ZGOI0`ZB@"'%2X4A%7E]GP-0N@Y6L242SK-6AF`XC58UZS32,3V M?+E!S8!T3A*4"MI?O&X9)/I5D%"5&]&EA1KGY#0EW;[5/EY6!;2R0^M%-0I$ M-QG<(D(#'EVP\#'-RF>4% M?']2^N)GPDM7WV85.6KO4Y>(AW6VC,%(*/PHGX>8PB%E<6\N_KT5B095.7+O MZTE#&LWA2(C\*(^&^J3^3I'22ER07Z;W&MUE/B])A9=0LEMNB^HRR'`E"(K" MLVM>)46_V)N*+SE@]Y'&P>W2_I[P(8>F@XN,L>R%'W2$8_BW0I0>:;.&0(-> M/5N$T[:3H)$_Y[FLNBI32UN.;PG,"K M"36'(Z&OCF/FPP/_#!+W>PB[G4LUE\@@YE96)6BO)"_Q$G#;20LPO612T&?R M0*()HP4E^?5KE$R`M!NP4Y[&>S(EM]M?!2,+5-S.AT!E**Z;J"F5G-IM01-- MB)VLJ8V+-W$#&A?N%K\*U*`XW-J&P8E->^O*;$)(J!@CSR:K]47KJH*24%P7 MVKH=V)C?JGJ:$&U:4\$J7X7K3X#2O>Z4=VX47-%<$V)J;U/8I/!#XS"999,)]E666B-5H.VWX2YVS$5L3G65I/[ M\%^?-S7G[ZHUXJKF\:G_=#?5:X&;K/K7"X,B<-V3-^V_,BC-6%#/L-V'+]_!Y!D-$R-:J^5! M'2BNJ4&[*X0%#W:EI[RF%*!CS]PX8L"D-! M%K+^>YA,R`7I9XS<@X[9,Y'%X:FJ`%P4OFHSPLS0N+JDAFHTO;N]Z2)POWN,W'+OA6\?>^+;B]LY.^7IZDZ>$1K\5/%Z7 M\JGV;V@_JR[GYD\<9TSGX]NP)=`*5D=1 MR=?ZCG5CD$W(0O?NV6:T@,'J1362KQ?F]R!Q3=Q*NK5`W">9^_"MS27_-AH1X>DMA?@[.^U@*LM`PZ64Y+:+5.<(XCYDC` ME894,9(F;&JJR/19==<*!^?((HS$3(GIE<%IP@YEH1"3'75HN&!RA\"9(B!&S*$#0H."A*;K99LJ8SY7RP=D9B@%70)6* M4R&*!@4-78;YD+]'!_^Y_F-"G\.$\/>XBLN0L3>:#LIS8-7,:E(_.$+A5%`P M*IEGC<$U*,1H]E)U?D\B`I!A^OI!BDOM\:FJ6H#C,4=K_K68'$4C8:!]DWBD M(Q31+=:TKF%PE"L;`XT]1L8AC6=I6V#PZA9#PI94I#KLT=<.CE#$NUB3;@JM M2?%-IK0O:P''X;W]8+T&PE4V;TS!HAM',J&X=&.\^)9!0+31)EK]97#W`K!.<8.*ML$8P67L+RP3$BYXUVC9W6I=2NLIO[W_W/A(VNR)/!F9.@='""K0_;4"O!XRKM M.@:&YV=JO?"-'ZB9'RPN5PA.4'BZ-N-9`4E"]4XZO``FFY#X(4Q"]JX@-=6" M"L$)"J?6QE3+($FHWDF?5H^D.:=C=JS6*]_0*N@T4>@5Z<.<%5^0%/XHN*]W MKH>*3E4>[]J-!R)SA!X6ZK M-;Y(4$DXWV%GW!3NNJZT7CE9Q>`$A7MN,_8-H$E,8">==E:TB_2!(EYITVV? M$(Z$WEWT\E4V/T;>=G&%X`2%Q]:%$T>.3\+Z3GKQKF8"P^1549J1!>BJ!B3ZC[57KP#)/$>E9Z,1+49EM'7*K\(6-!V0-%+O$Q2U@E-L'K]- M+4$'4F($.^D-W.BH1Z'54VR^P4V-0(-18@,[Z2_LS24N,>NNHPA*!Z$7W(A8(18)J]8.0?^L=N*83F'T0AK? MII?AF+Z_%\11JQPUVLK!*0IWWD;,&Z*3V,).>NON>8[&E,3SYZ8Z430939*P M?&ZX3R/EN:V^OLU&C0V@2HQF)SU_C_Q1\@E[,UHHK!<.3E%X_C:B M7H)&PJZYXP]1HN9UO5CM[P(N9K=;(V@SP)&5R6V\ MGARI)">,O7O/=_IN[M#VG[>[E,(F9;>X`K#J+5LWE^@V!3DF)MGK!*5!>!1= M2*5:F4-<`J8)R>ON*B&>-V'$1P9=>FY9E>#D$(7G6\J7;$!4P6E"_CH1PCL^ MG#)M-CM=55`2$D>WBD1SXM>Q^4UT)TS;_!#R2XP@QT68_OQ.1D^$"2B4E`S: M6`+43+2_S)P24A/RV%F-PT)K1W$`83D"RX`T(6WV,C9]]E!!<5`&BM,'&4TF MI%:1N$^=[% MJ2&#NBJ`$\79@"EY9G@<99WSVE2\&F#H5G884,!6-5N5TEC_/*V??PE8XF(RUK2^4`/XH] MZ!HE8N8$LKM*!.>7.YJ:<53U,E&I[G12%_*Z2G#D]6R!\ZV#(C;APT#H\Q--AU.PH$;A*:^:4'_IJ MS(Z@*$>V*SU'(;^KU&(NF?E!C?N-J"@@:WF=]2V845N\OI0B"QF6XDI?F+K+O"CQJ"J^1;7G>>R[N&.X.G]20U0(HVE$QZ$JL;U-,Z!$%.Y.1Z:BAMFD_%SBCA+QVTO02:;_+>^NJ1^Y ML&DF.,<8W%QC6%'!=)7("\TJQ=`(`'T3YHXI#%?INESN]W0SW'0(ZQ3=E'S/ M8)LDV0C:-@,*07$F:<'KYC!=)>SRP?LCM#'%(CLHVZ`E4,NN3?.UD+K*S>7# M`![HJQ/Z%^V`2E#$U&Z)_!67,]8:(K@RN%@$@**Y86Q*V#L%59BR7 M7*Q$:G?BYS"-2-X9A!2@7B>T?!EM\2+F_`<);1NV!NK9-5].;;2NLFA]@#'P MX<6.<%XC./=[>N66U'=$KA)E(7+)?P^+">-W`\1$ZRL%YSC2(&VP3=*!,!?U`"=[)KSQ`A1[:Q6 M6^C%7-@P24KW_=2+W^T;[)]TU7AXP:X-SQ:X7&6PJC#YX8F*+OFO:4YXFNT\ M2VC,,Z5=A`D?G1Z&A/`7O+B&AZ2@D6T6(Z&MR1M7)"@RJQA\:?D:]A;/F>I2 M%"T7#+YX'>,LU"H>Z01HFI"=:`'K,@GSO-LOTY7I+N_*Z@3G7U"L701<:4@5 M(VE":J(J,GURC+7"H`@4:Q,-4V)Z97#\9AQRW'$7<[Q)CWU?$'Q!<6)CWU.7 M$30A)5$G2;*7"2OQW4F1\Z1]-!U8,E^I&>"X M#5";^E5(CE(L8>"^\K+(!E.`0>W`[TWLC6S`%):C3$S([,!BY%?4"OQ>]Z[+ MNQ".JW1,*`F_S?.)'=G3&L$9BBB">D17H+C*W8229+-I756-7TW=O16]`:)& MY']:>@YFBE3!LZ!T@..PV(I<&0Q76:'6>[*/LZ;%$=-"-WFWWQT35GXI]_%( MQO1IJ84\!J]D2&H$9\?>W9Z6IT]G*-Q=*GT:'3N=29U:?^YC)XS.;,Z5_;&3 M_"+A3A%<_]@)18?5,&5Q["2_.[!3O-8]=CK#M1@U[JG+")IP[/00)B2_Y\E2 M)N1;EL6Y^BJOJ'APAM57?"9-)"O%T:"SHLLL+[K]$MU#EJB=!$LE@S.L'F`Y MH2((#3KF^<:R/.^QK*^\8UTI%9QA]>#*.5P5W]%IC?\',V<;OG1P_3KFP8>Y MP:9+6BWH+4-8+SE$$5&["OQY7DTYCUC1D,V<'YRA<4INP+,;BZKP%T9ILZHV]@Z6G M";/OI8-S7+XIJW78"@Q7AR[^:9W?*-4/SRLE@_/=\V*((-1^F:,]I3(E`WYN MY9G,N97>@*(NLQ1,=P+6^WZ`=D'Z&2/3-I$;01K$= MW,!,Q%!4?'?4Z]#EL(XE,\#0R_" MG$9\/T.32:&,I]/4#-HHMG561)M`_#OA3P61N`/"A`/R8\)?!NCV MUT+,2CTH3,&J'?Z@RN[M%S:!Z.K-&,2F,NL9-M&9EBUQ7:)P';@P%PU(5T_9 MX(CX6\\N40W]NPSSX4V2O7B)_%L(4I'#X"1*52UHM?@<+A>=F"E)?(H$SE_1@'G0.L+E M[C#OJRL8FA`0"-M^/AWU6/9,805T\?8;+&=NT\7)02A%U^.C+42CD"8%HR[>/?F=T8)<92\J0UDO#`I! M<2_DHRU$IHDF1:J6JLH!B2`QHL)(5-5`22A\Y1]M+GJ=N`J$Q6`XJX^45M1V M&8YIH*.N!FE#LF[9E&&M0:T?4HK:('B/CD,97,R2S<--.&I=O M:W?RG"B7.YLU"(I%L;/:E@V9ZZ!V+"]JXRKAOL_O]L8D:@`4A\*5MRWCD6.N M'3&,VECF,W(O?./3,;\0&T5L`G+2\(F_3.-&P$%HG!# MN30'B3?34B<2HS)WBB-:M:UAOP6&T_+%>.WJ7EL7U(7"Y>3!A,2JD%B.N5<< MD>744^K6YCY0-`I/Q/9MSH6>)`:Y@XDM)-JXH6F81EM.^F%K_:*\GY4 MM\257[\2%M%<\XJAIF[0.OT3#BX*54@L9R=#K>LI=6MK(5`TBKM)V[Y0/5EI;QTI]4!H*QY0+LQ!"DUR;MO9[CTN;`S%9\:>P M"A2!4-NQ"OG3.M;1W%.KN$[]KHL?)N-Q4NHI3.890F[3?L9&4\(,,K>8M0#* M0^%2M+,+*W`2R]C1<.UI]LQ>2%5;HVHQ4`(.KYP-9[*(D558$FYW-4YZGD15 M2^]225`%BK`@)PP+D$E(WDFOZEPO/"DN_/E^H)'&@IW3%_V>Y6O^$@]UV6#,)U=RGS/ MC<=M*HVKLG7[,\+"Y#UMGLEK22[:#UI?6K[&!`%/(/H#':2T3R,>IC&-BP1+ M[@&X".SX$:SC`D3ZJ=!+G69!'2A\"PZY%0\?]97D*/\>@I'CCL(>*Z8%'SN^ M93R8%\94PBP'C:>8E89^V#X^+,TFY;W9V&YX+S=MN^7:AE4G4=<,&@? M>CU)4*AFV:Q5XKM/%/GA%CI/5\WO9\Y35ON8TE;39AO,4K(J0;OE;>)9E$]A3DHU_C]02P,$%`````@`H$9P1X=X M-_K>"```3$L``!``'`!B9'(M,C`Q-3`Y,S`N>'-D550)``.\WTE6O-])5G5X M"P`!!"4.```$.0$``.U;46\B.1)^7VG_@X^GV8<.(9GL3:)D5R0ALT@$4&#O M5EJM5J;;@#7&9FPW`9WNOU_9W0W=T&T:B#*,CI?$;5>5O_)GE^WNXO;7^82A M&9&*"GY7J9V=5Q#AO@@H']U5?N\_>9\JZ-=??OSA]A^>ASX33B36)$"#!7K$ M&OA:`!6TMG/EB@CS/]*/\,9E@I+$<$=W&$Z*FV"=WE;'6TYMJU>@-F.`! MD5KP44B,:M5T='Y]:<`S,B%21#'#)]5_D:8D:'E`05!-YR=3,(9&F# M5B,C_7IY)N0(1,YKU3^>6ST+.#'-*/^2D9X/)$OD+ZNF>8`52<1-:Z"7"FGA MJVK4N!1E#KM_M,!PVBAU"%.N-.;^"L0&Z-C%VO7U==6V)J*A\D883Y?"0ZP& M5C1NL`/GG=>\RUJBXHN0:[G(^JB(?S82LVK<:-0NU]1"*6$F%NG%K4;Q8U8Q M(#1?!QIRQ,G<'^?+FY8`AAQQ M($`OID3E4F-;BH+.H&6G%X",I7$-R&@<'Y=5['TI6`$$/C:(_,IPQQK M(1=/\+P<$,%Y.,DW$FA9-8BK(.2!%)'47^IM5XH5()@@=(LY%Q!E(#K99U,S MG5(^%/$C5)CY?6,`]T$=F<+O+\TM\<'Z]RC\T`2;.@\:7%.]:()=.;&]51"% M(7)*+!$D&`(RI)Q:K+7S&@3)1#U=!%,HLH52QFZKZQ9^_&'=?*A(T.&_V#*P MJ,":U36A(]:/1=RZJTYVU?0Q\T-6V&FL5LT0DC*Y/U,/II9#/U!0@M'`S.![ MS$P4[(T)T2KBJX2I]5\K/?AX;[>JKME_O0BO[,=/'7B>9M-"^)6HZU MZ@P[4W/F!#BK-;I-SDWFQTTR5Q3V^O#ON=$&^CI/J--MO-3[31`XD;?[&DVS M\X#5^(F)5U>@S9=WDWE5;F5F:7VH]WY#3ZW.OT^T;J-U,L5\`6>.>ZPHT-)- M^9\PZ1)QD_>S.=A0Y3.A0DD,>Y$QA.&08\TA,41I@R>^G'RUZ->0!G`V!#H^ M"[C#P_+RB8RI*FQUL_3/=9:6=BQ/UA**39WXB,66J3^8Z3-ZVE91UDW:UPST#?8A-H]CVBSLG&/-Q;^K^DP?TPFRPL9(ILBWM:M:*VEDU+@*9VT8JO`*R$U MXKGY<$7975$J74OXUI1#Q3QYB9YGJKS:A7=9.YNK8#7XNX!8^;@;B$1O#Q#Y MN7,ENT\43+]797MT)K\5=&P[S56L$J954N.M3.WDOR,1S04H1RTN>RL3>P') M2_`K@R2MESPEL&PTHJ* MWLK`7BC6$QK+8$AT3.'@_M=S'4L!2)1L:0\(FWF3=K/A9&1R([0LI+25QLK('@B=.<1E9DJB8PI[Q`QWEFNI M`5G7.I2G_`3=W9`(WMX;C#NU>?^=U]HJCJGQ;PLL('=N;WV@S`\;8+Y&IU*; MD7\#=92/FII,S(VJ@G`L=5?1,C1G5BL%QT0J@K[5"T(9I]IPRIAY;9W(JA"4 MJ0Y-ZVA\LO0V;)9W<'>^!CO?AZAN94M^+[QG( M![K?H_/OR_D4X`+7ZU`.[&_;"'F#^%2\;@\*4%F4!:Z\D)E@,_.9T(Y+/9B9 MKE1]A,UP-Q@=4<"SC'5)Q=%&Y;W]V6U\S'SYUO/9":UPT29?AX_EV)"#:!MV M\XK_G@G_R]J.J9/Z-UI]NWJ0PK75!;RQB-YA[`-],UZ8J1H.2+/`!^Q:#=UH MFN,1!-(G.A3+==06_,&^BS$_]WVBG*HQ"3X+$1P<]0^F9R_,VP)_?4[5MZ`O MH-"[^8%W,S_41[@*T/<@VF#S;>X>\R_'.GGLOD54S'0-&#`$`D"'UC-58]FE53`F.1>V,J@VZB_'*L#I9"610FV)'N MFX7`"M^Q*XT9,S5=O##_.L/OXSW6=N3&Y=MJ]+')>O\_4$L!`AX#%`````@` MH$9P1R_KK=%6/0``EH4"`!``&````````0```*2!`````&)D`L``00E#@``!#D!``!02P$"'@,4````"`"@1G!' M%.MU=#4)``"5?P``%``8```````!````I(&@/0``8F1R+3(P,34P.3,P7V-A M;"YX;6Q55`4``[S?259U>`L``00E#@``!#D!``!02P$"'@,4````"`"@1G!' M>S[I#K@:``#;C0$`%``8```````!````I($C1P``8F1R+3(P,34P.3,P7V1E M9BYX;6Q55`4``[S?259U>`L``00E#@``!#D!``!02P$"'@,4````"`"@1G!' M?,=@&'\J```.2`(`%``8```````!````I($I8@``8F1R+3(P,34P.3,P7VQA M8BYX;6Q55`4``[S?259U>`L``00E#@``!#D!``!02P$"'@,4````"`"@1G!' M:VLI;[4=``!WRP$`%``8```````!````I('VC```8F1R+3(P,34P.3,P7W!R M92YX;6Q55`4``[S?259U>`L``00E#@``!#D!``!02P$"'@,4````"`"@1G!' MAW@W^MX(``!,2P``$``8```````!````I('YJ@``8F1R+3(P,34P.3,P+GAS M9%54!0`#O-])5G5X"P`!!"4.```$.0$``%!+!08`````!@`&`!0"```AM``` "```` ` end XML 35 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash Flows From Operating Activities:    
Net loss $ (4,635) $ (230)
Adjustments to reconcile net loss to cash provided by (used in) operating activities:    
Stock compensation expense 158 186
Depreciation 367 339
Amortization 634 735
Provision for inventory reserves 1,026 107
Provision for doubtful accounts. 15 0
Changes in operating assets and liabilities:    
Accounts receivable 239 560
Inventories 845 958
Prepaid and other current assets 367 (244)
Other assets (102) 24
Accounts payable, accrued compensation and other accrued expenses 730 272
Net cash provided by (used in) operating activities (356) 2,707
Cash Flows From Investing Activities:    
Capital expenditures (188) (508)
Additional licenses (448) (369)
Net cash used in investing activities (636) (877)
Cash Flows From Financing Activities:    
Net borrowings (repayments) on line of credit 1,270 (275)
Repayments of long-term debt (206) (204)
Proceeds from exercise of stock options 0 12
Net cash provided by (used in) financing activities 1,064 (467)
Net increase in cash 72 1,363
Cash, beginning of period 232 67
Cash, end of period 304 1,430
Supplemental Cash Flow Information:    
Cash paid for interest 221 190
Cash paid for income taxes $ 0 $ 0

XML 36 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814
Inventories
9 Months Ended
Sep. 30, 2015
Inventory Disclosure [Abstract]  
Inventory Disclosure [Text Block]
Note 5 – Inventories
 
Inventories net of reserves are summarized as follows:
 
 
 
September 30,
 
December 31,
 
 
 
2015
 
2014
 
Raw Materials
 
$
4,791
 
$
5,151
 
Work in process
 
 
2,233
 
 
3,045
 
Finished Goods
 
 
5,391
 
 
5,487
 
 
 
 
12,415
 
 
13,683
 
Less current inventory
 
 
(7,623)
 
 
(9,257)
 
 
 
 
4,792
 
 
4,426
 
Less reserve for slow moving and obsolete inventory
 
 
(3,401)
 
 
(2,798)
 
 
 
$
1,391
 
$
1,628
 
 
Inventories are stated at the lower of cost, determined by the first-in, first-out (“FIFO”) method, or market.
 
The Company periodically analyzes anticipated product sales based on historical results, current backlog and marketing plans. Based on these analyses, the Company anticipates that certain products will not be sold during the next twelve months. Inventories that are not anticipated to be sold in the next twelve months, have been classified as non-current.
 
Approximately 100% and 66% of the non-current inventories were comprised of finished goods at both September 30, 2015 and December 31, 2014, respectively. The Company has established a program to use interchangeable parts in its various product offerings and to modify certain of its finished goods to better match customer demands. In addition, the Company has instituted additional marketing programs to dispose of the slower moving inventories. During the three and nine months ended September 30, 2015, the Company increased the inventory reserve by $1,008 and $1,026, respectively.
 
The Company continually analyzes its slow-moving inventories. Based on historical and projected sales volumes and anticipated selling prices, the Company establishes reserves.
XML 37 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.0.814 html 48 121 1 false 13 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.blondertongue.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.blondertongue.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] Sheet http://www.blondertongue.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] Statements 3 false false R4.htm 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.blondertongue.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.blondertongue.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 106 - Disclosure - Company and Basis of Presentation Sheet http://www.blondertongue.com/role/CompanyAndBasisOfPresentation Company and Basis of Presentation Notes 6 false false R7.htm 107 - Disclosure - Liquidity and Going Concern Sheet http://www.blondertongue.com/role/LiquidityAndGoingConcern Liquidity and Going Concern Notes 7 false false R8.htm 108 - Disclosure - Earnings (loss) Per Share Sheet http://www.blondertongue.com/role/EarningsLossPerShare Earnings (loss) Per Share Notes 8 false false R9.htm 109 - Disclosure - New Accounting Pronouncements Sheet http://www.blondertongue.com/role/NewAccountingPronouncements New Accounting Pronouncements Notes 9 false false R10.htm 110 - Disclosure - Inventories Sheet http://www.blondertongue.com/role/Inventories Inventories Notes 10 false false R11.htm 111 - Disclosure - Debt Sheet http://www.blondertongue.com/role/Debt Debt Notes 11 false false R12.htm 112 - Disclosure - Legal Proceedings Sheet http://www.blondertongue.com/role/LegalProceedings Legal Proceedings Notes 12 false false R13.htm 113 - Disclosure - Subsequent Events Sheet http://www.blondertongue.com/role/SubsequentEvents Subsequent Events Notes 13 false false R14.htm 114 - Disclosure - Inventories (Tables) Sheet http://www.blondertongue.com/role/InventoriesTables Inventories (Tables) Tables http://www.blondertongue.com/role/Inventories 14 false false R15.htm 115 - Disclosure - Liquidity and Going Concern (Details Textual) Sheet http://www.blondertongue.com/role/LiquidityAndGoingConcernDetailsTextual Liquidity and Going Concern (Details Textual) Details http://www.blondertongue.com/role/LiquidityAndGoingConcern 15 false false R16.htm 116 - Disclosure - Earnings (loss) Per Share (Details Textual) Sheet http://www.blondertongue.com/role/EarningsLossPerShareDetailsTextual Earnings (loss) Per Share (Details Textual) Details http://www.blondertongue.com/role/EarningsLossPerShare 16 false false R17.htm 117 - Disclosure - Inventories (Details) Sheet http://www.blondertongue.com/role/InventoriesDetails Inventories (Details) Details http://www.blondertongue.com/role/InventoriesTables 17 false false R18.htm 118 - Disclosure - Inventories (Details Textual) Sheet http://www.blondertongue.com/role/InventoriesDetailsTextual Inventories (Details Textual) Details http://www.blondertongue.com/role/InventoriesTables 18 false false R19.htm 119 - Disclosure - Debt (Details Textual) Sheet http://www.blondertongue.com/role/DebtDetailsTextual Debt (Details Textual) Details http://www.blondertongue.com/role/Debt 19 false false All Reports Book All Reports In ''CONDENSED CONSOLIDATED BALANCE SHEETS'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS'', column(s) 1, 2 are contained in other reports, so were removed by flow through suppression. bdr-20150930.xml bdr-20150930_cal.xml bdr-20150930_def.xml bdr-20150930_lab.xml bdr-20150930_pre.xml bdr-20150930.xsd true true